Companies:
10,813
total market cap:
A$203.480 T
Sign In
๐บ๐ธ
EN
English
$ AUD
$
USD
๐บ๐ธ
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Alexandria Real Estate Equities
ARE
#2403
Rank
A$10.99 B
Marketcap
๐บ๐ธ
United States
Country
A$63.10
Share price
4.63%
Change (1 day)
-42.23%
Change (1 year)
๐ Real estate
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Dividends
Dividend yield
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Alexandria Real Estate Equities
Quarterly Reports (10-Q)
Submitted on 2026-04-27
Alexandria Real Estate Equities - 10-Q quarterly report FY
Text size:
Small
Medium
Large
0001035443
false
12/31
2026
Q1
http://fasb.org/us-gaap/2025#OtherAssets
http://fasb.org/us-gaap/2025#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
http://fasb.org/us-gaap/2025#RevenueFromContractWithCustomerIncludingAssessedTax
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
utr:sqft
are:property
xbrli:pure
are:directFinancingLease
are:landParcel
are:investment
utr:Rate
are:transfer
iso4217:CAD
are:segment
0001035443
2026-01-01
2026-03-31
0001035443
2026-04-15
0001035443
2026-03-31
0001035443
2025-12-31
0001035443
are:IncomefromrentalsMember
2026-01-01
2026-03-31
0001035443
are:IncomefromrentalsMember
2025-01-01
2025-03-31
0001035443
us-gaap:ProductAndServiceOtherMember
2026-01-01
2026-03-31
0001035443
us-gaap:ProductAndServiceOtherMember
2025-01-01
2025-03-31
0001035443
2025-01-01
2025-03-31
0001035443
us-gaap:CommonStockMember
2025-12-31
0001035443
us-gaap:AdditionalPaidInCapitalMember
2025-12-31
0001035443
us-gaap:RetainedEarningsMember
2025-12-31
0001035443
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-12-31
0001035443
us-gaap:NoncontrollingInterestMember
2025-12-31
0001035443
are:RedeemableNoncontrollingInterestsMember
2025-12-31
0001035443
us-gaap:RetainedEarningsMember
2026-01-01
2026-03-31
0001035443
us-gaap:NoncontrollingInterestMember
2026-01-01
2026-03-31
0001035443
are:RedeemableNoncontrollingInterestsMember
2026-01-01
2026-03-31
0001035443
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-01-01
2026-03-31
0001035443
us-gaap:AdditionalPaidInCapitalMember
2026-01-01
2026-03-31
0001035443
us-gaap:CommonStockMember
2026-01-01
2026-03-31
0001035443
us-gaap:CommonStockMember
2026-03-31
0001035443
us-gaap:AdditionalPaidInCapitalMember
2026-03-31
0001035443
us-gaap:RetainedEarningsMember
2026-03-31
0001035443
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-03-31
0001035443
us-gaap:NoncontrollingInterestMember
2026-03-31
0001035443
are:RedeemableNoncontrollingInterestsMember
2026-03-31
0001035443
us-gaap:CommonStockMember
2024-12-31
0001035443
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001035443
us-gaap:RetainedEarningsMember
2024-12-31
0001035443
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0001035443
us-gaap:NoncontrollingInterestMember
2024-12-31
0001035443
2024-12-31
0001035443
are:RedeemableNoncontrollingInterestsMember
2024-12-31
0001035443
us-gaap:RetainedEarningsMember
2025-01-01
2025-03-31
0001035443
us-gaap:NoncontrollingInterestMember
2025-01-01
2025-03-31
0001035443
are:RedeemableNoncontrollingInterestsMember
2025-01-01
2025-03-31
0001035443
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-03-31
0001035443
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-03-31
0001035443
us-gaap:CommonStockMember
2025-01-01
2025-03-31
0001035443
us-gaap:CommonStockMember
2025-03-31
0001035443
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0001035443
us-gaap:RetainedEarningsMember
2025-03-31
0001035443
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-31
0001035443
us-gaap:NoncontrollingInterestMember
2025-03-31
0001035443
2025-03-31
0001035443
are:RedeemableNoncontrollingInterestsMember
2025-03-31
0001035443
are:OperatingPropertiesMember
srt:NorthAmericaMember
2026-03-31
0001035443
are:ActiveDevelopmentRedevelopmentMember
srt:NorthAmericaMember
2026-03-31
0001035443
srt:MaximumMember
us-gaap:BuildingAndBuildingImprovementsMember
2026-03-31
0001035443
srt:MaximumMember
us-gaap:LandImprovementsMember
2026-03-31
0001035443
country:CA
2026-03-31
0001035443
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
are:IncomefromrentalsMember
2026-01-01
2026-03-31
0001035443
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
are:IncomefromrentalsMember
2025-01-01
2025-03-31
0001035443
srt:NorthAmericaMember
2026-03-31
0001035443
srt:NorthAmericaMember
2025-12-31
0001035443
us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember
2026-03-31
0001035443
us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember
2025-12-31
0001035443
are:OperatingPropertiesMember
us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember
2026-03-31
0001035443
us-gaap:LandMember
us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember
2026-03-31
0001035443
are:AlexandriaCenterForLifeScienceNewYorkCityMember
2026-03-31
0001035443
are:HHAndEDCLitigationMember
us-gaap:SubsequentEventMember
2026-04-10
2026-04-10
0001035443
are:HHAndEDCLitigationMember
us-gaap:SubsequentEventMember
2026-04-10
0001035443
are:A50And60BinneyStreetMember
are:AlexandriaMember
2026-03-31
0001035443
are:A75125BinneyStreetMember
are:AlexandriaMember
2026-03-31
0001035443
are:A100And225BinneyStreetAnd300ThirdStreetMember
are:AlexandriaMember
2026-03-31
0001035443
are:A15NeccoStreetMember
are:AlexandriaMember
2026-03-31
0001035443
are:AlexandriaCenterForScienceAndTechnologyMissionBayMember
are:AlexandriaMember
2026-03-31
0001035443
are:A211And213EastGrandAvenueMember
are:AlexandriaMember
2026-03-31
0001035443
are:A500ForbesBoulevardMember
are:AlexandriaMember
2026-03-31
0001035443
are:AlexandriaCenterForLifeScienceMillbraeMember
are:AlexandriaMember
2026-03-31
0001035443
are:A3215MerryfieldRowMember
are:AlexandriaMember
2026-03-31
0001035443
are:CampusPointByAlexandriaMember
are:AlexandriaMember
2026-03-31
0001035443
are:A5200IlluminaWayMember
are:AlexandriaMember
2026-03-31
0001035443
are:A9625TowneCentreDriveMember
are:AlexandriaMember
2026-03-31
0001035443
are:SDTechbyAlexandriaMember
are:AlexandriaMember
2026-03-31
0001035443
are:SummersRidgeScienceParkMember
are:AlexandriaMember
2026-03-31
0001035443
are:A1201And1208EastlakeAvenueEastMember
are:AlexandriaMember
2026-03-31
0001035443
are:A400DexterAvenueNorthMember
are:AlexandriaMember
2026-03-31
0001035443
are:A800MercerStreetMember
are:AlexandriaMember
2026-03-31
0001035443
are:A1655And1725ThirdStreetMember
2026-03-31
0001035443
are:A101WestDickmanStreetMember
2026-03-31
0001035443
are:A99CoolidgeAvenueMember
2025-07-31
0001035443
are:A99CoolidgeAvenueMember
2025-09-30
0001035443
are:A99CoolidgeAvenueMember
2026-01-01
2026-03-31
0001035443
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2026-03-31
0001035443
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2025-12-31
0001035443
are:A1655And1725ThirdStreetMember
2025-12-31
0001035443
are:A101WestDickmanStreetMember
2025-12-31
0001035443
are:OtherunconsolidatedrealestatejointventuresMember
2026-03-31
0001035443
are:OtherunconsolidatedrealestatejointventuresMember
2025-12-31
0001035443
are:A101WestDickmanStreetMember
2026-01-01
2026-03-31
0001035443
are:A1655And1725ThirdStreetMember
2026-01-01
2026-03-31
0001035443
us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember
2026-03-31
0001035443
are:PurchaseOptionTermOneMember
2026-01-01
2026-03-31
0001035443
are:PurchaseOptionTermTwoMember
2026-01-01
2026-03-31
0001035443
are:PurchaseOptionTermThreeMember
2026-01-01
2026-03-31
0001035443
2017-10-01
2017-10-01
0001035443
are:LandparcelssubjecttoleaseagreementthatcontainsapurchaseoptionMember
2026-01-01
2026-03-31
0001035443
are:A1201And1208EastlakeAvenueEastMember
2026-03-31
0001035443
are:A1208EastlakeAvenueEastMember
2026-03-31
0001035443
are:A1201EastlakeAvenueEastMember
2026-03-31
0001035443
are:A1208EastlakeAvenueEastMember
2026-01-01
2026-03-31
0001035443
are:A1201EastlakeAvenueEastMember
2026-01-01
2026-03-31
0001035443
are:OtherOperatingPropertiesMember
2026-03-31
0001035443
are:A30003018WesternAvenueMember
2026-01-01
2026-03-31
0001035443
are:GroundandOperatingLeasesMember
2026-03-31
0001035443
are:OperatingPropertyWithGroundLeaseMember
2026-03-31
0001035443
srt:MinimumMember
2026-01-01
2026-03-31
0001035443
srt:MaximumMember
2026-01-01
2026-03-31
0001035443
are:AlexandriaTechnologySquareMember
2025-01-01
2025-03-31
0001035443
are:DevelopmentEscrowsMember
2026-03-31
0001035443
are:DevelopmentEscrowsMember
2025-12-31
0001035443
are:SecurityDepositsMember
2026-03-31
0001035443
are:SecurityDepositsMember
2025-12-31
0001035443
are:OtherrestrictedcashMember
2026-03-31
0001035443
are:OtherrestrictedcashMember
2025-12-31
0001035443
are:LimitedpartnershipsMember
2026-01-01
2026-03-31
0001035443
are:InvestmentsinpubliclytradedcompaniesMember
2026-03-31
0001035443
are:LimitedpartnershipsMember
2026-03-31
0001035443
are:EntitieswithobservablepricechangeMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2026-03-31
0001035443
are:EntitieswithoutobservablepricechangesMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2026-03-31
0001035443
are:InvestmentsinpubliclytradedcompaniesMember
2025-12-31
0001035443
are:LimitedpartnershipsMember
2025-12-31
0001035443
are:EntitieswithobservablepricechangeMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2025-12-31
0001035443
are:EntitieswithoutobservablepricechangesMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2025-12-31
0001035443
us-gaap:EquityMethodInvestmentsMember
2026-01-01
2026-03-31
0001035443
are:EntitieswithobservablepricechangeMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2026-01-01
2026-03-31
0001035443
are:EntitieswithobservablepricechangeMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2025-01-01
2025-03-31
0001035443
are:EntitiesWithObservablePriceChangeMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2026-01-01
2026-03-31
0001035443
are:EntitiesWithObservablePriceChangeMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2025-01-01
2025-03-31
0001035443
are:TotalInvestmentsHeldMember
2026-01-01
2026-03-31
0001035443
are:TotalInvestmentsHeldMember
2025-01-01
2025-03-31
0001035443
are:SanDiegoMember
us-gaap:NotesReceivableMember
2026-01-01
2026-03-31
0001035443
are:SanDiegoMember
us-gaap:NotesReceivableMember
2026-03-31
0001035443
are:SanDiegoMember
us-gaap:NotesReceivableMember
2025-12-31
0001035443
are:GreaterBostonMember
us-gaap:NotesReceivableMember
2026-01-01
2026-03-31
0001035443
are:GreaterBostonMember
us-gaap:NotesReceivableMember
2026-03-31
0001035443
are:GreaterBostonMember
us-gaap:NotesReceivableMember
2025-12-31
0001035443
are:InvestmentsInPubliclyTradedCompaniesMember
2026-03-31
0001035443
are:InvestmentsInPubliclyTradedCompaniesMember
us-gaap:FairValueInputsLevel1Member
2026-03-31
0001035443
are:InvestmentsInPubliclyTradedCompaniesMember
us-gaap:FairValueInputsLevel2Member
2026-03-31
0001035443
are:InvestmentsInPubliclyTradedCompaniesMember
us-gaap:FairValueInputsLevel3Member
2026-03-31
0001035443
are:InvestmentsInPubliclyTradedCompaniesMember
2025-12-31
0001035443
are:InvestmentsInPubliclyTradedCompaniesMember
us-gaap:FairValueInputsLevel1Member
2025-12-31
0001035443
are:InvestmentsInPubliclyTradedCompaniesMember
us-gaap:FairValueInputsLevel2Member
2025-12-31
0001035443
are:InvestmentsInPubliclyTradedCompaniesMember
us-gaap:FairValueInputsLevel3Member
2025-12-31
0001035443
us-gaap:CurrencySwapMember
2026-03-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel1Member
2026-03-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel2Member
2026-03-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel3Member
2026-03-31
0001035443
us-gaap:CurrencySwapMember
2025-12-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel1Member
2025-12-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel2Member
2025-12-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel3Member
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel1Member
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel2Member
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel3Member
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel1Member
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel2Member
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel3Member
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
are:EntitieswithoutobservablepricechangesMember
us-gaap:FairValueMeasurementsNonrecurringMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2026-03-31
0001035443
us-gaap:FairValueMeasurementsNonrecurringMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
are:EntitieswithoutobservablepricechangesMember
us-gaap:FairValueInputsLevel1Member
2026-03-31
0001035443
us-gaap:FairValueMeasurementsNonrecurringMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
are:EntitieswithoutobservablepricechangesMember
us-gaap:FairValueInputsLevel2Member
2026-03-31
0001035443
us-gaap:FairValueMeasurementsNonrecurringMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
are:EntitieswithoutobservablepricechangesMember
us-gaap:FairValueInputsLevel3Member
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
are:EntitieswithoutobservablepricechangesMember
us-gaap:FairValueMeasurementsNonrecurringMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
2025-12-31
0001035443
us-gaap:FairValueMeasurementsNonrecurringMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
are:EntitieswithoutobservablepricechangesMember
us-gaap:FairValueInputsLevel1Member
2025-12-31
0001035443
us-gaap:FairValueMeasurementsNonrecurringMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
are:EntitieswithoutobservablepricechangesMember
us-gaap:FairValueInputsLevel2Member
2025-12-31
0001035443
us-gaap:FairValueMeasurementsNonrecurringMember
are:InvestmentsinprivatelyheldentitiesthatdonotreportNAVMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
are:EntitieswithoutobservablepricechangesMember
us-gaap:FairValueInputsLevel3Member
2025-12-31
0001035443
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2026-03-31
0001035443
us-gaap:CarryingReportedAmountFairValueDisclosureMember
are:A22BillionUnsecuredSeniorLineOfCreditMember
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel1Member
are:A22BillionUnsecuredSeniorLineOfCreditMember
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel2Member
are:A22BillionUnsecuredSeniorLineOfCreditMember
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel3Member
are:A22BillionUnsecuredSeniorLineOfCreditMember
2026-03-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
are:A22BillionUnsecuredSeniorLineOfCreditMember
2026-03-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2026-03-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel1Member
2026-03-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel2Member
2026-03-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel3Member
2026-03-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
2026-03-31
0001035443
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2025-12-31
0001035443
us-gaap:CarryingReportedAmountFairValueDisclosureMember
are:A22BillionUnsecuredSeniorLineOfCreditMember
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel1Member
are:A22BillionUnsecuredSeniorLineOfCreditMember
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel2Member
are:A22BillionUnsecuredSeniorLineOfCreditMember
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel3Member
are:A22BillionUnsecuredSeniorLineOfCreditMember
2025-12-31
0001035443
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
are:A22BillionUnsecuredSeniorLineOfCreditMember
2025-12-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2025-12-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel1Member
2025-12-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel2Member
2025-12-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:FairValueInputsLevel3Member
2025-12-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsNonrecurringMember
2025-12-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:LineOfCreditMember
2026-03-31
0001035443
us-gaap:CommercialPaperMember
us-gaap:LineOfCreditMember
2026-01-01
2026-03-31
0001035443
are:A3.80UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A3.80UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A3.95UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A3.95UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A3.95UnsecuredSeniorNotesPayableDuein2028Member
2026-03-31
0001035443
are:A3.95UnsecuredSeniorNotesPayableDuein2028Member
2026-01-01
2026-03-31
0001035443
are:UnsecuredSeniorNotesDueinJuly2029Member
2026-03-31
0001035443
are:UnsecuredSeniorNotesDueinJuly2029Member
2026-01-01
2026-03-31
0001035443
are:A2.75UnsecuredSeniorNotesPayableDue2029Member
2026-03-31
0001035443
are:A2.75UnsecuredSeniorNotesPayableDue2029Member
2026-01-01
2026-03-31
0001035443
are:A4.70UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A4.70UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A4.90UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A4.90UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A3.375UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A3.375UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A200UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A200UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A1875UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A1875UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A295UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A295UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A475UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A475UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A5.50UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A5.50UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A5.25UnsecuredSeniorNotesPayableDue2036Member
2026-03-31
0001035443
are:A5.25UnsecuredSeniorNotesPayableDue2036Member
2026-01-01
2026-03-31
0001035443
are:A5.25UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A5.25UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A4.85UnsecuredSeniorNotePayableMember
2026-03-31
0001035443
are:A4.85UnsecuredSeniorNotePayableMember
2026-01-01
2026-03-31
0001035443
are:A4.00UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A4.00UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A300UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A300UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A355UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A355UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A515UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A515UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A5.625UnsecuredSeniorNotesPayableMember
2026-03-31
0001035443
are:A5.625UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
us-gaap:UnsecuredDebtMember
2026-03-31
0001035443
are:A3.80UnsecuredSeniorNotesPayableMember
us-gaap:SubsequentEventMember
2026-04-01
2026-04-27
0001035443
us-gaap:SeniorNotesMember
2026-03-31
0001035443
us-gaap:SeniorNotesMember
2026-01-01
2026-03-31
0001035443
us-gaap:LineOfCreditMember
2026-03-31
0001035443
us-gaap:CommercialPaperMember
2026-03-31
0001035443
us-gaap:CommercialPaperMember
2026-01-01
2026-03-31
0001035443
are:A4.00UnsecuredSeniorNotes3.00UnsecuredSeniorNotesAnd3.55UnsecuredSeniorNotesMember
2026-02-10
0001035443
are:A4.00UnsecuredSeniorNotes3.00UnsecuredSeniorNotesAnd3.55UnsecuredSeniorNotesMember
2026-02-01
2026-02-28
0001035443
are:A5.25UnsecuredSeniorNotesPayableMember
2025-02-28
0001035443
us-gaap:CommercialPaperMember
are:A4.00UnsecuredSeniorNotes3.00UnsecuredSeniorNotesAnd3.55UnsecuredSeniorNotesMember
2026-02-01
2026-02-28
0001035443
are:A4.00UnsecuredSeniorNotes3.00UnsecuredSeniorNotesAnd3.55UnsecuredSeniorNotesMember
2026-01-01
2026-03-31
0001035443
are:A4.30UnsecuredSeniorNotesPayableMember
2026-01-01
2026-03-31
0001035443
are:A4.30UnsecuredSeniorNotesPayableMember
2025-12-31
0001035443
us-gaap:LineOfCreditMember
2026-01-01
2026-03-31
0001035443
us-gaap:LineOfCreditMember
2025-07-01
2025-09-30
0001035443
us-gaap:LineOfCreditMember
2025-01-01
2025-06-30
0001035443
us-gaap:CommercialPaperMember
srt:MinimumMember
2026-01-01
2026-03-31
0001035443
us-gaap:CommercialPaperMember
srt:MaximumMember
2026-01-01
2026-03-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2026-03-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2025-12-31
0001035443
us-gaap:CurrencySwapMember
us-gaap:NetInvestmentHedgingMember
2026-01-01
2026-03-31
0001035443
are:December2025SharesRepurchaseProgramMember
2026-03-31
0001035443
are:December2025SharesRepurchaseProgramMember
2026-01-01
2026-03-31
0001035443
are:ATMCommonStockOfferingProgramEstablishedFebruary2024Member
2024-02-15
0001035443
are:ATMCommonStockOfferingProgramEstablishedFebruary2024Member
2026-03-31
0001035443
us-gaap:CorporateMember
2026-01-01
2026-03-31
0001035443
us-gaap:CorporateAndOtherMember
2026-01-01
2026-03-31
0001035443
are:IncomeFromRentalsMember
us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
2026-01-01
2026-03-31
0001035443
are:IncomeFromRentalsMember
us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
2025-01-01
2025-03-31
0001035443
us-gaap:ProductAndServiceOtherMember
us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
2026-01-01
2026-03-31
0001035443
us-gaap:ProductAndServiceOtherMember
us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
2025-01-01
2025-03-31
0001035443
us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
2026-01-01
2026-03-31
0001035443
us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
2025-01-01
2025-03-31
0001035443
us-gaap:AllOtherSegmentsMember
2026-01-01
2026-03-31
0001035443
us-gaap:AllOtherSegmentsMember
2025-01-01
2025-03-31
0001035443
us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
2026-03-31
0001035443
us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
2025-12-31
0001035443
us-gaap:AllOtherSegmentsMember
2026-03-31
0001035443
us-gaap:AllOtherSegmentsMember
2025-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended
March 31, 2026
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission file number
1-12993
ALEXANDRIA REAL ESTATE EQUITIES, INC.
(Exact name of registrant as specified in its charter)
Maryland
95-4502084
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification Number)
26 North Euclid Avenue
,
Pasadena
,
California
91101
(Address of principal executive offices) (Zip code)
(
626
)
578-0777
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
ARE
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and
posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period
that the registrant was required to submit and post such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Smaller reporting company
☐
Accelerated filer
☐
Emerging growth company
☐
Non-accelerated filer
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
As of
April 15, 2026
,
174,269,480
shares of common stock, par value $0.01 per share, were outstanding.
i
TABLE OF CONTENTS
Page
PART I – FINANCIAL INFORMATION
Item 1.
FINANCIAL STATEMENTS (UNAUDITED)
Consolidated Balance Sheets as of
March 31, 2026
and
December 31, 2025
..........................................................
1
Consolidated Financial Statements for the
Three Months Ended March 31, 2026
and
2025
:
Consolidated Statements of Operations
...................................................................................................................
2
Consolidated Statements of Comprehensive Income
............................................................................................
3
Consolidated Statements of Changes in Stockholders’ Equity and Noncontrolling Interests
..........................
4
Consolidated Statements of Cash Flows
................................................................................................................
6
Notes to Consolidated Financial Statements
....................................................................................................................
8
Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
........................................................................................................................................................................
45
Item 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
.........................................................
116
Item 4.
CONTROLS AND PROCEDURES
.....................................................................................................................................
117
PART II – OTHER INFORMATION
Item 1.
LEGAL PROCEEDINGS
......................................................................................................................................................
118
Item 1A.
RISK FACTORS
....................................................................................................................................................................
118
Item 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
...................................................
118
Item 5.
OTHER INFORMATION
.......................................................................................................................................................
118
Item 6.
EXHIBITS
...............................................................................................................................................................................
119
SIGNATURES
.................................................................................................................................................................................................
120
ii
GLOSSARY
The following abbreviations or acronyms that may be used in this document
shall have the adjacent meanings set forth below:
ASU
Accounting Standards Update
ATM
At the Market
CAD
Canadian Dollar
CIP
Construction in Progress
EPS
Earnings per Share
FASB
Financial Accounting Standards Board
FFO
Funds From Operations
GAAP
U.S. Generally Accepted Accounting Principles
IRS
Internal Revenue Service
JV
Joint Venture
Nareit
National Association of Real Estate Investment Trusts
NAV
Net Asset Value
NYSE
New York Stock Exchange
REIT
Real Estate Investment Trust
RSF
Rentable Square Feet/Foot
SEC
Securities and Exchange Commission
SF
Square Feet/Foot
SoDo
South of Downtown submarket of Seattle
SOFR
Secured Overnight Financing Rate
U.S.
United States
USD
U.S. Dollar
VIE
Variable Interest Entity
1
PART I – FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
Alexandria Real Estate Equities, Inc.
Consolidated Balance Sheets
(In thousands)
March 31, 2026
December 31, 2025
(Unaudited)
Assets
Investments in real estate
$
28,830,116
$
28,689,996
Investments in unconsolidated real estate joint ventures
30,520
30,677
Cash and cash equivalents
418,720
549,062
Restricted cash
4,665
4,693
Tenant receivables
7,362
6,672
Deferred rent
1,200,047
1,179,403
Deferred leasing costs
456,405
458,311
Investments
1,536,419
1,501,249
Other assets
1,683,143
1,661,772
Total assets
$
34,167,397
$
34,081,835
Liabilities, Noncontrolling Interests, and Equity
Unsecured senior notes payable
$
11,166,009
$
12,047,394
Unsecured senior line of credit and commercial paper
1,353,986
353,161
Accounts payable, accrued expenses, and other liabilities
2,154,782
2,397,073
Dividends payable
128,880
127,771
Total liabilities
14,803,657
14,925,399
Commitments and contingencies
Redeemable noncontrolling interests
9,234
58,788
Alexandria Real Estate Equities, Inc.’s stockholders’ equity:
Common stock
1,707
1,705
Additional paid-in capital
15,763,321
15,497,760
Accumulated other comprehensive loss
(
30,936
)
(
29,395
)
Alexandria Real Estate Equities, Inc.’s stockholders’ equity
15,734,092
15,470,070
Noncontrolling interests
3,620,414
3,627,578
Total equity
19,354,506
19,097,648
Total liabilities, noncontrolling interests, and equity
$
34,167,397
$
34,081,835
The accompanying notes are an integral part of these consolidated financial statements.
2
Alexandria Real Estate Equities, Inc.
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended March 31,
2026
2025
Revenues:
Income from rentals
$
653,013
$
743,175
Other income
18,009
14,983
Total revenues
671,022
758,158
Expenses:
Rental operations
224,142
226,395
General and administrative
34,685
30,675
Interest
64,584
50,876
Depreciation and amortization
305,441
342,062
Impairment of real estate
5,499
32,154
Total expenses
634,351
682,162
Equity in losses of unconsolidated real estate joint ventures
(
147
)
(
507
)
Investment loss
(
4,582
)
(
49,992
)
Gain on early extinguishment of debt
366,435
—
Gain on sales of real estate
—
13,165
Net income
398,377
38,662
Net income attributable to noncontrolling interests
(
36,724
)
(
47,601
)
Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s stockholders
361,653
(
8,939
)
Net income attributable to unvested restricted stock awards
(
2,779
)
(
2,660
)
Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common stockholders
$
358,874
$
(
11,599
)
Net income (loss) per share attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders:
Basic
$
2.10
$
(
0.07
)
Diluted
$
2.10
$
(
0.07
)
The accompanying notes are an integral part of these consolidated financial statements.
3
Alexandria Real Estate Equities, Inc.
Consolidated Statements of Comprehensive Income
(In thousands)
(Unaudited)
Three Months Ended March 31,
2026
2025
Net income
$
398,377
$
38,662
Other comprehensive (loss) income
Change in foreign currency translation adjustments:
Unrealized foreign currency translation (losses) gains arising during the period
(
1,518
)
50
Reclassification of gains
(
23
)
—
Unrealized (losses) gains on foreign currency translation, net
(
1,541
)
50
Total other comprehensive (loss) income
(
1,541
)
50
Comprehensive income
396,836
38,712
Less: comprehensive income attributable to noncontrolling interests
(
36,724
)
(
47,601
)
Comprehensive income (loss) attributable to Alexandria Real Estate Equities, Inc.’s stockholders
$
360,112
$
(
8,889
)
The accompanying notes are an integral part of these consolidated financial statements.
4
Alexandria Real Estate Equities, Inc.
Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests
(Dollars in thousands)
(Unaudited)
Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity
Number of
Common
Shares
Common
Stock
Additional
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Noncontrolling
Interests
Total
Equity
Redeemable
Noncontrolling
Interests
Balance as of December 31, 2025
170,537,867
$
1,705
$
15,497,760
$
—
$
(
29,395
)
$
3,627,578
$
19,097,648
$
58,788
Net income
—
—
—
361,653
—
36,377
398,030
347
Total other comprehensive loss
—
—
—
—
(
1,541
)
—
(
1,541
)
—
Contributions from and sales of noncontrolling interests
—
—
7,079
—
—
16,377
23,456
—
Distributions to and redemption of noncontrolling interests
—
—
—
—
—
(
59,918
)
(
59,918
)
(
49,901
)
Issuance pursuant to stock plan
289,485
3
28,262
—
—
—
28,265
—
Taxes related to net settlement of equity awards
(
115,062
)
(
1
)
(
5,960
)
—
—
—
(
5,961
)
—
Dividends declared on common stock (
$
0.72
per share)
—
—
—
(
125,473
)
—
—
(
125,473
)
—
Reclassification of earnings in excess of distributions
—
—
236,180
(
236,180
)
—
—
—
—
Balance as of March 31, 2026
170,712,290
$
1,707
$
15,763,321
$
—
$
(
30,936
)
$
3,620,414
$
19,354,506
$
9,234
The accompanying notes are an integral part of these consolidated financial statements.
5
Alexandria Real Estate Equities, Inc.
Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests
(Dollars in thousands)
(Unaudited)
Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity
Number of
Common
Shares
Common
Stock
Additional
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Noncontrolling
Interests
Total
Equity
Redeemable
Noncontrolling
Interests
Balance as of December 31, 2024
172,203,443
$
1,722
$
17,933,572
$
—
$
(
46,252
)
$
4,489,447
$
22,378,489
$
19,972
Net (loss) income
—
—
—
(
8,939
)
—
47,331
38,392
270
Total other comprehensive income
—
—
—
—
50
—
50
—
Contributions from and sales of noncontrolling interests
—
—
54
—
—
54,354
54,408
—
Distributions to and redemption of noncontrolling interests
—
—
(
7,048
)
—
—
(
65,833
)
(
72,881
)
(
10,630
)
Issuance pursuant to stock plan
125,280
1
32,755
—
—
—
32,756
—
Taxes related to net settlement of equity awards
(
46,547
)
—
(
4,735
)
—
—
—
(
4,735
)
—
Repurchase of common stock
(
2,152,293
)
(
22
)
(
208,165
)
—
—
—
(
208,187
)
—
Dividends declared on common stock (
$
1.32
per share)
—
—
—
(
228,346
)
—
—
(
228,346
)
—
Reclassification of distributions and net loss
—
—
(
237,285
)
237,285
—
—
—
—
Balance as of March 31, 2025
170,129,883
$
1,701
$
17,509,148
$
—
$
(
46,202
)
$
4,525,299
$
21,989,946
$
9,612
The accompanying notes are an integral part of these consolidated financial statements.
6
Alexandria Real Estate Equities, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Three Months Ended March 31,
2026
2025
Operating Activities:
Net income
$
398,377
$
38,662
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
305,441
342,062
Impairment of real estate
5,499
32,154
Gain on sales of real estate
—
(
13,165
)
Gain on early extinguishment of debt
(
366,435
)
—
Equity in losses of unconsolidated real estate joint ventures
147
507
Distributions of earnings from unconsolidated real estate joint ventures
233
172
Amortization of loan fees
4,428
4,691
Amortization of debt discounts
320
349
Amortization of acquired above- and below-market leases
(
5,615
)
(
15,222
)
Deferred rent
(
17,862
)
(
22,023
)
Stock compensation expense
11,032
10,064
Investment loss
4,582
49,992
Changes in operating assets and liabilities:
Tenant receivables
(
693
)
(
467
)
Deferred leasing costs
(
20,121
)
(
26,645
)
Other assets
(
35,274
)
(
37,034
)
Accounts payable, accrued expenses, and other liabilities
(
87,435
)
(
156,148
)
Net cash provided by operating activities
196,624
207,949
Investing Activities:
Proceeds from sales of real estate
—
68,182
Additions to real estate
(
545,999
)
(
645,841
)
Change in escrow deposits
—
(
9,506
)
Investments in unconsolidated real estate joint ventures
(
297
)
(
10,994
)
Return of capital from unconsolidated real estate joint ventures
113
—
Additions to non-real estate investments
(
73,627
)
(
69,311
)
Sales of and distributions from non-real estate investments
35,000
12,691
Net cash used in investing activities
$
(
584,810
)
$
(
654,779
)
7
Alexandria Real Estate Equities, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Three Months Ended March 31,
2026
2025
Financing Activities:
Borrowings under secured note payable
$
—
$
824
Repayments of borrowings under secured notes payable
(
8,892
)
—
Proceeds from issuance of unsecured senior notes payable
747,592
548,532
Repayment of unsecured senior notes payable
(
1,252,203
)
—
Proceeds from issuances under commercial paper program
12,319,811
2,700,000
Repayments of borrowings under commercial paper program
(
11,318,040
)
(
2,400,000
)
Payments of loan fees
(
8,814
)
(
5,406
)
Taxes paid related to net settlement of equity awards
(
5,946
)
(
5,558
)
Repurchase of common stock
—
(
208,187
)
Dividends on common stock
(
123,752
)
(
229,987
)
Contributions from and sales of noncontrolling interests
18,065
54,409
Distributions to noncontrolling interests
(
60,111
)
(
66,034
)
Purchases and redemptions of noncontrolling interests
(
49,707
)
(
17,818
)
Net cash provided by financing activities
258,003
370,775
Effect of foreign exchange rate changes on cash and cash equivalents
(
187
)
(
38
)
Net decrease in cash, cash equivalents, and restricted cash
(
130,370
)
(
76,093
)
Cash, cash equivalents, and restricted cash as of the beginning of period
553,755
559,847
Cash, cash equivalents, and restricted cash as of the end of period
$
423,385
$
483,754
Supplemental Disclosure and Non-Cash Investing and Financing Activities:
Cash paid during the period for interest, net of interest capitalized
$
56,403
$
33,776
Accrued construction for current-period additions to real estate
$
137,633
$
147,045
Transfer of real estate assets and/or equipment from tenants
$
2,694
$
39,950
Notes receivable issued in connection with sales of real estate
$
—
$
91,000
Derecognition of net investment in real estate from sales-type lease
$
—
$
4,677
Acquisition of real estate and other assets in connection with assumption of related secured
notes payable of unconsolidated joint venture
$
8,892
$
—
The accompanying notes are an integral part of these consolidated financial statements.
8
Alexandria Real Estate Equities, Inc.
Notes to Consolidated Financial Statements
(Unaudited)
1.
ORGANIZATION AND BASIS OF PRESENTATION
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500
®
life science REIT, is the pioneer of the life science real estate
niche since its founding in 1994.
Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative
Megacampus™ ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area,
San Diego, Seattle, Maryland, Research Triangle, and New York City.
As of
March 31, 2026
, Alexandria has a
total market capitalization
o
f
$
20.44
billion
and an asset base that includes
35.8
million
RSF
of operating properties
and
3.4
million
RSF
of Class A/A+ properties
undergoing construction
. As used in this
quarterly report
on Form 10-Q, references to the “Company,” “Alexandria,” “ARE,” “we,” “us,”
and “our” refer to Alexandria Real Estate Equities, Inc. and its consolidated subsidiaries. The accompanying unaudited consolidated
financial statements include the accounts of Alexandria Real Estate Equities, Inc. and its consolidated subsidiaries. All significant
intercompany balances and transactions have been eliminated.
We have prepared the accompanying interim consolidated financial statements in accordance with GAAP and in conformity
with the rules and regulations of the SEC. In our opinion, these interim consolidated financial statements presented herein reflect all
adjustments, of a normal recurring nature, that are necessary to fairly present the interim consolidated financial statements. The results
of operations for the interim period are not necessarily indicative of the results that may be expected for the year ending
December 31,
2026
. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial
statements and the notes thereto included in our annual report on Form 10-K for the year ended
December 31, 2025
. Any references to
our total market capitalization, number or quality of buildings or tenants, quality of location, square footage, number of leases, or
occupancy percentage, and any amounts derived from these values in these notes to consolidated financial statements are outside the
scope of our independent registered public accounting firm’s procedures.
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Consolidation
On an ongoing basis, as circumstances indicate the need for reconsideration, we evaluate each legal entity that is not wholly
owned by us in accordance with the consolidation accounting guidance. Our evaluation considers all of our variable interests, including
equity ownership, as well as fees paid to us for our involvement in the management of each partially owned entity. To fall within the
scope of the consolidation guidance, an entity must meet both of the following criteria:
•
The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity
can be in the form of a partnership, limited liability company, or corporation, among others; and
•
We have a variable interest in the legal entity — i.e., variable interests that are contractual, such as equity ownership, or
other financial interests that change with changes in the fair value of the entity’s net assets.
If an entity does not meet both criteria above, we apply other accounting literature, such as the equity method of accounting. If
an entity does meet both criteria above, we evaluate such entity for consolidation under either the variable interest model if the legal
entity meets any of the characteristics below to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.
A legal entity is determined to be a VIE if it has any of the following three characteristics:
1)
The entity does not have sufficient equity to finance its activities without additional subordinated financial support;
2)
The entity is established with non-substantive voting rights (i.e., the entity deprives the majority economic interest
holder(s) of voting rights); or
3)
The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion
if they lack any of the following:
•
The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence
the entity’s economic performance, as evidenced by:
•
Substantive participating rights in day-to-day management of the entity’s activities; or
•
Substantive kick-out rights over the party responsible for significant decisions;
•
The obligation to absorb the entity’s expected losses; or
•
The right to receive the entity’s expected residual returns.
9
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
For an entity, including our real estate joint ventures, structured as a limited partnership or a limited liability company, our
evaluation of whether the equity holders (equity partners other than the general partner or the managing member of a joint venture) lack
the characteristics of a controlling financial interest includes the evaluation of whether the limited partners or non-managing members
(the noncontrolling equity holders) lack both substantive participating rights and substantive kick-out rights, defined as follows:
•
Participating rights provide the noncontrolling equity holders the ability to direct significant financial and operating
decisions made in the ordinary course of business that most significantly influence the entity’s economic performance.
•
Kick-out rights allow the noncontrolling equity holders to remove the general partner or managing member without cause.
If we conclude that any of the three characteristics of a VIE are met, including that the equity holders lack the characteristics of
a controlling financial interest because they lack both substantive participating rights and substantive kick-out rights, we conclude that
the entity is a VIE and evaluate it for consolidation under the variable interest model.
Variable interest model
If an entity is determined to be a VIE, we evaluate whether we are the primary beneficiary. The primary beneficiary analysis is
a qualitative analysis based on power and benefits. We consolidate a VIE if we have both power and benefits — that is, (i) we have the
power to direct the activities of a VIE that most significantly influence the VIE’s economic performance (power) and (ii) we have the
obligation to absorb losses of or the right to receive benefits from the VIE that could potentially be significant to the VIE (benefits). We
consolidate VIEs whenever we determine that we are the primary beneficiary. Refer to Note 4 – “Consolidated and unconsolidated real
estate joint ventures” and Note 7 – “Investments” to our unaudited consolidated financial statements for information on specific entities
that qualify as VIEs. If we have a variable interest in a VIE but are not the primary beneficiary, we account for our investment using the
equity method.
Voting model
If a legal entity fails to meet any of the three characteristics of a VIE (i.e., insufficiency of equity, existence of non-substantive
voting rights, or lack of a controlling financial interest), we then evaluate such entity under the voting model. Under the voting model, we
consolidate the entity if we determine that we, directly or indirectly, have greater than 50% of the voting shares (or own a majority of the
limited partnership’s kick-out rights through voting interests), and that other equity holders do not have substantive participating rights.
Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements for
information on specific joint ventures that qualify for evaluation under the voting model.
Noncontrolling interests in consolidated real estate joint ventures
Noncontrolling interests represent the third-party interests in consolidated real estate joint ventures in which we have a
controlling interest. Certain of our partners’ noncontrolling interests have the right to require us to redeem their ownership interests in
the respective entities. We classify the ownership interests in these entities as redeemable noncontrolling interests outside of total
equity in our consolidated balance sheets. Redeemable noncontrolling interests are adjusted for additional contributions and
distributions, the proportionate share of net earnings or losses, and other comprehensive income or loss. If the amount of a redeemable
noncontrolling interest is less than the maximum redemption value at the balance sheet date, such amount is adjusted to the maximum
redemption value. Subsequent declines in the redemption value are recognized only to the extent that previous increases have been
recognized.
Use of estimates
The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions
that affect the reported amounts of assets, liabilities, and equity; the disclosure of contingent assets and liabilities as of the date of the
consolidated financial statements; and the amounts of revenues and expenses during the reporting period. Actual results could
materially differ from those estimates.
10
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Investments in real estate
Evaluation of business combination or asset acquisition
We evaluate each acquisition of real estate or in-substance real estate (including equity interests in entities that predominantly
hold real estate assets) to determine whether the integrated set of assets and activities acquired meets the definition of a business and
needs to be accounted for as a business combination. An acquisition of an integrated set of assets and activities that does not meet the
definition of a business is accounted for as an asset acquisition. If either of the following criteria is met, the integrated set of assets and
activities acquired would not qualify as a business:
•
Substantially all of the fair value of the gross assets acquired is concentrated in either a single identifiable asset or a group
of similar identifiable assets; or
•
The integrated set of assets and activities is lacking, at a minimum, an input and a substantive process that together
significantly contribute to the ability to create outputs (i.e., revenue generated before and after the transaction).
An acquired process is considered substantive if:
•
The process includes an organized workforce (or includes an acquired contract that provides access to an organized
workforce) that is skilled, knowledgeable, and experienced in performing the process;
•
The process cannot be replaced without significant cost, effort, or delay; or
•
The process is considered unique or scarce.
Generally, our acquisitions of real estate or in-substance real estate do not meet the definition of a business because
substantially all of the fair value is concentrated in a single identifiable asset or group of similar identifiable assets (i.e., land, buildings,
and related intangible assets) or because the acquisition does not include a substantive process in the form of an acquired workforce or
an acquired contract that cannot be replaced without significant cost, effort, or delay. When evaluating acquired service or management
contracts, we consider the nature of the services performed, the terms of the contract relative to similar arm’s-length contracts, and the
availability of comparable vendors in evaluating whether the acquired contract constitutes a substantive process.
Recognition of real estate acquired
We evaluate each acquisition of real estate or in-substance real estate (including equity interests in entities that predominantly
hold real estate assets) to determine whether the integrated set of assets and activities acquired meets the definition of a business and
needs to be accounted for as a business combination. An acquisition of an integrated set of assets and activities that does not meet the
definition of a business is accounted for as an asset acquisition.
For acquisitions of real estate or in-substance real estate that are accounted for as business combinations, we allocate the
acquisition consideration (excluding acquisition costs) to the assets acquired, liabilities assumed, noncontrolling interests, and
previously existing ownership interests at fair value as of the acquisition date. Assets include intangible assets such as tenant
relationships, acquired in-place leases, and favorable intangibles associated with in-place leases in which we are the lessor. Liabilities
include unfavorable intangibles associated with in-place leases in which we are the lessor. In addition, for acquired in-place finance or
operating leases in which we are the lessee, acquisition consideration is allocated to lease liabilities and related right-of-use assets,
adjusted to reflect favorable or unfavorable terms of the lease when compared with market terms. Any excess (deficit) of the
consideration transferred relative to the fair value of the net assets acquired is accounted for as goodwill (bargain purchase gain).
Acquisition costs related to business combinations are expensed as incurred.
Generally, we expect that acquisitions of real estate or in-substance real estate will not meet the definition of a business
because substantially all of the fair value is concentrated in a single identifiable asset or group of similar identifiable assets (i.e., land,
buildings, and related intangible assets). The accounting model for asset acquisitions is similar to the accounting model for business
combinations, except that the acquisition consideration (including acquisition costs) is allocated to the individual assets acquired and
liabilities assumed on a relative fair value basis. Any excess (deficit) of the consideration transferred relative to the sum of the fair value
of the assets acquired and liabilities assumed is allocated to the individual assets and liabilities based on their relative fair values. As a
result, asset acquisitions do not result in the recognition of goodwill or a bargain purchase gain. Incremental and external direct
acquisition costs related to acquisitions of real estate or in-substance real estate (such as legal and other third-party services) are
capitalized.
We exercise judgment to determine the key assumptions used to allocate the purchase price of real estate acquired among its
components. The allocation of the consideration to the various components of properties acquired during the year can have an effect on
our net income due to the useful depreciable and amortizable lives applicable to each component and the recognition of the related
depreciation and amortization expense in our consolidated statements of operations. We apply judgment in utilizing available
comparable market information to assess relative fair value. We assess the relative fair values of tangible and intangible assets and
liabilities based on available comparable market information, including estimated replacement costs, rental rates, and recent market
transactions. In addition, we may use estimated cash flow projections that utilize appropriate discount and capitalization rates.
11
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Estimates of future cash flows are based on a number of factors, including the historical operating results, known and anticipated
trends, and market/economic conditions that may affect the property.
The value of tangible assets acquired is based upon our estimation of fair value on an “as if vacant” basis. The value of
acquired in-place leases includes the estimated costs during the hypothetical lease-up period and other costs that would have been
incurred in the execution of similar leases under the market conditions at the acquisition date of the acquired in-place lease. If there is a
bargain fixed-rate renewal option for the period beyond the noncancelable lease term of an in-place lease, we evaluate intangible
factors, such as the business conditions in the industry in which the lessee operates, the economic conditions in the area in which the
property is located, and the ability of the lessee to sublease the property during the renewal term, in order to determine the likelihood
that the lessee will renew. When we determine that there is reasonable assurance that such bargain purchase option will be exercised,
we consider the option in determining the intangible value of such lease and its related amortization period. We also recognize the
relative fair values of assets acquired, the liabilities assumed, and any noncontrolling interest in acquisitions of less than a 100%
interest when the acquisition constitutes a change in control of the acquired entity.
Depreciation and amortization
The values allocated to buildings and building improvements, land improvements, tenant improvements, and equipment are
depreciated on a straight-line basis. For buildings and building improvements, we depreciate using the shorter of the respective ground
lease terms or their estimated useful lives, not to exceed
40
years
. Land improvements are depreciated over their estimated useful
lives, not to exceed
20
years
. Tenant improvements are depreciated over their respective lease terms or estimated useful lives, and
equipment is depreciated over the shorter of the lease term or its estimated useful life. The values of the right-of-use assets are
amortized on a straight-line basis over the remaining terms of each related lease. The values of acquired in-place leases and
associated favorable intangibles (i.e., acquired above-market leases) are classified in other assets in our consolidated balance sheets
and are amortized over the remaining terms of the related leases as a reduction of income from rentals in our consolidated statements
of operations. The values of unfavorable intangibles (i.e., acquired below-market leases) associated with acquired in-place leases are
classified in accounts payable, accrued expenses, and other liabilities in our consolidated balance sheets and are amortized over the
remaining terms of the related leases as an increase in income from rentals in our consolidated statements of operations.
Capitalized project costs
We capitalize project costs, including pre-construction costs, interest, property taxes, insurance, and other costs directly
related and essential to the development, redevelopment, pre-construction, or construction of a project. Capitalization of development,
redevelopment, pre-construction, and construction costs is required while activities are ongoing to prepare an asset for its intended use.
Fluctuations in our development, redevelopment, pre-construction, and construction activities could result in significant changes to total
expenses and net income. Costs incurred after a project is substantially complete and ready for its intended use are expensed as
incurred. Should development, redevelopment, pre-construction, or construction activity cease, interest, property taxes, insurance, and
certain other costs would no longer be eligible for capitalization and would be expensed as incurred. Expenditures for repairs and
maintenance are expensed as incurred.
Real estate sales
A property is classified as held for sale when all of the following criteria for a plan of sale have been met: (i) management,
having the authority to approve the action, commits to a plan to sell the property; (ii) the property is available for immediate sale in its
present condition, subject only to terms that are usual and customary; (iii) an active program to locate a buyer and other actions
required to complete the plan to sell have been initiated; (iv) the sale of the property is probable and is expected to be completed within
one year
; (v) the property is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and
(vi) actions necessary to complete the plan of sale indicate that it is unlikely that significant changes to the plan will be made or that the
plan will be withdrawn. Depreciation of assets ceases upon designation of a property as held for sale.
If the disposal of a property represents a strategic shift that has (or will have) a major effect on our operations or financial
results, such as (i) a major line of business, (ii) a major geographic area, (iii) a major equity method investment, or (iv) other major parts
of an entity, then the operations of the property, including any interest expense directly attributable to it, are classified as discontinued
operations in our consolidated statements of operations, and amounts for all prior periods presented are reclassified from continuing
operations to discontinued operations. The disposal of an individual property generally will not represent a strategic shift and therefore
will typically not meet the criteria for classification as a discontinued operation.
We recognize gains or losses on real estate sales in accordance with the accounting standard on the derecognition of
nonfinancial assets arising from contracts with noncustomers. Our ordinary output activities consist of the leasing of space to our
tenants in our operating properties, not the sales of real estate. Therefore, sales of real estate (in which we are the seller) qualify as
contracts with noncustomers. In our transactions with noncustomers, we apply certain recognition and measurement principles
consistent with our method of recognizing revenue arising from contracts with customers. Derecognition of the asset is based on the
transfer of control. If a real estate sales contract includes our ongoing involvement with the property, then we evaluate each promised
good or service under the contract to determine whether it represents a separate performance obligation, constitutes a guarantee, or
12
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
prevents the transfer of control. If a good or service is considered a separate performance obligation, an allocated portion of the
transaction price is recognized as revenue as we transfer the related good or service to the buyer.
The recognition of gain or loss on the sale of a partial interest also depends on whether we retain a controlling or
noncontrolling interest in the property. If we retain a controlling interest in the property upon completion of the sale, we continue to
reflect the asset at its book value, record a noncontrolling interest for the book value of the partial interest sold, and recognize additional
paid-in capital for the difference between the consideration received and the partial interest at book value. Conversely, if we retain a
noncontrolling interest upon completion of the sale of a partial interest of real estate, we recognize a gain or loss as if 100% of the asset
were sold.
Impairment of long-lived assets
Prior to and subsequent to the end of each quarter, we review current activities and changes in the business conditions of all of
our long-lived assets to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If
triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows, including, if
necessary, a probability-weighted approach if multiple outcomes are under consideration.
Long-lived assets to be held and used, including our rental properties, CIP, land held for development, right-of-use assets
related to operating leases in which we are the lessee, and intangibles, are individually evaluated for impairment when conditions exist
that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be
held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual
disposition of the asset. Triggering events or impairment indicators for long-lived assets to be held and used are assessed by project
and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations,
current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market
factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, projected rental
rates, estimated exit capitalization rates, and anticipated construction costs for projects under construction, which are based on
available market information, current and historical operating results, known trends, current market/economic conditions that may affect
the asset, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes
are under consideration.
Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount of the asset to
its estimated fair value. If an impairment charge is not required to be recognized, the recognition of depreciation or amortization is
adjusted prospectively, as necessary, to reduce the carrying amount of the asset to its estimated disposition value over the remaining
period that the asset is expected to be held and used. We may adjust depreciation of properties that are expected to be disposed of or
redeveloped prior to the end of their useful lives.
We use the held for sale impairment model for our properties classified as held for sale, which is different from the held and
used impairment model. Under the held for sale impairment model, an impairment charge is recognized if the carrying amount of the
long-lived asset classified as held for sale exceeds its fair value less cost to sell. Because of these two different models, it is possible for
a long-lived asset previously classified as held and used to require the recognition of an impairment charge upon classification as held
for sale.
International operations
As of March 31, 2026, in addition to operating properties in the U.S., we had
11
pr
operties in Canada
. The functional currency
for our subsidiaries operating in the U.S. is the U.S. dollar. The local currency of a foreign subsidiary serves as its functional currency.
The assets and liabilities of our foreign subsidiaries are translated into U.S. dollars at the exchange rate in effect as of the financial
statement date. Revenue and expense accounts of our foreign subsidiaries are translated using the weighted-average exchange rate
for the periods presented. Gains or losses resulting from the translation are classified in accumulated other comprehensive income
(loss) as a separate component of total equity and are excluded from net income (loss).
Whenever a foreign investment meets the criteria for classification as held for sale, we evaluate the recoverability of the
investment under the held for sale impairment model. We may recognize an impairment charge if the carrying amount of the investment
exceeds its fair value less cost to sell. In determining an investment’s carrying amount, we consider its net book value and any
cumulative unrealized foreign currency translation adjustment related to the investment. The appropriate amounts of foreign exchange
rate gains or losses classified in accumulated other comprehensive income (loss) are reclassified to net income (loss) when realized
upon the sale of our investment or upon the complete or substantially complete liquidation of our investment.
13
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Investments
We hold investments in publicly traded companies and privately held entities primarily involved in the life science industry. As a
REIT, we generally limit our ownership of each individual entity’s voting stock to less than
10
%
.
We evaluate each investment to
determine whether we have the ability to exercise significant influence, but not control, over an investee. We evaluate investments in
which our ownership is equal to or greater than 20%, but less than or equal to 50%, of an investee’s voting stock with a presumption
that we have this ability. For our investments in limited partnerships that maintain specific ownership accounts, we presume that such
ability exists when our ownership interest exceeds 3% to 5%. In addition to our ownership interest, we consider whether we have a
board seat or whether we participate in the investee’s policymaking process, among other criteria, to determine if we have the ability to
exert significant influence, but not control, over an investee. If we determine that we have such ability, we account for the investment
under the equity method, as described below. From time to time, we may hold equity investments in publicly traded companies that are
subject to temporary contractual sale restrictions. We do not recognize a discount related to a contractual sale restriction.
Investments accounted for under the equity method
Under the equity method of accounting, we initially recognize our investment at cost and subsequently adjust the carrying
amount of the investment for our share of earnings or losses reported by the investee, distributions received, and other-than-temporary
impairments.
For additional information about our investments accounted for under the equity method, refer to Note 7 – “Investments” to
our unaudited consolidated financial statements.
Investments that do not qualify for the equity method of accounting
For investees over which we determine that we do not have the ability to exercise significant influence or control, we account
for each investment depending on whether it is an investment in a (i) publicly traded company, (ii) privately held entity that reports NAV
per share, or (iii) privately held entity that does not report NAV per share, as described below.
Investments in publicly traded companies
Our investments in publicly traded companies are classified as investments with readily determinable fair values and are
presented at fair value in our consolidated balance sheets, with changes in fair value classified in investment income (loss) in our
consolidated statements of operations. The fair values for our investments in publicly traded companies are determined based on sales
prices or quotes available on securities exchanges.
Investments in privately held companies
Our investments in privately held entities without readily determinable fair values consist of (i) investments in privately held
entities that report NAV per share and (ii) investments in privately held entities that do not report NAV per share. These investments are
accounted for as follows:
Investments in privately held entities that report NAV per share
Investments in privately held entities that report NAV per share, such as our privately held investments in limited partnerships,
are presented at fair value using NAV as a practical expedient, with changes in fair value classified in investment income (loss) in our
consolidated statements of operations. We use NAV per share reported by limited partnerships generally without adjustment, unless we
are aware of information indicating that the NAV reported by a limited partnership does not accurately reflect the fair value of the
investment at our reporting date.
Investments in privately held entities that do not report NAV per share
Investments in privately held entities that do not report NAV per share are accounted for using a measurement alternative
under which these investments are measured at cost, adjusted for observable price changes and impairments, with changes classified
in investment income (loss) in our consolidated statements of operations.
An observable price arises from an orderly transaction for an identical or similar investment of the same issuer, which is
observed by an investor without expending undue cost and effort. Observable price changes result from, among other things, equity
transactions of the same issuer executed during the reporting period, including subsequent equity offerings or other reported equity
transactions related to the same issuer. To determine whether these transactions are indicative of an observable price change, we
evaluate, among other factors, whether these transactions have similar rights and obligations, including voting rights, distribution
preferences, and conversion rights to the investments we hold.
14
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
I
mpairment evaluation of equity method investments and investments in privately held entities that do not report NAV per share
We monitor equity method investments and investments in privately held entities that do not report NAV per share for new
developments, including operating results, prospects and results of clinical trials, new product initiatives, new collaborative agreements,
capital-raising events, and merger and acquisition activities. These investments are evaluated on the basis of a qualitative assessment
for indicators of impairment by monitoring the presence of the following triggering events or impairment indicators:
(i)
a significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee;
(ii)
a significant adverse change in the regulatory, economic, or technological environment of the investee;
(iii)
a significant adverse change in the general market condition, including the research and development of technology and
products that the investee is bringing or attempting to bring to the market;
(iv)
significant concerns about the investee’s ability to continue as a going concern; and/or
(v)
a decision by investors to cease providing support or reduce their financial commitment to the investee.
If such indicators are present, we are required to estimate the investment’s fair value and immediately recognize an
impairment charge in an amount equal to the investment’s carrying value in excess of its estimated fair value.
Investment income/loss recognition and classification
We recognize both realized and unrealized gains and losses in our consolidated statements of operations, classified in
investment income (loss) in our consolidated statements of operations. Unrealized gains and losses represent:
(i)
changes in fair value for investments in publicly traded companies;
(ii)
changes in NAV for investments in privately held entities that report NAV per share;
(iii)
observable price changes for investments in privately held entities that do not report NAV per share; and
(iv)
our share of unrealized gains or losses reported by our equity method investees.
Realized gains and losses on our investments represent the difference between proceeds received upon disposition of
investments and their historical or adjusted cost basis. For our equity method investments, realized gains and losses represent our
share of realized gains or losses reported by the investee. Impairments are realized losses, which result in an adjusted cost basis, and
represent charges to reduce the carrying values of investments in privately held entities that do not report NAV per share and equity
method investments, if impairments are deemed other than temporary, to their estimated fair value.
Revenues
The table below provides details of our consolidated total revenues for the
three months ended March 31, 2026
and
2025
(in thousands):
Three Months Ended March 31,
2026
2025
Income from rentals:
Revenues subject to the lease accounting standard:
Operating leases
$
640,659
$
731,421
Direct financing and sales-type leases
964
810
Revenues subject to the lease accounting standard
641,623
732,231
Revenues subject to the revenue recognition accounting standard
11,390
10,944
Income from rentals
653,013
743,175
Other income
18,009
14,983
Total revenues
$
671,022
$
758,158
During the
three months ended March 31, 2026
and
2025
,
revenues that were subject to the lease accounting standard
aggregated
$
641.6
million
, or
95.6
%
, and
$
732.2
million
, or
96.6
%
,
of our total revenue, respectively. Our other income consisted
primarily of management fees and interest income earned during each period presented. For a detailed discussion related to our
revenue streams, refer to “
Lease accounting
” and “
Recognition of revenue arising from contracts with customers
” in Note 2 – “Summary
of significant accounting policies” to our unaudited consolidated financial statements.
15
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Lease accounting
Definition and classification of a lease
When we enter into a contract or amend an existing contract, we evaluate whether the contract meets the definition of a lease.
To meet the definition of a lease, the contract must meet all three criteria:
(i)
One party (lessor) must hold an identified asset;
(ii)
The counterparty (lessee) must have the right to obtain substantially all of the economic benefits from the use of the asset
throughout the period of the contract; and
(iii)
The counterparty (lessee) must have the right to direct the use of the identified asset throughout the period of the contract.
We classify our leases as either finance leases or operating leases if we are the lessee, or sales-type, direct financing, or
operating leases if we are the lessor. We use the following criteria to determine if a lease is a finance lease (as a lessee) or sales-type
or direct financing lease (as a lessor):
(i)
Ownership is transferred from lessor to lessee by the end of the lease term;
(ii)
An option to purchase is reasonably certain to be exercised;
(iii)
The lease term is for the major part of the underlying asset’s remaining economic life;
(iv)
The present value of lease payments equals or exceeds substantially all of the fair value of the underlying asset; or
(v)
The underlying asset is specialized and is expected to have no alternative use at the end of the lease term.
If we meet any of the above criteria, we account for the lease as a finance, a sales-type, or a direct financing lease. If we do
not meet any of the criteria, we account for the lease as an operating lease.
A lease is accounted for as a sales-type lease if it is considered to transfer control of the underlying asset to the lessee. A
lease is accounted for as a direct financing lease if risks and rewards are conveyed without the transfer of control, which is normally
indicated by the existence of a residual value guarantee from an unrelated third party other than the lessee.
This classification will determine the method of recognition of the lease:
•
For an operating lease, we recognize income from rentals if we are the lessor, or rental operations expense if we are the
lessee, over the term of the lease on a straight-line basis.
•
For a sales-type lease or a direct financing lease, we recognize the income from rentals, or for a finance lease, we
recognize rental operations expense, over the term of the lease using the effective interest method.
•
At inception of a sales-type lease or a direct financing lease, if we determine the fair value of the leased property is lower
than its carrying amount, we recognize a selling loss immediately at lease commencement. If fair value exceeds the
carrying amount of a lease, a gain is recognized at lease commencement on a sales-type lease. For a direct financing
lease, a gain is deferred at lease commencement and amortized over the lease term.
Lessor accounting
Costs to execute leases
We capitalize initial direct costs, which represent only incremental costs to execute a lease that would not have been incurred
if the lease had not been obtained. Costs that we incur to negotiate or arrange a lease, regardless of its outcome, such as for fixed
employee compensation, tax or legal advice to negotiate lease terms, and other costs, are expensed as incurred.
Operating leases
We account for the revenue from our lease contracts by utilizing the single component accounting policy. This policy requires
us to account for, by class of underlying asset, the lease component and nonlease component(s) associated with each lease as a single
component if two criteria are met:
(i)
The timing and pattern of transfer of the lease component and the nonlease component(s) are the same; and
(ii)
The lease component would be classified as an operating lease if it were accounted for separately.
Lease components consist primarily of fixed rental payments, which represent scheduled rental amounts due under our
leases, and contingent rental payments. Nonlease components consist primarily of tenant recoveries representing reimbursements of
rental operating expenses under our triple net lease structure, including recoveries for property taxes, insurance, utilities, repairs and
maintenance, and common area expenses.
16
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
If the lease component is the predominant component, we account for all revenues under such lease as a single component in
accordance with the lease accounting standard. Conversely, if the nonlease component is the predominant component, all revenues
under such lease are accounted for in accordance with the revenue recognition accounting standard. Our operating leases qualify for
the single component accounting, and the lease component in each of our leases is predominant. Therefore, we account for all
revenues from our operating leases under the lease accounting standard and classify these revenues as income from rentals in our
consolidated statements of operations.
We commence recognition of income from rentals related to the operating leases at the date the property is ready for its
intended use by the tenant and the tenant takes possession or controls the physical use of the leased asset. When a lease includes
construction of improvements, we determine whether the improvements are landlord or tenant assets. In determining if the
improvements are landlord or tenant improvements, we consider various factors, including, but not limited to, the following:
•
Which party retains legal title to the improvements upon lease expiration;
•
Whether the improvements are expected to have significant residual value at the end of the lease term;
•
Whether the improvements are unique to the tenant;
•
What happens to the improvements upon lease expiration (i.e., whether they are removed or preserved for the landlord);
•
Which party bears all costs of the improvements (including the risk of cost overruns); and
•
Which party supervises the construction of the improvements.
If the improvements are landlord assets, we capitalize such improvements. If the improvements are tenant assets, we do not
capitalize these assets. Improvements that qualify as tenant assets, if funded by us, are accounted for as lease incentives and
amortized as a reduction of revenue over the term of the lease. If the tenant funds improvements without reimbursement from us, and
we determine these improvements to be landlord assets, we consider the amount associated with the improvements to be non-cash
lease payments, which are recognized as incremental revenue over the term of the lease.
Income from rentals related to fixed rental payments under operating leases is recognized on a straight-line basis over the
respective operating lease terms. We classify amounts expected to be received in later periods as deferred rent in our consolidated
balance sheets. Amounts received currently but recognized as revenue in future periods are classified in accounts payable, accrued
expenses, and other liabilities in our consolidated balance sheets.
Income from rentals related to variable payments includes tenant recoveries and contingent rental payments. Tenant
recoveries, including reimbursements of utilities, repairs and maintenance, common area expenses, real estate taxes and insurance,
and other operating expenses, are recognized as revenue in the period during which the applicable expenses are incurred and the
tenant’s obligation to reimburse us arises. Income from rentals related to other variable payments is recognized when associated
contingencies are removed.
We assess collectibility from our tenants of future lease payments for each of our operating leases. If we determine that
collectibility is probable, we recognize income from rentals based on the methodology described above. If we determine that
collectibility is not probable, we recognize an adjustment to lower our income from rentals. Furthermore, we may recognize a general
allowance at a portfolio level (not the individual level) if we do not expect to collect future lease payments in full.
For each lease for which we determine that collectibility of future lease payments is not probable, we cease the recognition of
income from rentals on a straight-line basis and limit the recognition of income to the lesser of payments collected from the lessee or
lease income that would have been recognized on a straight-line basis. We do not resume straight-line recognition of income from
rentals for these leases until we determine that the collectibility of future payments related to these leases is probable. We also record a
general allowance related to the deferred rent balances that at the portfolio level (not the individual level) are not expected to be
collected in full through the lease term.
As of
March 31, 2026
and
December 31, 2025
,
o
ur general allowance balance aggregated
$
14.3
million
and
$
14.3
million
, respectively.
Direct financing and sales-type leases
Income from rentals related to direct financing and sales-type leases is recognized over the lease term using the effective
interest rate method. At lease commencement, we derecognize the underlying asset classified within investments in real estate and
record net investment in a lease within other assets in our consolidated balance sheets. This initial net investment is determined by
aggregating the present values of the total future lease payments and the estimated residual value of the property, less any unearned
income related to a direct financing lease. Over the lease term, the investment in the lease accretes in value, producing a constant
periodic rate of return on the net investment in the lease. Income from these leases is classified in income from rentals in our
consolidated statements of operations. Our net investment is reduced over time as lease payments are received.
We evaluate our net investment in direct financing and sales-type leases for impairment under the current expected credit
losses accounting standard. For additional information, refer to “
Provision for expected credit losses
” in Note 2 – “Summary of
significant accounting policies” to our unaudited consolidated financial statements.
17
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
As a lessor, we classify a lease with variable lease payments that do not depend on an index or a rate as an operating lease
on the commencement date of the lease if both of the following criteria are met:
(i)
The lease would have been classified as a sales-type lease or direct financing lease under the current lease accounting
standard; and
(ii)
The sales-type lease or direct financing lease classification would have resulted in a selling loss at lease commencement.
We do not derecognize the underlying asset and do not recognize a loss upon lease commencement but continue to
depreciate the underlying asset over its useful life.
Lessee accounting
We have operating lease agreements in which we are the lessee consisting of ground and office leases. At the lease
commencement date (or at the acquisition date if the lease is acquired as part of a real estate acquisition), we are required to recognize
a liability to account for our future obligations under these operating leases, and a corresponding right-of-use asset.
The lease liability is measured based on the present value of the future lease payments, including payments during the term
under our extension options that we are reasonably certain to exercise. The present value of the future lease payments is calculated for
each operating lease using each respective remaining lease term and a corresponding estimated incremental borrowing rate, which is
the interest rate that we estimate we would have to pay to borrow on a collateralized basis over a similar term for an amount equal to
the lease payments. Subsequently, the lease liability is accreted by applying a discount rate established at the lease commencement
date to the lease liability balance as of the beginning of the period and is reduced by the payments made during the period. We classify
the operating lease liability in accounts payable, accrued expenses, and other liabilities in our consolidated balance sheets.
The right-of-use asset is measured based on the corresponding lease liability, adjusted for initial direct leasing costs and any
other consideration exchanged with the landlord prior to the commencement of the lease, as well as adjustments to reflect favorable or
unfavorable terms of an acquired lease when compared with market terms at the time of acquisition. Subsequently, the right-of-use
asset is amortized on a straight-line basis during the lease term. We classify the right-of-use asset in other assets in our consolidated
balance sheets.
Recognition of revenue arising from contracts with customers
We recognize revenues associated with transactions arising from contracts with customers, excluding revenues subject to the
lease accounting standard discussed in “
Lease accounting
” above, in accordance with the revenue recognition accounting standard. A
customer is distinguished from a noncustomer by the nature of the goods or services that are transferred. Customers are provided with
goods or services that are generated by a company’s ordinary output activities, whereas noncustomers are provided with nonfinancial
assets that are outside of a company’s ordinary output activities.
We generally recognize revenue representing the transfer of goods and services to customers in an amount that reflects the
consideration to which we expect to be entitled in the exchange. In order to determine the recognition of revenue from customer
contracts, we use a five-step model to (i) identify the contract with the customer, (ii) identify the performance obligations in the contract,
(iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will
not occur, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we
satisfy the performance obligation.
We identify contractual performance obligations and determine whether revenue should be recognized at a point in time or
over time, based on when control of goods and services transfers to a customer. We consider whether we control the goods or services
prior to the transfer to the customer in order to determine whether we should account for the arrangement as a principal or agent. If we
determine that we control the goods or services provided to the customer, then we are the principal to the transaction, and we recognize
the gross amount of consideration expected in the exchange. If we simply arrange but do not control the goods or services being
transferred to the customer, then we are considered to be an agent to the transaction, and we recognize the net amount of
consideration we are entitled to retain in the exchange.
Total revenues subject to the revenue recognition accounting standard and classified within income from rentals in our
consolidated statements of operations for the
three months ended March 31, 2026
included
$
11.4
million
primarily related to short-term
parking revenues associated with long-term lease agreements
. Short-term parking revenues do not qualify for the single component
accounting policy, as discussed in “
Lessor accounting
” in Note 2 – “Summary of significant accounting policies,” due to the difference in
the timing and pattern of transfer of our parking service obligations and associated lease components within the same lease agreement.
We recognize short-term parking revenues in accordance with the revenue recognition accounting standard when the service is
provided and the performance obligation is satisfied, which normally occurs at a point in time.
18
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Monitoring of tenant credit quality
During the term of each lease, we monitor the credit quality and any related material changes of our tenants by (i) monitoring
the credit rating of tenants that are rated by a nationally recognized credit rating agency, (ii) reviewing financial statements of the
tenants that are publicly available or that are required to be delivered to us pursuant to the applicable lease, (iii) monitoring news
reports regarding our tenants and their respective businesses, and (iv) monitoring the timeliness of lease payments.
Notes receivable
We carry notes receivable at amortized cost, adjusted for an estimated provision for expected credit losses. Interest income on
notes receivable is recognized using the effective interest rate method and is classified within other income in our consolidated
statements of operations. Direct costs incurred in originating notes, along with any premium or discount, are deferred and amortized as
an adjustment to interest income over the note’s term using the effective interest rate method. Notes receivable are classified within
other assets in our consolidated balance sheets. Refer to Note 8 – “Other assets” to our unaudited consolidated financial statements for
additional details.
Provision for expected credit losses
We are required to estimate and recognize lifetime expected losses, rather than incurred losses, for most financial assets
measured at amortized cost and certain other instruments, including trade, notes, and other receivables (excluding receivables arising
from operating leases), loans, held-to-maturity debt securities, net investments in leases arising from sales-type and direct financing
leases, and off-balance-sheet credit exposures (e.g., loan commitments). The recognition of such expected losses, even if the expected
risk of credit loss is remote, typically results in earlier recognition of credit losses. At each reporting date, we reassess our provision for
expected credit losses, and, if necessary, we recognize an adjustment for our current estimate of expected credit losses. Refer to
Note 5 – “Leases” and Note 8 – “Other assets” to our unaudited consolidated financial statements for additional details.
An assessment of the collectibility of operating lease payments and the recognition of an adjustment to lease income based on
this assessment is governed by the lease accounting standard discussed in “
Lease accounting
” earlier in Note 2 — “Summary of
significant accounting policies” to our unaudited consolidated financial statements.
Income taxes
We are organized and operate as a REIT pursuant to the Internal Revenue Code (the “Code”). Under the Code, a REIT that
distributes at least
90
%
of its REIT taxable
income
to its stockholders annually (excluding net capital gains) and meets certain other
conditions is not subject to federal income tax on its distributed taxable income, but could be subject to certain federal, foreign, state,
and local taxes. We distribute
100
%
of our taxable income annuall
y
; therefore, a provision for federal income taxes is not required. In
addition to our REIT returns, we file federal, foreign, state, and local tax returns for our subsidiaries. We file with jurisdictions located in
the U.S., Canada, and other international locations. Our tax returns are subject to routine examination in various jurisdictions for the
2020
through
2025
c
alendar years
.
Employee and non-employee share-based payments
We have implemented an entity-wide accounting policy to account for forfeitures related to unmet service conditions of share-
based awards granted to employees and non-employees when they occur. Under this policy, when forfeitures occur, any previously
recognized expense related to those forfeited awards is reversed in the period of forfeiture.
Our employee and non-employee share-based awards are measured at fair value on the grant date and recognized over the
recipient’s required service period. For share-based awards with performance conditions, we continue to assess the probability of
achieving the performance conditions and recognize expense only when it becomes probable that the performance targets will be met.
Conversely, for share-based awards with market conditions, expense is recognized regardless of whether the market condition is met.
Dividends paid on share-based awards with nonforfeitable dividends are initially classified in retained earnings and reclassified
to compensation cost only if the underlying awards are forfeited. Conversely, for share-based awards with forfeitable dividends,
declared dividends are initially classified in retained earnings and in dividends payable within our consolidated balance sheets. If the
underlying awards are forfeited, the corresponding accrued dividend is reversed in the period of forfeiture. Upon vesting of the
underlying share-based awards with forfeitable dividends, the accumulated dividend payment is made and the dividend payable liability
is settled.
19
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Forward equity sales agreements
From time to time, we enter into forward equity sales agreements and account for them in accordance with the accounting
guidance governing financial instruments and derivatives. Under the accounting guidance, our forward equity sales agreements are not
deemed to be liabilities as they do not embody obligations to repurchase our shares, nor do they embody obligations to issue a variable
number of shares for which the monetary value is predominantly fixed, varied with something other than the fair value of our shares, or
varied inversely in relation to our shares. We also evaluate whether the agreements meet the derivatives and hedging guidance scope
exception to be accounted for as equity instruments. Our forward equity sales agreements are classified as equity contracts based on
the following assessment: (i) none of the agreements’ exercise contingencies are based on observable markets or indices besides
those related to the market for our own stock price and operations; and (ii) none of the settlement provisions preclude the agreements
from being indexed to our own stock.
Hedge accounting
From time to time, we utilize derivative instruments to manage our exposure to certain risks. We are exposed to foreign
currency exchange rate risk related to our net investment in Canada. To mitigate the impact of fluctuations in the USD-CAD exchange
rate associated with our net investment in Canada, we use cross-currency swap agreements designated and qualifying as net
investment hedges under applicable derivatives and hedging standards.
We designate the USD-CAD cross-currency swap agreements as net investment hedges using the spot method to assess
hedge effectiveness. The spot component represents changes in fair value attributable to movements in the USD-CAD spot exchange
rate, which reflects the market exchange rate between the two currencies as of each reporting date. Changes in the fair value of the
designated spot component are recorded in other comprehensive income (loss) as part of the foreign currency translation adjustment,
to the extent the relationship is highly effective, until the net investment is sold or substantially liquidated. The related amounts due from
or due to counterparties are included in other assets or in accounts payable, accrued expenses, and other liabilities, respectively, within
our consolidated balance sheet.
We elected to account for the forward points (the portion of the derivative’s fair value attributable to the difference between the
forward exchange rate and spot exchange rate) as an excluded component in accordance with applicable derivatives and hedging
accounting standards. The excluded component is recognized over the life of the cross-currency swap agreements using a systematic
and rational basis (as interest settlements occur) and is classified within other income in our consolidated statement of operations.
Issuer and guarantor subsidiaries of guaranteed securities
Generally, a parent entity of an issuer that holds guaranteed securities must provide separate subsidiary issuer or guarantor
financial statements, unless it qualifies for disclosure exceptions. A parent entity may be eligible for disclosure exceptions if it meets the
following criteria:
(i)
The subsidiary issuer or guarantor is a consolidated subsidiary of the parent company, and
(ii)
The subsidiary issues a registered security that is:
•
issued jointly and severally with the parent company, or
•
fully and unconditionally guaranteed by the parent company.
A parent entity that meets the above criteria may instead present summarized financial information (“alternative disclosures”)
either within the consolidated financial statements or in “Item 2. Management’s discussion and analysis of financial condition and results
of operations” (“Item 2”). We evaluated the criteria and determined that we are eligible for the disclosure exceptions, which allow us to
provide alternative disclosures; as such, we present alternative disclosures in Item 2.
Loan fees
Fees incurred in obtaining long-term financing are capitalized and classified with the corresponding debt instrument appearing
on our consolidated balance sheets. Loan fees related to our unsecured senior line of credit are capitalized and classified within other
assets. Capitalized amounts are amortized over the term of the related loan, and the amortization is classified in interest expense in our
consolidated statements of operations.
Distributions from equity method investments
We use the “nature of the distribution” approach to determine the classification within our consolidated statements of cash
flows of cash distributions received from equity method investments, including our unconsolidated real estate joint ventures and equity
method non-real estate investments. Under this approach, distributions are classified based on the nature of the underlying activity that
generated the cash distributions. If we lack the information necessary to apply this approach in the future, we will be required to apply
the “cumulative earnings” approach as an accounting change on a retrospective basis. Under the cumulative earnings approach,
distributions up to the amount of cumulative equity in earnings recognized are classified as cash inflows from operating activities, and
those in excess of that amount are classified as cash inflows from investing activities.
20
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Restricted cash
We present cash and cash equivalents separately from restricted cash within our consolidated balance sheets. However, we
include restricted cash with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown
in the consolidated statements of cash flows. We provide a reconciliation between the consolidated balance sheets and the
consolidated statements of cash flows, which is required when the balance includes greater than one line item for cash, cash
equivalents, and restricted cash. We also provide a disclosure of the nature of the restrictions related to material restricted cash
balances.
Recent accounting pronouncements
On November 4, 2024, the FASB issued ASU 2024-03,
Disaggregation of Income Statement Expenses
, which will require
entities to provide enhanced disclosures related to certain expense categories included in line items on the statement of operations.
The ASU aims to increase transparency and provide investors with additional detailed information about the nature of expenses
reported on the face of the income statement. The new standard does not change the requirements for the presentation of expenses on
the face of the statement of operations.
Under this ASU, entities are required to disaggregate, in a tabular format, expense line items presented on the face of the
statement of operations — excluding earnings or losses from equity method investments — if they include any of the following expense
categories: purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depreciation or depletion.
For any remaining items within each relevant expense line item, entities must provide a qualitative description of the nature of those
expenses. The new ASU is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods
beginning after December 15, 2027. Early adoption is permitted. We expect to adopt this ASU on January 1, 2027. Although the
adoption is not expected to have an impact on our financial statements, it is expected to result in incremental disclosures within the
notes to our consolidated financial statements.
21
3.
INVESTMENTS IN REAL ESTATE
Our consolidated investments in real estate consisted of the following as of
March 31, 2026
and
December 31, 2025
(in
thousands):
March 31, 2026
December 31, 2025
Rental properties:
Land (related to rental properties)
$
3,639,219
$
3,204,479
Buildings and building improvements
19,607,116
19,738,825
Other improvements
4,465,630
4,371,720
Rental properties
27,711,965
27,315,024
Current and future development and redevelopment projects
6,857,569
6,788,464
Gross investments in real estate
34,569,534
34,103,488
Less: accumulated depreciation
(
6,232,579
)
(
5,970,171
)
Investments in real estate assets held for sale, less accumulated depreciation
(1)
493,161
556,679
Investments in real estate
$
28,830,116
$
28,689,996
(1)
Refer to
“Assets held for sale” below
.
Assets held for sale
As of
March 31, 2026
, we had
19
operating
properties
aggregating
1.4
million
RS
F
and land parcels aggregating
1.6
million
SF
that were classified as held for sale.
The disposal of properties classified as held for sale does not represent a strategic shift that has, or will have, a major effect on
our operations or financial results, as the dispositions relate to individual assets across multiple markets and do not represent the exit
from any significant market. Accordingly, these assets do not meet the criteria for classification as a discontinued operation. We cease
depreciation of our properties upon their classification as held for sale.
The following table presents the components of net assets related to real estate investments that met the criteria for
classification as held for sale as of
March 31, 2026
and
December 31, 2025
(in thousands):
March 31, 2026
December 31, 2025
Investments in real estate, less accumulated depreciation
$
493,161
$
556,679
Other assets
41,409
37,859
Total assets
534,570
594,538
Total liabilities
(
11,841
)
(
12,235
)
Total accumulated other comprehensive loss
(
181
)
(
566
)
Net assets classified as held for sale
$
522,548
$
581,737
For additional information, refer to “
Real estate sales
” in Note 2 – “Summary of significant accounting policies” to our unaudited
consolidated financial statements.
S
ales of real estate assets and impairment of real estate
Impairment of real estate
During the
three months ended March 31, 2026
, we recognized impairment charges aggre
gating
$
5.5
million
,
classified within
impairment of real estate in our consolidated statement of operations. The impairment
primarily reflects an incremental charge
recognized in connection with the amendment of the sales agreement during the
three months ended March 31, 2026
related to our
Canada portfolio,
which is classified as held for sale as of March 31, 2026.
22
3.
INVESTMENTS IN REAL ESTATE (continued)
Other
ARE‑East River Science Park, LLC (“ARE”), a subsidiary of Alexandria Real Estate Equities, Inc., holds an option granted in
2006 to incorporate a land parcel adjacent to and north of the Alexandria Center
®
for Life Science – New York City campus (the “Option
Parcel”) into the existing ground lease, which would allow for the future development of an additional life science building within the
campus. ARE’s investment in pre‑construction costs related to the Option Parcel aggregated
$
180.6
million
as of March 31, 2026
.
On August 6, 2024, ARE filed a lawsuit in the U.S. District Court for the Southern District of New York against New York City
Health + Hospitals Corporation (“H+H”) and the New York City Economic Development Corporation (“EDC”) relating to disputes under
the ground lease and option arrangements governing the Option Parcel. ARE filed an amended complaint on January 24, 2025,
asserting claims for fraudulent inducement, breach of contract, breach of the implied covenant of good faith and fair dealing, and
declaratory relief concerning the continued validity of the option.
On March 27, 2026, the court granted defendants’ partial motion to dismiss the fraud in the inducement and implied covenant
of good faith and fair dealing claims. ARE intends to appeal this order at the appropriate time and to vigorously pursue its claims. The
court did not dismiss ARE’s claim for declaratory relief, which remains pending.
On April 10, 2026, H+H and EDC answered the amended complaint and asserted counterclaims seeking, among other things,
declaratory relief relating to the alleged expiration of the option and entitlement to a
$
5.0
million
security deposit, and damages of at
least
$
3.8
million
. As a result of the foregoing matters, the timing of any development of the Option Parcel is currently indeterminate.
Excluding the potential impact of the counterclaims filed by H+H and EDC, this matter exposes us to potential losses ranging from zero
to the full amount of the investment in the project aggregating
$
180.6
million
as of March 31, 2026
, depending on the resolution of the
remaining declaratory relief proceedings, the outcome of any appeal, and/or the ability to develop the project. We performed a
probability-weighted recoverability analysis based on initial estimates of various possible outcomes and determined no impairment was
present
as of March 31, 2026
.
Separately from, and not part of, the pending litigation related to the Option Parcel, on April 21, 2026, EDC, on behalf of H+H,
the landlord, and itself, lease administrator, delivered a notice alleging that ARE is in default of certain information delivery obligations
under the ground lease relating to the existing operating towers at the Alexandria Center
®
for Life Science – New York City campus,
including sublease, tax, and financial information. The notice asserts that the failure to cure the alleged defaults within the applicable
30
-day cure period would result in daily charges of
$
1,000
increasing thereafter to up to
$
2,000
. ARE disputes the allegations set forth
in the notice of default, and intends to vigorously defend against them.
23
4.
CONSOLIDATED AND UNCONSOLIDATED REAL ESTATE JOINT VENTURES
From time to time, we enter into joint venture agreements through which we own a partial interest in real estate entities that
own, develop, and operate real estate properties. As of
March 31, 2026
, our real estate joint ventures held the following properties:
Property
(1)
Market
Submarket
Our Ownership
Interest
Consolidated real estate joint ventures:
50 and 60 Binney Street
Greater Boston
Cambridge/Inner Suburbs
34.0
%
75/125 Binney Street
Greater Boston
Cambridge/Inner Suburbs
40.0
%
100 and 225 Binney Street and 300 Third Street
Greater Boston
Cambridge/Inner Suburbs
30.0
%
15 Necco Street
Greater Boston
Seaport Innovation District
56.7
%
Alexandria Center
®
for Science and Technology –
Mission Bay
(2)
San Francisco Bay Area
Mission Bay
25.0
%
211 and 213 East Grand Avenue
San Francisco Bay Area
South San Francisco
30.0
%
500 Forbes Boulevard
San Francisco Bay Area
South San Francisco
10.0
%
Alexandria Center
®
for Life Science – Millbrae
San Francisco Bay Area
South San Francisco
48.6
%
3215 Merryfield Row
San Diego
Torrey Pines
30.0
%
Campus Point by Alexandria
(3)
San Diego
University Town Center
57.2
%
(4)
5200 Illumina Way
San Diego
University Town Center
51.0
%
9625 Towne Centre Drive
San Diego
University Town Center
30.0
%
SD Tech by Alexandria
(5)
San Diego
Sorrento Mesa
50.0
%
Summers Ridge Science Park
(6)
San Diego
Sorrento Mesa
30.0
%
1201 and 1208 Eastlake Avenue East
Seattle
Lake Union
30.0
%
400 Dexter Avenue North
Seattle
Lake Union
30.0
%
800 Mercer Street
Seattle
Lake Union
60.0
%
Unconsolidated real estate joint ventures:
1655 and 1725 Third Street
San Francisco Bay Area
Mission Bay
10.0
%
101 West Dickman Street
Maryland
Beltsville
58.4
%
(7)
(1)
Refer to the table on the next page that shows the categorization of our real estate joint ventures under the consolidation framework.
(2)
Includes 1450, 1500, and 1700 Owens Street, and 455 Mission Bay Boulevard South.
(3)
Includes 10200, 10290, and 10300 Campus Point Drive and 4135, 4155, 4165, 4224, and 4242 Campus Point Court.
(4)
The noncontrolling interest share of our joint venture partner is anticipated to decrease to
25%
, as we expect to fund the majority of future construction costs at the
campus until our ownership interest increases to
75%
, after which future capital would be contributed pro rata with our partner.
(5)
Includes 9605, 9645, 9675, 9725, 9735, 9805, 9808, 9855, and 9868 Scranton Road and 10055, 10065, and 10075 Barnes Canyon Road.
(6)
Includes 9965, 9975, 9985, and 9995 Summers Ridge Road.
(7)
Represents a joint venture with a local real estate operator in which our joint venture partner manages the day-to-day activities that significantly affect the economic
performance of the joint venture.
Our consolidation policy is described under “Consolidation” in Note 2 – “Summary of significant accounting policies” to our
unaudited consolidated financial statements. Consolidation accounting is highly technical, but its framework is primarily based on the
controlling financial interests and benefits of the joint ventures. We generally consolidate a joint venture that is a legal entity that we
control (i.e., we have the power to direct the activities of the joint venture that most significantly affect its economic performance)
through contractual rights, regardless of our ownership interest, and where we determine that we have benefits through the allocation of
earnings or losses and fees paid to us that could be significant to the joint venture (the “VIE model”).
We also generally consolidate joint ventures when we have a controlling financial interest through voting rights and where our
voting interest is greater than 50% (the “voting model”). Voting interest differs from ownership interest for some joint ventures. We
account for joint ventures that do not meet the consolidation criteria under the equity method of accounting by recognizing our share of
income and losses.
24
4.
CONSOLIDATED AND UNCONSOLIDATED REAL ESTATE JOINT VENTURES (continued)
The table below shows the categorization of our real estate joint ventures under the consolidation framework:
Property
Consolidation
Model
Voting Interest
Consolidation Analysis
Conclusion
50 and 60 Binney Street
VIE model
Not applicable
under VIE
model
Consolidated
75/125 Binney Street
We have:
100 and 225 Binney Street and 300
Third Street
15 Necco Street
(i)
The power to direct the
activities of the joint venture
that most significantly affect its
economic performance; and
Alexandria Center
®
for Science and
Technology – Mission Bay
211 and 213 East Grand Avenue
500 Forbes Boulevard
Alexandria Center
®
for Life Science –
Millbrae
(ii)
Benefits that can be significant
to the joint venture.
3215 Merryfield Row
Campus Point by Alexandria
5200 Illumina Way
Therefore, we are the primary
beneficiary of each VIE
9625 Towne Centre Drive
SD Tech by Alexandria
Summers Ridge Science Park
1201 and 1208 Eastlake Avenue East
400 Dexter Avenue North
800 Mercer Street
101 West Dickman Street
We do not control the joint venture
and are therefore not the primary
beneficiary.
Equity method
of accounting
1655 and 1725 Third Street
Voting model
Does not
exceed 50%
Our voting interest is 50% or less.
Consolidated real estate joint ventures
99 Coolidge Avenue
In July 2025, we amended the agreement for our consolidated real estate joint venture at
99 Coolidge Avenue in our
Cambridge/Inner Suburbs submarket.
Pursuant to the amendment, the carrying amount of our partner’s noncontrolling interest was
adjusted from
$
42.0
million
to
$
48.7
million
, and converted into a redeemable noncontrolling interest that accrued a fixed
4.05
%
annual
preferred return (“distributions”).
In January 2026, the partner exercised its option to require us to purchase its preferred interest, and
the redemption was completed in January 2026 for
$
49.7
million
,
inclusive of unpaid distributions.
Consolidated VIEs’ balance sheet information
We, together with joint venture partners, hold interests in real estate joint ventures that we consolidate in our financial
statements. These existing joint ventures provide significant equity capital to fund a portion of our future construction spending, and our
joint venture partners may also contribute equity into these entities for financing-related activities.
25
4.
CONSOLIDATED AND UNCONSOLIDATED REAL ESTATE JOINT VENTURES (continued)
The table below aggregates the balance sheet information of our consolidated VIEs (in thousands):
March 31, 2026
December 31, 2025
Investments in real estate
$
5,797,860
$
6,129,668
Cash and cash equivalents
185,263
258,755
Other assets
724,923
712,154
Total assets
$
6,708,046
$
7,100,577
Secured note payable
$
—
$
—
Other liabilities
287,285
324,513
Total liabilities
287,285
324,513
Redeemable noncontrolling interests
—
49,554
Alexandria Real Estate Equities, Inc.’s share of equity
2,800,347
3,098,932
Noncontrolling interests’ share of equity
3,620,414
3,627,578
Total liabilities and equity
$
6,708,046
$
7,100,577
In determining whether to aggregate the balance sheet information of consolidated VIEs, we considered the similarity of each
VIE, including the primary purpose of these entities to own, manage, operate, and lease real estate properties owned by the VIEs, and
the similar nature of our involvement in each VIE as a managing member. Due to the similarity of the characteristics, we present the
balance sheet information of these entities on an aggregated basis. None of our consolidated VIEs’ assets have restrictions that limit
their use to settle specific obligations of the VIE. There are no creditors or other partners of our consolidated VIEs that have recourse to
our general credit, and our maximum exposure to our consolidated VIEs is limited to our variable interests in each VIE.
Noncontrolling interests in consolidated real estate joint ventures
Noncontrolling interests represent the third-party interests in consolidated real estate joint ventures in which we have a
controlling interest. Noncontrolling interests are adjusted for additional contributions and distributions, the proportionate share of the net
earnings or losses, and other comprehensive income or loss. Distributions, profits, and losses related to these entities are allocated in
accordance with the respective operating agreements. During the
three months ended March 31, 2026
and
2025
, we distributed
$
60.1
million
and
$
66.0
million
, respectively, to our consolidated real estate joint venture partners.
Unconsolidated real estate joint ventures
Our investments in unconsolidated real estate joint ventures, accounted for under the equity method and classified in
investments in unconsolidated real estate joint ventures in our consolidated balance sheets, consisted of the following as of
March 31,
2026
and
December 31, 2025
(in thousands):
Property
March 31, 2026
December 31, 2025
1655 and 1725 Third Street
$
19,333
$
19,484
101 West Dickman Street
9,666
9,669
Other
1,521
1,524
$
30,520
$
30,677
Our maximum exposure to our 1655 and 1725 Third Street unconsolidated VIE is limited to our investment in this VIE. With
respect to our unconsolidated real estate joint venture at 101 West Dickman Street, we guarantee up to
$
6.7
million
of the outstanding
balance related to the VIE’s secured construction loan.
Below are key terms of unconsolidated real estate joint ventures’ secured loans as of
March 31, 2026
(dollars in thousands):
Interest
Rate
(1)
At 100%
Our
Share
Unconsolidated Joint Venture
Maturity Date
Stated Rate
Aggregate
Commitment
Debt
Balance
(2)
101 West Dickman Street
10/29/26
SOFR+
1.95
%
(3)
5.68
%
$
26,750
$
19,048
58.4
%
1655 and 1725 Third Street
2/10/35
6.37
%
6.44
%
500,000
496,967
10.0
%
$
526,750
$
516,015
(1)
Includes interest expense and amortization of loan fees.
(2)
Represents outstanding principal, net of unamortized deferred financing costs,
as of March 31, 2026
.
(3)
This loan is subject to a fixed SOFR floor of
0.75
%
.
26
5.
LEASES
Refer
to “
Lease accounting
” in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated financial
statements for information about lease accounting standards that set principles for the recognition, measurement, presentation, and
disclosure of leases for both parties to a lease agreement (i.e., lessees and lessors).
Leases in which we are the lessor
As of
March 31, 2026
, we had
339
propertie
s aggregating
35.8
million
operating RSF
in key cluster locations, including
Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. We primarily focus
on developing Class A/A+ properties in AAA life science innovation clusters that offer the scale and strategic design integral to our
Megacampus strategy. Strategically located near top academic and medical research institutions, our Megacampus ecosystems feature
curated amenities and services and convenient access to transit, creating environments that help our tenants attract and retain top
talent.
As of
March 31, 2026
, all leases in which we are the lessor were classified as operating leases, w
ith the
exception of
one
direct financing
and
one
sales-type leas
e
. Our leases are described below.
Operating leases
As of
March 31, 2026
, our
339
properties were subject to operating lease agreements
.
Five
of these properties
are subject to
operating lease agreements that each contain a purchase option as described below:
(i)
Two
of these properties, representing
two
land parcels in the San Francisco Bay Area market, are subject to lease
agreements that each contain an option for the lessee to purchase the underlying asset from us at fair market value during
each of the 30-day periods commencing on the dates that are
15
years
,
30
years
, and
74.5
years
after the rent
commencement date of
October 1, 2017
.
The remaining lease term related to each of the
two
land p
arcel
s is
66.7
years
.
(ii)
Two
operating properties in the Seattle market, held by a consolidated real estate joint venture, are subject to purchase
options held by our partner in this joint venture, which is also a tenant at these properties. One purchase option allows our
partner to purchase our
30
%
interest in one property for
$
40.0
million
in
2031
. Contingent upon the exercise of this option,
the second purchase option allows our partner to purchase our
30
%
interest in one property for
$
69.1
million
in
2034
. Our
partner’s re
maining lease terms for these operating leases are
6.9
years
and
18.5
years
, res
pectively
.
(iii)
One
property subject to an operating lease agreement contains a purchase option exercisable at fair market value in
March 2034
.
Certain operating leases contain options for the tenant to extend their lease at prevailing market rates at the time of expiration.
In addition, certain operating leases contain an early termination option that requires advance notification and payment of an early
termination fee by the tenant.
At the commencement of each lease, we establish the lease term comprising the noncancelable period for each lease together
with periods covered by options to extend or terminate the lease that we determine the lessee is reasonably certain to exercise. Our
assessment of whether a lessee is reasonably certain to exercise or not exercise an option considers all economic factors relevant to
the assessment, including property-based, market-based, and tenant-based factors. We do not reassess the lease term or a lessee
option to purchase the underlying asset unless there is a lease modification that is not accounted for as a separate contract.
Future lease payments to be received under the terms of our operating lease agreements, excluding expense
reimbursements, in effect as of
March 31, 2026
are outlined in the table below (in thousands):
Year
Amount
2026
$
1,220,483
2027
1,494,928
2028
1,359,084
2029
1,261,862
2030
1,193,688
Thereafter
7,152,763
Total
$
13,682,808
Refer to Note 3 – “Investments in real estate” to our unaudited consolidated financial statements for additional information
about our owned real estate assets, which are the underlying assets under our operating leases.
27
5.
LEASES (continued)
Direct financing and sales-type leases
As of
March 31, 2026
, we have
one
direct financing lease agreemen
t
, with a net investment balance of
$
42.8
million
, for a
parking structure with a
remaining lease
term of
66.7
years
.
The lessee has an option to purchase the underlying asset at fair market
value during each of the
30
-day
periods commencing on the dates that are
15
years
,
30
years
, and
74.5
years
after the rent
commencement date of
October 1, 2017
.
As of
March 31, 2026
, we also have
one
sales-type lease
for a property in the Seattle marke
t.
As of
March 31, 2026
,
the net
investment in this lease is
$
16.6
million
.
At the end of the lease term in 2026, the property under this lease will transfer to the tenant for
a sales price of approximately
$
18.0
million
.
As of
March 31, 2026
, our estimated provision for expected credit loss related to our direct financing lease and sales-type
lease aggregated
$
1.8
million
,
which was predominantly related to our direct financing lease. We estimate the provision for expected
credit loss related to our direct financing lease using a probability of default methodology, which incorporates the borrower’s investment-
grade credit rating from S&P Global Ratings, to evaluate the probability of default. Additionally, we incorporate the projected value of the
real estate securing the investments to estimate potential recoveries in the event of default, among other inputs. The estimate of the
expected credit loss related to our sales-type lease was determined using historical industry losses and transaction-specific information,
including the estimated fair value of the underlying real estate asset securing this transaction, the short-term nature of this lease, and
other available information. For further details, refer to “Provision for expected credit losses” in Note 2 – “Summary of significant
accounting policies” to our unaudited consolidated financial statements.
The components of our aggregate net investment in our direct financing and sales-type leases as of
March 31, 2026
and
December 31, 2025
are summarized in the table below (in thousands):
March 31, 2026
December 31, 2025
Gross investment in direct financing and sales-type leases
$
265,618
$
265,839
Less: unearned income on direct financing lease
(
204,355
)
(
205,037
)
Less: provision for expected credit losses
(
1,817
)
(
1,817
)
Net investment in leases
$
59,446
$
58,985
Future lease payments to be received under the terms of our direct financing and sales-type leases as of
March 31, 2026
are
outlined in the table below (in thousands):
Year
Total
2026
$
18,225
2027
2,097
2028
2,160
2029
2,224
2030
2,291
Thereafter
238,621
Total
$
265,618
Income from rentals
Our income from rentals includes revenue related to agreements for the rental of our real estate, which primarily includes
revenues subject to the lease accounting standard and the revenue recognition accounting standard as shown below (in thousands):
Three Months Ended March 31,
2026
2025
Income from rentals:
Revenues subject to the lease accounting standard:
Operating leases
$
640,659
$
731,421
Direct financing and sales-type leases
964
810
Revenues subject to the lease accounting standard
641,623
732,231
Revenues subject to the revenue recognition accounting standard
11,390
10,944
Income from rentals
$
653,013
$
743,175
28
5.
LEASES (continued)
Revenues subject to the revenue recognition accounting standard and classified in income from rentals consist primarily of
short-term parking revenues that are not considered lease revenues under the lease accounting standard. Refer to “
Revenues
” and
“
Recognition of revenue arising from contracts with customers
” in Note 2 – “Summary of significant accounting policies” to our
unaudited consolidated financial statements for additional information.
Residual value risk management strategy
Our leases do not have guarantees of residual value on the underlying assets. We manage risk associated with the residual
value of our leased assets by (i) evaluating each potential acquisition of real estate to determine whether it meets our business
objective to invest primarily in high-demand markets, (ii) directly managing our leased properties, conducting frequent property
inspections, proactively addressing potential maintenance issues, and/or timely resolving any occurring issues, and (iii) carefully
selecting our tenants and monitoring their credit quality throughout their respective lease terms.
Leases in which we are the lessee
Operating lease agreements
We have operating lease agreements in which we are the lessee consisting of ground and office leases. Certain of these
leases have options to extend or terminate the contract terms upon meeting certain criteria. There are no notable restrictions or
covenants imposed by the leases, nor guarantees of residual value.
We recognize a right-of-use asset, which is classified within other assets in our consolidated balance sheets, and a related
liability, which is classified within accounts payable, accrued expenses, and other liabilities in our consolidated balance sheets, to
account for our future obligations under ground and office lease arrangements in which we are the lessee. Refer to “
Lessee accounting
”
in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated financial statements.
As of
March 31, 2026
, the present value of the remaining contractual payments aggregating
$
767.2
million
under our operating
lease agreements, including our extension options that we are reasonably certain to exercise, was
$
358.6
million
. Our corresponding
operating lease right-of-use assets, adjusted for initial direct leasing costs and other consideration exchanged with the landlord prior to
the commencement of the lease, aggregated
$
693.8
million
. As of
March 31, 2026
, the weighted-average remaining lease term of
operating leases in which we are the lessee was approximately
60
years
, including extension options that we are reasonably certain to
exercise, and the weighted-average discount rate was
4.7
%
. The weighted-average discount rate is based on the incremental
borrowing rate estimated for each lease, which is the interest rate that we estimate we would have to pay to borrow on a collateralized
basis over a similar term for an amount equal to the lease payments.
Ground lease obligations as of
March 31, 2026
included leases for
31
of our properties
, which accounted for approximately
9
%
of our total number of properties.
Excluding
one
ground lease that expires in
2036
related to
one
operating property
with a net book
value of
$
5.0
million
as of
March 31, 2026
,
our ground lease obligations have remaining lease terms ranging from approximately
28
to
97
years
,
including extension options that we are reasonably certain to exercise.
29
5.
LEASES (continued)
The reconciliation of future lease payments under noncancelable operating leases in which we are the lessee to the operating
lease liability reflected in our unaudited consolidated balance sheet as of
March 31, 2026
is in the table below (in thousands):
Year
Total
2026
$
17,206
2027
21,650
2028
21,318
2029
20,825
2030
20,743
Thereafter
665,496
Total future payments under our operating leases in which we are the lessee
767,238
Effect of discounting
(
408,628
)
Operating lease liability
$
358,610
Lessee operating costs
Operating lease costs relate to our ground and office leases in which we are the lessee. Ground leases generally require fixed
annual rent payments and may also include escalation clauses and renewal options. For the
three months ended March 31, 2026
and
2025
, amounts paid and classified as operating activities in our unaudited consolidated statements of cash flows for leases in which we
are the lessee aggregated
$
6.2
million
and
$
144.6
million
, respectively. The decrease is primarily due to the ground lease prepayment
o
f
$
135.0
million
made in
January 2025
for a 24-year lease term extension
to our existing ground lease agreement at the Alexandria
Technology Square
®
Megacampus in our Cambridge submarket.
Our operating lease obligations related to our office leases have remaining terms of up to
10
years
, exclusive of extension
options.
For the
three months ended March 31, 2026
and
2025
, our costs for operating leases in which we are the lessee were as
follows (in thousands):
Three Months Ended March 31,
2026
2025
Gross operating lease costs
$
8,417
$
12,359
Capitalized lease costs
(
759
)
(
693
)
Expenses for operating leases in which we are the lessee
$
7,658
$
11,666
6.
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
Cash, cash equivalents, and restricted cash consisted of the following as of
March 31, 2026
and
December 31, 2025
(in
thousands):
March 31, 2026
December 31, 2025
Cash and cash equivalents
$
418,720
$
549,062
Restricted cash:
Development escrows
2,129
2,142
Security deposits
1,804
1,729
Other
732
822
4,665
4,693
Total
$
423,385
$
553,755
30
7.
INVESTMENTS
We hold investments in publicly traded companies and privately held entities primarily involved in the life science industry. As a
REIT, we generally limit our ownership of each individual entity’s voting stock to less than
10
%
. We
evaluate each investment to
determine whether we have the ability to exercise significant influence, but not control, over an investee. We evaluate investments in
which our ownership is equal to or greater than 20%, but less than or equal to 50%, of an investee’s voting stock with a presumption
that we have this ability. For our investments in limited partnerships that maintain specific ownership accounts, we presume that such
ability exists when our ownership interest exceeds 3% to 5%. In addition to our ownership interest, we consider whether we have a
board seat or whether we participate in the investee’s policy-making process, among other criteria, to determine if we have the ability to
exert significant influence, but not control, over an investee. If we determine that we have such ability, we account for the investment
under the equity method, as described below.
From time to time, we may hold equity investments in publicly traded companies that are subject to
temporary
contractual sale
restrictions. We do not recognize a discount related to such contractual sale
restrictions
.
Investments accounted for under the equity method
Under the equity method of accounting, we initially recognize our investment at cost and subsequently adjust the carrying
amount of the investment for our share of earnings or losses reported by the investee, distributions received, and other-than-temporary
impairments.
As of
March 31, 2026
, we had
nine
investments in limited partnerships
maintaining specific ownership accounts for each
investor, which were accounted for under the equity method.
These investments aggregated
$
367.9
million
. Our ownership interest in
each of these
nine
investments was greater than 5%
.
Investments that do not qualify for the equity method of accounting
For investees over which we determine that we do not have the ability to exercise significant influence or control, we account
for each investment depending on whether it is an investment in a (i) publicly traded company, (ii) privately held entity that reports NAV
per share, or (iii) privately held entity that does not report NAV per share, as described below.
Investments in publicly traded companies
Our investments in publicly traded companies are classified as investments with readily determinable fair values and are
presented at fair value in our consolidated balance sheets, with changes in fair value classified in investment income (loss) in our
consolidated statements of operations. The fair values for our investments in publicly traded companies are determined based on sales
prices or quotes available on securities exchanges.
Investments in privately held companies
Our investments in privately held entities without readily determinable fair values consist of (i) investments in privately held
entities that report NAV per share and (ii) investments in privately held entities that do not report NAV per share. These investments are
accounted for as follows:
Investments in privately held entities that report NAV per share
Investments in privately held entities that report NAV per share, such as our privately held investments in limited partnerships,
are presented at fair value using NAV as a practical expedient, with changes in fair value classified in investment income (loss) in our
consolidated statements of operations. We use NAV per share reported by limited partnerships generally without adjustment, unless we
are aware of information indicating that the NAV reported by a limited partnership does not accurately reflect the fair value of the
investment at our reporting date.
Investments in privately held entities that do not report NAV per share
Investments in privately held entities that do not report NAV per share are accounted for using a measurement alternative
under which these investments are measured at cost, adjusted for observable price changes and impairments, with changes classified
in investment income (loss) in our consolidated statements of operations.
An observable price arises from an orderly transaction for an identical or similar investment of the same issuer, which is
observed by an investor without expending undue cost and effort. Observable price changes result from, among other things, equity
transactions of the same issuer executed during the reporting period, including subsequent equity offerings or other reported equity
transactions related to the same issuer. To determine whether these transactions are indicative of an observable price change, we
evaluate, among other factors, whether these transactions have similar rights and obligations, including voting rights, distribution
preferences, and conversion rights to the investments we hold.
31
7.
INVESTMENTS (continued)
I
mpairment evaluation of equity method investments and investments in privately held entities that do not report NAV per share
We monitor equity method investments and investments in privately held entities that do not report NAV per share for new
developments, including operating results, prospects and results of clinical trials, new product initiatives, new collaborative agreements,
capital-raising events, and merger and acquisition activities. These investments are evaluated on the basis of a qualitative assessment
for indicators of impairment by monitoring the presence of the following triggering events or impairment indicators:
(i)
a significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee;
(ii)
a significant adverse change in the regulatory, economic, or technological environment of the investee;
(iii)
a significant adverse change in the general market condition, including the research and development of technology and
products that the investee is bringing or attempting to bring to the market;
(iv)
significant concerns about the investee’s ability to continue as a going concern; and/or
(v)
a decision by investors to cease providing support or reduce their financial commitment to the investee.
If such indicators are present, we are required to estimate the investment’s fair value and immediately recognize an
impairment charge in an amount equal to the investment’s carrying value in excess of its estimated fair value.
Investment income/loss recognition and classification
We recognize both realized and unrealized gains and losses in our consolidated statements of operations, classified in
investment income (loss) in our consolidated statements of operations. Unrealized gains and losses represent:
(i)
changes in fair value for investments in publicly traded companies;
(ii)
changes in NAV for investments in privately held entities that report NAV per share;
(iii)
observable price changes for investments in privately held entities that do not report NAV per share; and
(iv)
our share of unrealized gains or losses reported by our equity method investees.
Realized gains and losses on our investments represent the difference between proceeds received upon disposition of
investments and their historical or adjusted cost basis. For our equity method investments, realized gains and losses represent our
share of realized gains or losses reported by the investee. Impairments are realized losses, which result in an adjusted cost basis, and
represent charges to reduce the carrying values of investments in privately held entities that do not report NAV per share and equity
method investments, if impairments are deemed other than temporary, to their estimated fair value.
Funding commitments to investments in privately held entities that report NAV
We are committed to funding approximately
$
327.8
million
for our investments in privately held entities that report NAV
.
Our
funding commitments expire at various dates over the next
12
years
, with a weighted-average expiration of
8.0
years
as of March 31,
2026
.
These investments are not redeemable by us, but we may receive distributions from these investments throughout their terms.
Our investments in privately held entities that report NAV generally have expected
initial terms
in
excess of
10
years
. The weighted-
average remaining term during which these investments are
expected to be liquidated was
5.5
years
as of March 31, 2026
.
The following tables summarize our investments as of
March 31, 2026
and
December 31, 2025
(in thousands):
March 31, 2026
Cost
Unrealized
Gains
Unrealized
Losses
Carrying
Amount
Publicly traded companies
$
83,916
$
34,674
$
(
16,514
)
$
102,076
Entities that report NAV
471,058
102,050
(
38,132
)
534,976
Entities that do not report NAV:
Entities with observable price changes
82,128
54,780
(
10,991
)
125,917
Entities without observable price changes
405,567
—
—
405,567
Investments accounted for under the equity method
N/A
N/A
N/A
367,883
Total investments
$
1,042,669
$
191,504
$
(
65,637
)
$
1,536,419
32
7.
INVESTMENTS (continued)
December 31, 2025
Cost
Unrealized
Gains
Unrealized
Losses
Carrying
Amount
Publicly traded companies
$
54,752
$
44,319
$
(
4,143
)
$
94,928
Entities that report NAV
460,160
89,514
(
37,298
)
512,376
Entities that do not report NAV:
Entities with observable price changes
82,252
50,601
(
9,615
)
123,238
Entities without observable price changes
413,324
—
—
413,324
Investments accounted for under the equity method
N/A
N/A
N/A
357,383
Total investments
$
1,010,488
$
184,434
$
(
51,056
)
$
1,501,249
Cumulative gains and losses (realized and unrealized) on investments in privately held entities that do not report NAV still held
as of March 31, 2026
aggregated to a
loss
of
$
125.7
million
, which consisted of
upward adjustments aggregating
$
54.8
million
,
downward
adjustments aggregating
$
11.0
million
, and impairments aggreg
ating
$
169.5
million
.
Our investment income (loss) for the
three months ended March 31, 2026
and
2025
consisted of the following (in thousands):
Three Months Ended March 31,
2026
2025
Realized gains
$
5,750
(1)
$
18,153
Unrealized losses
(
10,332
)
(
68,145
)
Investment loss
$
(
4,582
)
(2)
$
(
49,992
)
(1)
Consists of realized gains of
$
18.2
million
, partially offset by impairmen
t charges of
$
12.4
million
during the
three months ended March 31, 2026
.
(2)
Investment
loss
of
$
4.6
million
for the
three months ended March 31, 2026
also included
$
1.7
million
of equity in
losses
of our equity method investments.
Additional details on our non-real estate investments still held as of the
end of each period
are presented below (in thousands):
Three Months Ended March 31,
2026
2025
Investments in privately held entities that do not report NAV still held as of the end of
each period:
Upward adjustments
$
6,044
$
8,076
Downward adjustments and impairments
(
13,154
)
(
17,052
)
$
(
7,110
)
$
(
8,976
)
Unrealized gains (losses) on non-real estate investments still held as of the end of
each period (excluding equity method investments)
$
3,877
$
(
37,398
)
Refer to “Investments” in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated financial
statements for additional information
.
33
8.
OTHER ASSETS
The following table summarizes the components of other assets as of
March 31, 2026
and
December 31, 2025
(in thousands):
March 31, 2026
December 31, 2025
Acquired in-place leases
$
189,108
$
204,008
Deferred compensation plan
53,568
53,529
Deferred financing costs – unsecured senior line of credit
36,993
39,406
Deposits
28,472
28,618
Furniture, fixtures, equipment, and software
79,902
70,311
Net investment in leases
59,446
58,985
Notes receivable
260,167
258,033
Operating lease right-of-use assets
693,808
697,865
Other assets
87,894
87,036
Prepaid expenses
64,281
33,718
Property, plant, and equipment
129,504
130,263
Total
$
1,683,143
$
1,661,772
Notes receivable
Our notes receivable as of
March 31, 2026
and
December 31, 2025
consisted of the following (dollars in thousands):
March 31, 2026
Weighted-Average
Notes Receivable
Effective
Interest Rate
Maturity
Date
Balance
December 31, 2025
Secured by real estate assets in San Diego
9.9
%
1/10/29
$
245,204
$
240,476
Secured by real estate assets in Greater Boston
6.2
%
12/16/29
15,495
18,089
Less: provision for expected credit losses
(
532
)
(
532
)
Notes receivable
$
260,167
$
258,033
Our notes receivable represent held-to-maturity debt securities carried at amortized cost and are generally secured by real
estate. Under the current expected credit losses accounting standard, we are required to estimate and, if necessary, recognize a
provision for expected credit losses related to these notes. We do not have a history of losses on such securities; therefore, we utilize
available information on historical losses for the commercial real estate industry. We determine expected credit losses for our notes
receivable using historical industry losses and considering loan-specific information, including credit ratings of the borrowers, estimated
fair values of underlying real estate assets, loan-to-value ratios, the presence of guarantors, and/or other available information.
During
the three months ended
March 31, 2026
,
no
adjustment to the
provision for expected credit losses related to our notes receivable was
required
.
The provision is evaluated on an ongoing basis, with any necessary adjustments recognized in the corresponding period.
34
9.
FAIR VALUE MEASUREMENTS
We provide fair value information about all financial instruments for which it is practicable to estimate fair value. We measure
and disclose the estimated fair value of financial assets and liabilities by utilizing a fair value hierarchy that distinguishes between data
obtained from sources independent of the reporting entity and the reporting entity’s own assumptions about market participant
assumptions. This hierarchy consists of three broad levels, as follows: (i) quoted prices in active markets for identical assets or liabilities
(Level 1), (ii) significant other observable inputs (Level 2), and (iii) significant unobservable inputs (Level 3). Significant other observable
inputs can include quoted prices for similar assets or liabilities in active markets, as well as inputs that are observable for the asset or
liability, such as interest rates, foreign exchange rates, and yield curves. Significant unobservable inputs are typically based on an
entity’s own assumptions, since there is little, if any, related market activity. In instances in which the determination of the fair value
measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the
entire fair value measurement falls is based on the lowest level of input that is significant to the fair value measurement in its entirety.
Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers
factors specific to the asset or liability.
Assets and liabilities measured at fair value on a recurring basis
The following table sets forth the assets and liabilities that we measure at fair value on a recurring basis by level in the fair
value hierarchy as of
March 31, 2026
and
December 31, 2025
(in thousands).
There were
no
transfers of assets measured at fair value
on a recurring basis to or from Level 3 in the fair value hierarchy during the
three months ended March 31, 2026
.
Fair Value Measurement Using
Description
Total
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets:
Investments in publicly traded companies:
As of March 31, 2026
$
102,076
$
102,076
$
—
$
—
As of December 31, 2025
$
94,928
$
94,928
$
—
$
—
Cross-currency swap agreements:
As of March 31, 2026
$
2,409
$
—
$
2,409
$
—
Liabilities:
Cross-currency swap agreements:
As of December 31, 2025
$
928
$
—
$
928
$
—
Our investments in publicly traded companies represent investments with readily determinable fair values, and are carried at
fair value, with changes in fair value classified in investment income (loss) in our consolidated financial statements. We also hold
investments in privately held entities, which consist of (i) investments that report NAV and (ii) investments that do not report NAV, as
further described below.
Our investments in privately held entities that report NAV, such as our privately held investments in limited partnerships, are
carried at fair value using NAV as a practical expedient, with changes in fair value classified in
net income
.
As of March 31, 2026
and
December 31, 2025
, the carrying values of investments in privately held entities that report NAV aggregated
$
535.0
million
and
$
512.4
million
,
respectively
. These investments are excluded from the fair value hierarchy above as required by the fair value
accounting standard. We estimate the fair value of each of our investments in limited partnerships based on the most recent NAV
prepared by the general partner and reported by each limited partnership. As a result, the determination of fair values of our
investments in privately held entities that report NAV generally does not involve significant estimates, assumptions, or judgments on our
part.
Our cross-currency swap agreements are recognized at fair value. Refer to Note 2 – “Summary of significant accounting
policies” and Note 11 – “Hedge agreements” to our unaudited consolidated financial statements for additional information.
35
9.
FAIR VALUE MEASUREMENTS (continued)
Assets and liabilities measured at fair value on a nonrecurring basis
The following table sets forth the assets measured at fair value on a nonrecurring basis by level within the fair value hierarchy
as of
March 31, 2026
and
December 31, 2025
(in thousands).
Fair Value Measurement Using
Description
Carrying
Amount
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Real estate assets held for sale with carrying values
adjusted to fair value less costs to sell:
As of March 31, 2026
$
140,777
(1)
$
—
$
—
$
140,777
(2)
As of December 31, 2025
$
581,737
(1)
$
—
$
—
$
581,737
(2)
Investments in privately held entities that do not
report NAV:
As of March 31, 2026
$
137,303
$
—
$
125,917
(3)
$
11,386
(4)
As of December 31, 2025
$
139,251
$
—
$
123,238
(3)
$
16,013
(4)
(1)
These amounts are included in the total balances of our net assets classified as held for sale aggregating
$
522.5
million
and
$
581.7
million
as of
March 31, 2026
and
December 31, 2025
, respectively, disclosed in Note 3 – “Investments in real estate,” and represent assets held for sale as of
March 31, 2026
and
December 31, 2025
,
for which impairments were recognized.
(2)
These amounts represent the aggregate carrying amounts of assets held for sale after adjustments to their respective fair values less costs to sell based on
executed
purchase and sale agreements, letters of intent, valuations provided by third-party real estate brokers, or market comparables from recent transactions
.
(3)
T
hese amounts represent the total carrying amounts of our equity investments in privately held entities with observable price changes, which are included in the
investments balances of
$
1.54
billion
and
$
1.50
billion
in our unaudited consolidated balance sheets as of
March 31, 2026
and
December 31, 2025
, respectively,
disclosed in Note 7 – “Investments” to our unaudited consolidated financial statements.
(4)
These
amounts are included in the investments in privately held entities without observable price changes balances aggregating
$
405.6
million
and
$
413.3
million
as of
March 31, 2026
and
December 31, 2025
, respectively, disclosed in Note 7 – “Investments” to our unaudited consolidated financial statements, and represent the carrying
amounts of investments in privately held entities that do not report NAV for which impairments have been recognized in accordance with the measurement alternative
guidance described in “
Investments
” in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated financial statements.
Real estate assets classified as held for sale measured at fair value less costs to sell
Our real estate assets classified as held for sale and measured at fair value less costs to sell are presented in the table above.
These properties represent a subset of our total real estate assets classified as held for sale as of
March 31, 2026
and
December 31,
2025
. The fair values for these real estate assets were estimated based on
executed purchase and sale agreements, letters of intent,
valuations provided by third-party real estate brokers, or market comparables from recent transactions
. Refer to “Investments in real
estate” in Note 2 – “Summary of significant accounting policies” and “Assets held for sale” in Note 3 – “Investments in real estate” to our
unaudited consolidated financial statements for additional information.
Investments in privately held entities that do not report NAV
Our investments in privately held entities that do not report NAV are measured at cost, adjusted for observable price changes
and impairments, with changes recognized in net income (loss). These investments are adjusted based on the observable price
changes in orderly transactions for the identical or similar investment of the same issuer. Further adjustments are not made until
another observable transaction occurs. Therefore, the determination of fair values of our investments in privately held entities that do
not report NAV does not involve significant estimates and assumptions or subjective and complex judgments.
We also subject our investments in privately held entities that do not report NAV to a qualitative assessment for indicators of
impairment. If indicators of impairment are present, we are required to estimate the investment’s fair value and immediately recognize
an impairment charge in an amount equal to the investment’s carrying value in excess of its estimated fair value.
The estimates of fair value typically incorporate valuation techniques that include an income approach reflecting a discounted
cash flow analysis, and a market approach that includes a comparative analysis of acquisition multiples and pricing multiples generated
by market participants. In certain instances, we may use multiple valuation techniques for a particular investment and estimate its fair
value based on an average of multiple valuation results.
Refer to Note 7 – “Investments” to our unaudited consolidated financial statements for additional information.
36
9.
FAIR VALUE MEASUREMENTS (continued)
Assets and liabilities not measured at fair value in the statement of financial position but for which the fair value is disclosed
The fair value of our unsecured senior notes payable and the amounts outstanding on our unsecured senior line of credit and
commercial paper program were estimated using widely accepted valuation techniques, including discounted cash flow analyses using
significant other observable inputs such as available market information on discount and borrowing rates with similar terms, maturities,
and credit ratings. Because the valuations of our financial instruments are based on these types of estimates, the actual fair value of our
financial instruments may differ materially if our estimates do not prove to be accurate. Additionally, the use of different market
assumptions or estimation methods may have a material effect on the estimated fair value amounts.
As of
March 31, 2026
and
December 31, 2025
, the book and estimated fair values of our unsecured senior notes payable and
the amounts outstanding under our unsecured senior line of credit and commercial paper program, including the level within the fair
value hierarchy for which the estimates were derived, were as follows (in thousands):
March 31, 2026
Book Value
Fair Value Hierarchy
Estimated
Fair Value
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Liabilities:
Unsecured senior notes payable
$
11,166,009
$
—
$
10,096,063
$
—
$
10,096,063
Unsecured senior line of credit
$
—
$
—
$
—
$
—
$
—
Commercial paper program
$
1,353,986
$
—
$
1,354,081
$
—
$
1,354,081
December 31, 2025
Book Value
Fair Value Hierarchy
Estimated
Fair Value
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Liabilities:
Unsecured senior notes payable
$
12,047,394
$
—
$
10,675,433
$
—
$
10,675,433
Unsecured senior line of credit
$
—
$
—
$
—
$
—
$
—
Commercial paper program
$
353,161
$
—
$
353,189
$
—
$
353,189
The carrying values of cash and cash equivalents, restricted cash, tenant receivables, deposits, notes receivable, accounts
payable, accrued expenses, and other short-term liabilities approximate their fair value.
37
10.
SECURED AND UNSECURED SENIOR DEBT
T
h
e following table summarizes our outstanding indebtedness and respective principal payments remaining as of
March 31, 2026
(dollars in thousands):
Stated
Rate
Interest
Rate
(1)
Maturity
Date
(2)
Principal Payments Remaining for the Periods Ending December 31,
Unamortized
(Deferred
Financing
Cost),
(Discount)/
Premium
Debt
2026
2027
2028
2029
2030
Thereafter
Principal
Total
Unsecured senior line of credit and
commercial paper program
(3)
(3)
4.27
%
(3)
1/22/30
(3)
$
—
$
—
$
—
$
—
$
1,355,271
$
—
$
1,355,271
$
(
1,285
)
$
1,353,986
Unsecured senior notes payable
3.80
%
3.96
4/15/26
(4)
350,000
—
—
—
—
—
350,000
(
38
)
349,962
Unsecured senior notes payable
3.95
%
4.13
1/15/27
—
350,000
—
—
—
—
350,000
(
426
)
349,574
Unsecured senior notes payable
3.95
%
4.07
1/15/28
—
—
425,000
—
—
—
425,000
(
782
)
424,218
Unsecured senior notes payable
4.50
%
4.60
7/30/29
—
—
—
300,000
—
—
300,000
(
749
)
299,251
Unsecured senior notes payable
2.75
%
2.87
12/15/29
—
—
—
400,000
—
—
400,000
(
1,552
)
398,448
Unsecured senior notes payable
4.70
%
4.81
7/1/30
—
—
—
—
450,000
—
450,000
(
1,594
)
448,406
Unsecured senior notes payable
4.90
%
5.05
12/15/30
—
—
—
—
700,000
—
700,000
(
3,751
)
696,249
Unsecured senior notes payable
3.375
%
3.48
8/15/31
—
—
—
—
—
750,000
750,000
(
3,543
)
746,457
Unsecured senior notes payable
2.00
%
2.12
5/18/32
—
—
—
—
—
900,000
900,000
(
5,811
)
894,189
Unsecured senior notes payable
1.875
%
1.97
2/1/33
—
—
—
—
—
1,000,000
1,000,000
(
6,023
)
993,977
Unsecured senior notes payable
2.95
%
3.07
3/15/34
—
—
—
—
—
800,000
800,000
(
6,287
)
793,713
Unsecured senior notes payable
4.75
%
4.88
4/15/35
—
—
—
—
—
500,000
500,000
(
4,385
)
495,615
Unsecured senior notes payable
5.50
%
5.66
10/1/35
—
—
—
—
—
550,000
550,000
(
6,162
)
543,838
Unsecured senior notes payable
5.25
%
5.41
3/15/36
—
—
—
—
—
750,000
750,000
(
11,130
)
738,870
Unsecured senior notes payable
5.25
%
5.38
5/15/36
—
—
—
—
—
400,000
400,000
(
3,681
)
396,319
Unsecured senior notes payable
4.85
%
4.93
4/15/49
—
—
—
—
—
300,000
300,000
(
2,727
)
297,273
Unsecured senior notes payable
4.00
%
3.91
2/1/50
—
—
—
—
—
390,801
390,801
5,463
396,264
Unsecured senior notes payable
3.00
%
3.09
5/18/51
—
—
—
—
—
352,398
352,398
(
4,454
)
347,944
Unsecured senior notes payable
3.55
%
3.64
3/15/52
—
—
—
—
—
475,406
475,406
(
6,233
)
469,173
Unsecured senior notes payable
5.15
%
5.26
4/15/53
—
—
—
—
—
500,000
500,000
(
7,316
)
492,684
Unsecured senior notes payable
5.625
%
5.71
5/15/54
—
—
—
—
—
600,000
600,000
(
6,415
)
593,585
Unsecured debt weighted-average interest
rate/Total
4.06
%
$
350,000
$
350,000
$
425,000
$
700,000
$
2,505,271
$
8,268,605
$
12,598,876
$
(
78,881
)
$
12,519,995
(1)
Represents the weighted-average interest rate as of the end of the applicable period, including amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.
(2)
Reflects any extension options that we control.
(3)
Refer to footnote 3 on the following page.
(4)
In
April 2026
, we repaid our
3.80
%
unsecured senior notes payable upon maturity
.
No
gain or loss was incurred in connection with this repayment.
38
10.
SECURED AND UNSECURED SENIOR DEBT (continued)
The following table summarizes our unsecured senior debt and amounts outstanding under our unsecured senior line of credit
and commercial paper program as of
March 31, 2026
(dollars in thousands):
Fixed-Rate
Debt
Variable-Rate
Debt
Weighted-Average
Interest
Remaining
Term
(in years)
Total
Percentage
Rate
(1)
Unsecured senior notes payable
$
11,166,009
$
—
$
11,166,009
89.2
%
4.03
%
10.7
Unsecured senior line of credit
and commercial paper program
—
1,353,986
1,353,986
(2)
10.8
4.27
(2)
3.8
(3)
Total/weighted average
$
11,166,009
$
1,353,986
$
12,519,995
100.0
%
4.06
%
10.0
(3)
Percentage of total debt
89.2
%
10.8
%
100
%
(1)
Represents the weighted-average interest rate as of the end of the applicable period, including expense/income related to the amortization of loan fees, amortization of
debt premiums (discounts), and other bank fees.
(2)
As of
March 31, 2026
,
we had
no
outstanding balance on our unsecured senior line of credit and
$
1.35
billion
of commercial paper notes outstanding.
(3)
We calculate the weighted-average remaining term of our commercial paper notes by using the maturity date of our unsecured senior line of credit. Using the maturity
date of our outstanding commercial paper notes, the consolidated weighted-average maturity of our debt
i
s
9.6
years.
The commercial paper notes sold during the
three
months ended March 31, 2026
were issued at a
weighted-average yield to maturity of
4.08
%
and had a weighted-average maturity term of
13
days
.
Issuance and repayments of u
nsecured senior note
s payable
In February 2026, we completed tender offers to repurchase an aggregate debt principal amount of approximately
$
1.33
billion
of a portion of our outstanding
4.00
%
Senior Notes due
2050
,
3.00
%
Senior Notes due
2051
, and
3.55
%
Senior Notes due
2052
.
Cash
consideration paid was
$
952.2
million
. The repurchase was primarily funded through the issuance of
$
750.0
million
of
5.25
%
unsecured
senior notes due
2036
, and approximately
$
200
million
o
f short-term borrowings under our commercial paper program. In connection
with the debt repurchase, we recognized a gain on early extinguishment of debt aggregating
$
366.4
million
, including the write-off of
unamortized debt issuance costs and other transaction-related costs.
In
January 2026
, we repaid
$
300.0
million
of
4.30
%
unsecured senior notes payable upon maturity
.
No
gain or loss was
incurred in connection with this repayment.
In
April 2026
, we repaid
$
350.0
million
of
3.80
%
unsecured senior notes payable upon maturity.
No
gain or loss was incurred
in connection with this repayment.
$
5.0
billion
unsecured senior line of credit
As of
March 31, 2026
,
our unsecured senior line of credit,
which matures in
2030
, including extension options under our
control
, had aggregate commitments of
$
5.0
billion
, and bore an interest rate of SOFR plus
0.835
%
.
In addition to the cost of borrowing,
the unsecured senior line of credit is subject to an annual facility fee of
0.14
%
based on the aggregate commitments outstanding
.
Based on achievement of certain annual sustainability metrics, the interest rate and facility fee rate are also
subject to upward or
downward adjustments of up to
four
basis points with respect to the interest rate and up to
one
basis point with respect to the facility fee
rate.
During the three months ended March 31, 2026, we achieved certain annual sustainability targets, as described in our
unsecured senior line of credit agreement, which reduced the borrowing rate
by
four
basis points for a one-year period to
SOFR plus
0.835
%
, from SOFR plus
0.875
%
, and reduced the facility fee by
one
basis point to
0.14
%
from
0.15
%
.
As of
March 31, 2026
,
we had
no
outstanding balance on our unsecured senior line of credit.
$
2.50
billion
co
mmercial paper program
Our commercial paper program allows us to issue up to
$
2.50
billion
of commercial paper notes that bear interest at short-term
fixed rates with a maturity of generally
30
days or less and a maximum maturity of
397
days from the date of issuance.
This
program is
back-stopped by our unsecured senior line of credit, and at all times we expect to retain a minimum undrawn amount of borrowing
capacity under our unsecured senior line of credit equal to the amount of commercial paper notes outstanding. We use the net
proceeds from the issuances of the notes for general working capital and other general corporate purposes, which may include, but are
not limited to, the repayment of other debt and selective development, redevelopment, or acquisition of properties
. During the
three
months ended March 31, 2026
, the notes were issued at a
weighted-average yield to maturity of
4.08
%
and had a weighted-average
maturity term of
13
days
.
As of
March 31, 2026
, we had
$
1.35
billion
outstanding under our commercial paper program
.
39
10.
SECURED AND UNSECURED SENIOR DEBT (continued)
Interest expense
The following table summarizes interest expense for the
three months ended March 31, 2026
and
2025
(in thousands):
Three Months Ended March 31,
2026
2025
Interest incurred
$
134,557
$
130,941
Capitalized interest
(
69,973
)
(
80,065
)
Interest expense
$
64,584
$
50,876
11.
HEDGE AGREEMENTS
We have fixed-to-fixed cross-currency swap agreements designated as net investment hedges to mitigate the impact of
fluctuations in the USD
–
CAD exchange rate. The hedges were deemed effective on the commencement date. As of
March 31, 2026
,
t
he aggregate notional amount of the swaps was CAD
$
340.0
million
, and the corresponding total USD notional was approximately
$
246.8
million
. Under the terms of the swap agreements, USD fixed interest amounts are payable to us and CAD fixed interest amounts
are payable to the counterparty. The swap agreements mature on
April 30, 2026
. As of
March 31, 2026
, the hedge relationships
remained
highly effective
.
Refer to “Hedge accounting” in Note 2 – “Summary of significant accounting policies” to our unaudited
consolidated financial statements for additional information.
The tables below summarize the fair value of our cross-currency swap agreements designated as net investment hedges and
the impact on our consolidated financial statements. Amounts are presented in USD (in thousands).
Fair value of cross-currency swap agreements designated as net investment hedges
Balance Sheet Location
March 31, 2026
December 31, 2025
Other assets
$
2,409
$
—
Other liabilities
$
—
$
928
Effect on consolidated other comprehensive income
Location in Consolidated Statement of
Comprehensive Income
Three Months Ended
March 31, 2026
Total unrealized gains recognized in other comprehensive
income
Unrealized gains on foreign currency
translation, net
$
3,337
Effect on consolidated statements of operations
Location in Consolidated Statement of
Operations
Three Months Ended
March 31, 2026
Total gain recognized in net income
(1)
Other income
$
2,779
(1)
Represents net interest expense settlements and interest rate forward points excluded from assessment of hedge effectiveness. Refer to “Hedge accounting” in Note 2 –
“Summary of significant accounting policies” to our unaudited consolidated financial statements for additional information.
As of
March 31, 2026
, a majority of our assets in Canada were designated as held for sale. Unrealized gains or losses related
to our cross-currency swap agreements will be reclassified from accumulated other comprehensive income into net income upon sale
or substantially complete liquidation of our real estate investments in Canada.
40
12.
ACCOUNTS PAYABLE, ACCRUED EXPENSES, AND OTHER LIABILITIES
The following table summarizes the components of accounts payable, accrued expenses, and other liabilities as of
March 31,
2026
and
December 31, 2025
(in thousands):
March 31, 2026
December 31, 2025
Accounts payable and accrued expenses
$
368,098
$
510,580
Accrued construction
243,411
314,836
Acquired below-market leases
126,697
133,033
Conditional asset retirement obligations
34,267
34,342
Deferred rent liabilities
16,090
14,659
Operating lease liability
358,610
360,543
Unearned rent and tenant security deposits
860,519
876,252
Other liabilities
147,090
152,828
Total
$
2,154,782
$
2,397,073
As of March 31, 2026
and
December 31, 2025
, our conditional asset retirement obligations primarily consisted of the soil and
groundwater remediation liabilities associated with certain properties. Some of
our properties may contain asbestos or may be
subjected to other hazardous or toxic substances, which, under certain conditions, requires remediation.
We engage independent
environmental consultants to conduct Phase I or similar environmental assessments at our properties. This type of assessment
generally includes a site inspection, interviews, and a public records review; asbestos, lead-based paint, and mold surveys; subsurface
sampling; and other testing. We recognize a liability for the fair value of a conditional asset retirement obligation when the fair value of
the liability can be reasonably estimated. In addition, environmental laws and regulations subject our tenants, and potentially us, to
liability that may result from our tenants’ routine handling of hazardous substances and wastes as part of their operations at our
properties.
As of March 31, 2026
, we are not aware of any additional environmental liability that we believe would require additional
disclosures or recognition in our consolidated financial statements.
41
13.
EARNINGS PER SHARE
We grant two types of restricted stock awards: (i) restricted stock awards with nonforfeitable dividends and (ii) restricted stock
awards with forfeitable dividends.
Unvested restricted stock awards (“RSAs”) with nonforfeitable dividends are considered participating securities and included in
the computation of EPS using the two-class method. Under this method, we allocate net income (after amounts attributable to
noncontrolling interests) to common stockholders and these RSAs by using the weighted-average shares of each class outstanding for
quarter-to-date and year-to-date periods independently, based on their respective participation rights to dividends declared (or
accumulated) and undistributed earnings.
Unvested RSAs with forfeitable dividends do not qualify as participating securities under the two-class method because the
dividends are forfeited if the awards do not vest. As a result, undistributed earnings are not allocated to these awards prior to vesting,
and these awards have no effect on the computation of basic EPS while unvested. Once these awards vest, they are included in the
denominator of basic EPS, weighted for the portion of the reporting period they were vested. Prior to vesting, these awards are included
in the denominator of diluted EPS if they are dilutive, which is determined using the treasury stock method. Under this method,
incremental shares are calculated as the difference between the total unvested shares and the number of shares that could
hypothetically be repurchased using the assumed proceeds (including unrecognized compensation cost related to these awards).
These incremental shares are weighted for the portion of the reporting period they were unvested and are included in the diluted EPS
denominator only if their inclusion reduces EPS (i.e., if they are not antidilutive).
In addition, from time to time, we enter into forward equity sales agreements. We consider the potential dilution resulting from
the forward equity sales agreements on the EPS calculations. At inception, the agreements do not have an effect on the computation of
basic EPS as no shares are delivered until settlement. The common shares issued upon the settlement of the forward equity sales
agreements, weighted for the period these common shares were outstanding, are included in the denominator of basic EPS. To
determine the dilution resulting from the forward equity sales agreements during the period of time prior to settlement, we calculate the
number of weighted-average shares outstanding – diluted using the treasury stock method. As of
March 31, 2026
,
no
forward equity
sales agreements were outstanding.
The table below reconciles the numerators and denominators of the basic and diluted EPS computations for the
three months
ended March 31, 2026
and
2025
(in thousands, except per share amounts):
Three Months Ended March 31,
2026
2025
Net income
$
398,377
$
38,662
Net income attributable to noncontrolling interests
(
36,724
)
(
47,601
)
Net income attributable to unvested RSAs with nonforfeitable dividends
(
2,779
)
(
2,660
)
Numerator for basic and diluted EPS – net income (loss) attributable to Alexandria Real Estate
Equities, Inc.’s common stockholders
$
358,874
$
(
11,599
)
Denominator for basic EPS – weighted-average shares of common stock outstanding
170,598
170,522
Dilutive effect of unvested RSAs with forfeitable dividends
269
—
Denominator for diluted EPS – weighted-average shares of common stock outstanding
170,867
170,522
Net income (loss) per share attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders:
Basic
$
2.10
$
(
0.07
)
Diluted
$
2.10
$
(
0.07
)
42
14.
STOCKHOLDERS’ EQUITY
C
o
mmon equity transaction
s
Common stock repurchase program
On December 8, 2025, we announced that our Board of Directors authorized a new common stock repurchase program that
allows for the repurchase of up to
$
500.0
million
of our common stock through
December 31, 2026
. This new program replaced our
prior stock repurchase program. As of the date of this report, no repurchases have been made under the new program and
$
500.0
million
remains available for future share repurchases.
ATM common stock offering program
In February 2024, we entered into an ATM common stock offering program that allows us to sell up to an aggregate of
$
1.50
billion
of our common stock.
During the
three months ended March 31, 2026
, we had no activity under our ATM progra
m.
As of
March 31, 2026
, the
remaining aggregate amount available under our ATM program for future sales of common stock was
$
1.47
billion
.
Dividends
During the
three months ended March 31, 2026
, we declared cash dividends on our common stock aggregating
$
125.5
million
,
or
$
0.72
per share
.
Accumulated other comprehensive
loss
The change in accumulated other comprehensive
loss
attributable to Alexandria Real Estate Equities, Inc.’s stockholders
during the
three months ended March 31, 2026
was entirely due to net unrealized
losses
of
$
1.5
million
on foreign currency translation
related to our operations primarily in Canada.
The change in accumulated other comprehensive
loss
attributable to Alexandria Real Estate Equities, Inc.’s stockholders for
the
three months ended March 31, 2026
was primarily due to unrealized foreign currency translation
losses
of
$
4.9
million
related to our
operations in Canada and partially offset by
$
3.3
million
of unrealized gains
resulting from the changes in the fair value of our cross-
currency swap agreements due to the weakening of the Canadian dollar. Refer to Note 11 – “Hedge agreements” to our unaudited
consolidated financial statements for additional information.
Common stock, preferred stock, and excess stock authorizations
Our charter authorizes the
issuance of
400.0
million
shares
of common stock
,
of which
170.7
million
shares
were issued and
outstanding as of
March 31, 2026
. Our charter also authorizes the
issuance of up to
100.0
million
shares of preferred stock
,
none
of
which were issued and outstanding as of
March 31, 2026
. In addition,
200.0
million
shares of “excess stock”
(as defined in our charter)
are authorized,
none
of which were issued and outstanding as of
March 31, 2026
.
43
15.
SEGMENT INFORMATION
We are a life science REIT focused on developing, redeveloping, and operating properties that provide space for lease to
tenants primarily in the life science industry. Our properties are leased predominantly through triple-net lease agreements and share
key characteristics, including generic and reusable improvements, consistent lease structures, and business and financial strategy. All
properties are located within North America, predominantly in the U.S., and operate within a comparable regulatory environment.
Operating segments
Our Chief Operating Decision Maker (“CODM”), represented by our Executive Chairman and our Chief Executive Officer,
evaluates operating results at the geographic market level to assess performance and allocate resources. Our operating segments align
with our markets, including Greater Boston, the San Francisco Bay Area, San Diego, and Seattle, among others. Regular market
performance updates are provided directly to the CODM. These updates include each market’s net operating income (“NOI”), which
serves as the profit or loss measure used by the CODM for performance assessment and resource allocation. NOI provides useful
information regarding performance of each market as it reflects income and expenses incurred in connection with real estate operations
in each market. This metric enables the CODM to evaluate the profitability and performance of each market on a consistent and
comparable basis, supporting decisions on capital resource allocation, including in connection with development, redevelopment,
acquisition, and disposition activities in each market.
Evaluation of economic similarity and aggregation of operating segments
In accordance with the segment reporting accounting standard, we evaluate the economic similarity of our operating
segments.
Seven
of our
nine
operating segments exhibit consistent long-term economic characteristics, including similar historical long-
term NOI margins, which are also expected to remain similar in the future. Additionally, these markets share similar operational
characteristics, including nature of services provided (i.e., leasing, operating, developing, and redeveloping life science properties),
tenant base (i.e., a variety of tenants involved in the life science industry), methods of operation (i.e., consistent lease structures,
property management practices, and business strategies), nature of the regulatory environment (consistent across North America,
where all our operating segments are located). Based on shared economic characteristics, we have aggregated our
seven
operating
segments into
one
reportable segment for segment reporting purposes. The remaining operating segments, which do not meet the
aggregation criteria and individually do not meet the quantitative thresholds to qualify as reportable segments, were included in the “all
other” category in the tables below
.
The following table presents the reportable segment profit or loss measure, NOI, for the
three months ended March 31, 2026
and
2025
(in thousands):
Three Months Ended March 31,
2026
2025
Reportable segment revenues:
Revenues from external customers
$
621,259
$
699,199
Other income
4,535
6,527
Reportable segment total revenues
625,794
705,726
Reportable segment total rental operating expenses
(
212,658
)
(
212,436
)
Reportable segment net operating income (reportable segment profit or loss)
$
413,136
$
493,290
Significant expenses included in the reportable segment profit or loss measure (i.e., NOI) are represented by the reportable
segment total rental operating expenses and are disclosed in the table above. These expenses primarily include property taxes, utilities,
repairs and maintenance, engineering, janitorial, and other costs.
44
15.
SEGMENT INFORMATION (continued)
Presented below are reconciliations of the reportable segment total revenues to the consolidated revenues, the reportable
segment total rental operating expenses to consolidated rental operations, the reportable segment NOI to the consolidated net income,
and the reportable segment investments in real estate assets to the consolidated investments in real estate assets (in thousands):
Three Months Ended March 31,
2026
2025
Reconciliation of reportable segment revenues to consolidated total revenues:
Reportable segment total revenues
$
625,794
$
705,726
All other revenues
45,228
52,432
Consolidated total revenues
$
671,022
$
758,158
Reconciliation of reportable segment total rental operating expenses to consolidated rental
operations:
Reportable segment total rental operating expenses
$
(
212,658
)
$
(
212,436
)
All other rental operating expenses
(
11,484
)
(
13,959
)
Consolidated rental operations
$
(
224,142
)
$
(
226,395
)
Reconciliation of reportable segment net operating income to consolidated net losses:
Reportable segment net operating income (reportable segment profit or loss)
$
413,136
$
493,290
All other revenues
45,228
52,432
All other rental operating expenses
(
11,484
)
(
13,959
)
Other items not allocated to segments:
General and administrative
(
34,685
)
(
30,675
)
Interest expense
(
64,584
)
(
50,876
)
Depreciation and amortization
(
305,441
)
(
342,062
)
Impairment of real estate
(
5,499
)
(
32,154
)
Equity in losses of unconsolidated real estate joint ventures
(
147
)
(
507
)
Investment loss
(
4,582
)
(
49,992
)
Gain on early extinguishment of debt
366,435
—
Gain on sale of real estate
—
13,165
Consolidated net income
$
398,377
$
38,662
March 31, 2026
December 31, 2025
Reconciliation of reportable segment assets to consolidated investments in real
estate assets:
Reportable segment investments in real estate
$
27,660,991
$
27,510,082
All other investments in real estate
1,169,125
1,179,914
Consolidated investments in real estate
$
28,830,116
$
28,689,996
16.
SUBSEQUENT EVENTS
In
April 2026
, we repaid
$
350.0
million
of
3.80
%
unsecured senior notes payable upon maturity.
No
gain or loss was incurred
in connection with this repayment.
45
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-looking statements
Certain information and statements included in this quarterly report on Form 10-Q, including, without limitation, statements
containing the words “forecast,” “guidance,” “goals,” “projects,” “estimates,” “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,”
“seeks,” “should,” “targets,” or “will,” or the negative of those words or similar words, constitute “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-looking statements involve inherent risks and uncertainties regarding events, conditions, and financial trends that
may affect our future plans of operations, business and financial strategy, results of operations, and financial position. A number of
important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking
statements, including, but not limited to, the following:
•
Operating factors, such as a failure to operate our business successfully in comparison to market expectations or in
comparison to our competitors, our inability to obtain capital when desired or refinance debt maturities when desired, and/
or a failure to maintain our status as a REIT for federal tax purposes;
•
Market and industry factors, such as adverse developments concerning the life science industry and/or our tenants;
•
Government factors, such as any unfavorable effects resulting from federal, state, local, and/or foreign government
policies, laws, and/or funding levels;
•
Global factors, such as negative economic, social, political, financial, credit market, banking conditions, and/or regional
armed hostilities; and
•
Other factors, such as climate change, cyber intrusions, and/or changes in laws, regulations, and financial accounting
standards.
This list of risks and uncertainties is not exhaustive. Additional information regarding risk factors that may affect us is included
under Part I; “Item 1A. Risk factors”; and “Item 7. Management’s discussion and analysis of financial condition and results of
operations” in our annual report on Form 10-K for the year ended
December 31, 2025
and under respective sections in this quarterly
report on Form 10-Q. Readers of this quarterly report on Form 10-Q should also read our other documents filed publicly with the SEC
for further discussion regarding such factors.
46
Overview
We are a Maryland corporation formed in October 1994 that has elected to be taxed as a REIT for federal income tax
purposes.
Alexandria Real Estate Equities, Inc. (NYSE: ARE),
an
S&P 500
®
company, is a best-in-class, mission-driven life science
REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate
niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in
AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland,
Research Triangle, and New York City. As of
March 31, 2026
, Alexandria has a total market capitalization of
$20.44 billion
and an asset
base that includes
35.8 million
RS
F
of operating properties
and
3.4 million
RSF
of Class A/A+ properties undergoing construction.
We develop dynamic Megacampus ecosystems that enable and inspire some of the world’s most brilliant minds and innovative
companies to create life-changing scientific and technological innovations. We believe in the utmost professionalism, humility, and
teamwork. Our tenants include multinational pharmaceutical companies; life science product, service, and device companies; public
and private biotechnology companies; advanced technologies companies; biomedical institutions; U.S. government institutions; and
others. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and
collaborative Megacampus environments that enhance our tenants’ ability to successfully recruit and retain world-class talent and
inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science
companies through our venture capital platform.
As of
March 31, 2026
:
•
Investment-grade or publicly traded large cap tenants represented
55%
o
f our annual rental revenue;
•
Approximately
97%
of our leases (on an annual rental revenue basis) contained effective annual rent escalations
approximating
3%
that were either fixed
or indexed based on a consumer price index or other index;
•
Approximately
91%
of our leases (on an annual rental revenue basis) were triple net leases, which require tenants to pay
substantially all real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and other
operating expenses (including increases thereto) in addition to base rent;
•
Approximately
92%
of our leases (on an
annual rental revenue
basis)
provided for the recapture of capital expenditures
(such as HVAC maintenance and/or replacement, roof replacement, and parking lot resurfacing) that we believe would
typically be borne by the landlord in traditional office leases; and
•
78%
of our leasing activity during the last twelve months was generated from our existing tenant base.
A key element of our business and financial strategy is our unique focus on Class A/A+ properties primarily located in
collaborative Megacampus ecosystems in AAA life science innovation clusters. Our Megacampus ecosystems are designed for
optionality and scalability, offering our tenants a clear path to address their growth requirements, including through our future
developments and redevelopments. Strategically located near top academic and medical research institutions and equipped with
curated amenities and services and convenient access to transit, our Megacampus ecosystems are designed to support our tenants in
attracting and retaining top talent and in meeting our tenants’ growth needs, which we believe is a key driver of tenant demand for our
properties. Our strategy also includes drawing upon our deep, broad, and long-standing real estate and life science industry
relationships in order to retain tenants, identify and attract new and leading tenants, and source additional real estate.
47
Executive summary
Operating results
Three Months Ended March 31,
2026
2025
Net income (loss) attributable to Alexandria’s common stockholders – diluted:
In millions
$
358.9
$
(11.6)
Per share
$
2.10
$
(0.07)
Funds from operations attributable to Alexandria’s common stockholders – diluted, as
adjusted:
In millions
$
295.9
$
392.0
Per share
$
1.73
$
2.30
For additional information, refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria
Real Estate Equities, Inc.’s common stockholders” under “
Definitions and reconciliations
.”
A best-in-class REIT with a high-quality, diverse tenant base, strong margins, and long lease terms
(As of
March 31, 2026
, unless stated otherwise)
Occupancy of operating properties
87.7%
Percentage of total annual rental revenue in effect from Megacampus platform
78%
Percentage of total annual rental revenue in effect from investment-grade or publicly traded large cap tenants
55%
Adjusted EBITDA margin for the
three months ended March 31, 2026
66%
Percentage of leases containing annual rent escalations
97%
Weighted-average remaining lease term:
Top 20 tenants
9.9
years
All tenants
7.5
years
Strong tenant collections
(1)
:
Rents and receivables for the three months ended
March 31, 2026
, collected as of the date of this report
99.9%
(1)
Refer to “Tenant Collections” under “
Definitions and reconciliations
” for additional details.
Strong and flexible balance sheet with significant liquidity;
top 15%
credit rating ranking among all publicly traded U.S. REITs
•
Net debt and preferred stock to Adjusted EBITDA of
6.8x
and
fixed-charge coverage ratio of
3.4x
for the
three months ended
March 31, 2026
annualized,
with targets for the three months ending December 31, 2026 annualized of
5.6x
-
6.2x
and
3.6x
-
4.1x
, respectively.
•
We expect improvement in our quarter annualized net debt and preferred stock to Adjusted EBITDA ratio in the second
half of 2026 as we complete dispositions and sales of partial interests.
•
As of
March 31, 2026
:
•
Our credit ratings from S&P Global Ratings and Moody’s Ratings were
BBB+
and
Baa1
, respectively, which rank in the
top
15%
among all publicly traded U.S. REITs.
•
Significant liquidity of
$4.17 billion
, or
3.7x
of our debt maturities through
2028
.
•
Only
9%
of our total debt matures through
2028
.
•
10.0
-year weighted-average remaining debt term
, the
longest
among S&P 500 REITs
.
•
T
otal debt and preferred stock to gross assets of
31%
.
48
Solid leasing of development and redevelopment space
•
Leasing volume of
647,356
RSF during the
three months ended March 31, 2026
.
•
Leasing of development and redevelopment space aggregating
117,935
RSF during the
three months ended March 31,
2026
, up
135%
from the prior five quarter average, excluding a build-to-suit lease executed in July 2025 with a long-
standing multinational pharmaceutical tenant.
•
From April 1, 2026 through the date of this report, we have executed leases and/or letters of intent aggregating
276,188
RSF related to our development and redevelopment pipeline.
•
72%
of our leasing activity during the
three months ended March 31, 2026
was generated from our existing tenant base.
Three Months Ended
March 31, 2026
Leasing activity in RSF:
Leasing of development and redevelopment space
117,935
Leasing of previously vacant space
148,734
Lease renewals and re-leasing of space
380,687
647,356
Lease renewals and re-leasing of space:
Rental rate increase
(15.0)%
Rental rate increase (cash basis)
(15.8)%
•
Excluding the impact of one lease aggregating
47,719
RSF at 480 Arsenal Street in our Cambridge/Inner Suburbs submarket,
rental rates for renewed and re-leased space for the
three months ended March 31, 2026
would have decreased by
10.1%
and
9.1%
(cash basis
). The space at 480 Arsenal Street was re-leased to an entertainment studio user to accommodate their
expansion needs and secure a long-term extension. In addition, the reorientation of this building layout provides flexibility to
market the remaining available space to a broader range of user demand.
Key operating metrics
•
T
otal revenues of
$671.0 million
,
down
11.5%
,
for the
three months ended March 31, 2026
, compared to
$758.2 million
f
or the
three months ended March 31, 2025
. Excluding dispositions completed after
January 1, 2025
,
total revenues would have
decreased
by
5.1%
for the
three months ended March 31, 2026
compared to the
three months ended March 31, 2025
.
•
Net operating income (cash basis) of
$1.7 billion
for the
three months ended March 31, 2026
, annualized,
decreased
by
$300.6 million
, or
15.2%
,
compared to the
three months ended March 31, 2025
, annualized.
•
Change in net operating income (cash basis) reflects the impact of operating properties disposed of after
January 1, 2025
.
Excluding these dispositions, net operating income (cash basis), annualized, f
or the
three months ended March 31, 2026
,
would have
decreased
by
8.9%
.
•
Same property net operating income
decreased by
11.9%
and
11.7%
(cash basis) for the
three months ended March 31, 2026
,
compared to the
three months ended March 31, 2025
.
•
T
he quarter-over-quarter decline was due to a decrease in same property occupancy, primarily driven by the previously
disclosed 2026 key lease expirations aggregating
657,492
RSF that became vacant during the three months ended March
31, 2026, with a weighted-average lease expiration date of
January 2026
, and by vacancy during the three months ended
December 31, 2025 at one property aggregating
170,618
RSF at Alexandria Center
®
for Advanced Technologies – South
San Francisco in our South San Francisco submarket. We expect our same property performance to improve in the
second half of 2026, primarily due to changes in same property occupancy, including the anticipated delivery of
1.1 million
RSF of
vacant space that was leased but not yet delivered as of March 31, 2026, which has a weighted-average expected
delivery date of approximately
September 2026
, and is expected to generate annual rental revenue of approximately
$68
million
.
•
Same properties average occupancy for the
three months ended March 31, 2026
was
88.9%
, compared to
94.0%
average
same properties occupancy for the
three months ended March 31, 2025
.
Continued successful reduction and management of general and administrative expenses
•
General and administrative expenses for
the
three months ended March 31, 2026
aggregated
$34.7 million
, which represents
a
decrease
of
$7.4 million
, or
18%
, compared to the quarterly average for
2024
. For the trailing twelve months ended
March 31, 2026
, general and administrative expenses as a percentage of net operating income were
6.0%
,
approximately
half
the average of other S&P 500 REITs for 2023–2025.
•
During the
year ended December 31, 2025
, we achieved general and administrative expense reduction of
$51.3 million
, or
30%
, compared to the
year ended December 31, 2024
, primarily as a result of cost-control and efficiency initiatives.
Some of
these cost savings were temporary, and we anticipate that approximately
half
of the cost reduction achieved in 2025 will
continue in 2026.
49
Dividend strategy to share net cash flows from operating activities with stockholders while retaining a significant portion for reinvestment
•
Common stock dividend declared
o
f
$0.72
per share
for the
three months ended March 31, 2026
, consistent with the
preceding quarter. The declared dividend per common share reflects our commitment to maintaining the strength of our
balance sheet, enhancing financial flexibility, preserving liquidity, and sharing cash flows with our stockholders.
•
Significant net cash provided by operating activities, as adjusted, retained for reinvestment aggregating
$2.60 billion
for the
years ended December 31,
2022
through
2025 and the midpoint of our 2026 guidance range
.
•
Dividend yield of
6.2%
as of
March 31, 2026
and
dividend payout ratio of
42%
for the three months ended
March 31, 2026
.
Ongoing execution of Alexandria’s capital recycling strategy
We plan to continue funding a significant portion of our capital requirements for the year ending December 31, 2026 through
dispositions of land, non-core assets, and core assets (primarily sales of partial interests).
(dollars in millions)
Sales Price
%
Completed and pending transactions subject to non-refundable deposits, signed letters of intent, and/or
sale agreement negotiations as of the date of this report
$
151
5%
Identified and in process
2,181
75%
Additional projected
568
20%
2026
guidance midpoint for dispositions and sales of partial interests
$
2,900
Occupancy and leasing progress on temporary vacancy
Operating occupancy as of
December 31, 2025
90.9%
Reduction in occupancy related to previously disclosed key lease expirations during the three months ended
March 31, 2026
(1.9)
(1)
Other changes in occupancy
(1.3)
(2)
Operating occupancy as of
March 31, 2026
87.7
Vacant space leased but not yet delivered
3.2
(3)
Operating occupancy as of
March 31, 2026
, including vacant space leased but not yet delivered
90.9%
(1)
Represents previously disclosed key lease expirations aggregating
657,492
RSF,
with a weighted-average lease expiration date of
January 2026
and prior annual rental
revenue of approximately
$41.6 million
. These vacant spaces are currently
48%
leased or under negotiation and the remaining
52%
is being actively marketed for re-
lease.
(2)
Includes i)
139,408
RSF, or
0.4%
, resulting from spaces vacated by tenants winding down operations, which are being actively marketed for re-lease and ii) delivery of
50,531
vacant RSF
, or
0.2%
, at our 10075 Barnes Canyon Road development project located at our SD Tech by Alexandria Megacampus.
(3)
Represents temporary vacancies aggregating
1.1 million
RSF, primarily in the Greater Boston, San Francisco Bay Area, and Seattle markets, that are leased and
expected to be occupied upon completion of building and/or tenant improveme
nts. The weighted-average expected delivery date is approximately
September 2026
, with
expected annual rental revenue of approximately
$68 million
.
Key capital metrics as of or for the
three months ended March 31, 2026
•
$20.44 billion
in total market capitalization
.
•
$7.92 billion
in total equity capitalization
.
•
Non-real estate investments aggregating
$1.54 billion
:
•
Unrealized
gains
presented in our consolidated balance sheet were
$125.9 million
, c
omprising gross unrealized gains and
losses aggregating
$191.5 million
and
$65.6 million
, respectively
.
•
I
nvestment
loss
of
$4.6 million
for the
three months ended March 31, 2026
presented in our consolidated statement of
operations consisted of
$18.2 million
of realized
gains
,
$10.3 million
of unrealized
losses
, and
$12.4 million
of impairment
charges.
50
Key capital events
•
In February 2026, we completed tender offers to repurchase an aggregate debt principal amount of
$1.33 billion
across a
portion of our outstanding
4.00%
Senior Notes due
2050
,
3.00%
Senior Notes due
2051
, and
3.55%
Senior Notes due
2052
.
Cash consideration paid was
$952.2 million
. In connection with the debt repurchase,
we recognized a gain on early
extinguishment of debt of approximately
$366.4 million
, including the write-off of unamortized debt issuance costs and other
transaction-related costs.
•
We funded the repurchases as follows:
•
$750.0 million
through the issuance of
5.25%
unsecured senior notes due
2036
; and
•
Approximately
$200 million
through short-term borrowings under our commercial paper program, which will be repaid
through planned dispositions and sales of partial interests included in our 2026 guidance.
•
The repurchase reduced debt and improved leverage by approximately
0.2x
.
•
This transaction did not have a significant impact to our FFO per share diluted, as adjusted, interest expense, or fixed-
charge coverage ratio.
•
Following this transaction, our
weighted-average remaining term of debt as of
March 31, 2026
is
10.0
years
, which
continues to be the
longest
among S&P 500 REITs
.
•
In
January 2026
and
April 2026
, we repaid,
upon maturity,
$300.0 million
of
4.30%
unsecured senior notes payable and
$350.0 million
of
3.80%
unsecured senior notes payable, respectively
. These repayments were funded temporarily with
borrowings under our commercial paper program, which will be repaid through planned dispositions and sales of partial
interests included in our 2026 guidance.
No
gain or loss was incurred in connection with these repayments.
•
Under our common stock repurchase program authorized in December 2025, we may repurchase up to
$500.0 million
of our
common stock through
December 31, 2026
.
As of the date of this report, no shares have been repurchased.
Reduction of capital spend and funding needs
•
We are evaluating the business and financial strategy for certain projects aggregating
1.6 million
RSF
to reduce future
construction funding requirements within our active pipeline.
•
Driven by demand for our Megacampuses and access to amenities at our
311 Arsenal Street and 3000 Minuteman Road
redevelopment
projects, we executed letters of intent aggregating
242,408
RSF in April 2026. These letters of intent are
for
lower-cost alternative uses for all or a portion of these projects, including advanced technology.
If we are successful in
executing these potential leases, we expect to evaluate whether all or a portion of these projects will be placed back into
operation without the need to further redevelop.
•
Non-income-producing assets are
17%
as a percentage of gross assets, a reduction of
3%
since December 31, 2024;
targeting a further reduction to
11% to 16%
by December 31, 2026.
Alexandria’s development and redevelopment pipeline is anticipated to deliver
$92 million
of incremental annual net operating income
by
4Q26
primarily from projects that are
93%
leased/negotiating
.
•
Annual net operating income (cash basis) from recently delivered projects is expected to increase by
$25 million
upon the
burn-off of initial free rent, which has a weighted-average remaining period of approximately
four
months
.
•
77%
of the RSF in our total development and redevelopment pipeline is within our Megacampus ecosystems.
Development and Redevelopment Projects
Incremental
Annual Net
Operating Income
RSF
Leased/
Negotiating
Percentage
(dollars in millions)
Expected to be placed into service:
Second quarter of 2026
through
fourth quarter of 2026
$
92
(1)
601,589
(2)
93%
(3)
Fiscal years
2027
through
2028
93
1,258,004
68%
$
185
(1)
Includes expected partial deliveries through
2026
from projects expected to stabilize in 2027-2028, including speculative future leasing that is not yet fully
committed. Refer to the initial and stabilized occupancy years under “New Class A/A+ development and redevelopment properties:
under construction
” in Item 2 for
additional information.
(2)
Represents the RSF of projects expected to stabilize in
2026
. Does not include RSF for partial deliveries through
2026
from projects expected to stabilize in
2027-2028
.
(3)
Represents the current leased/negotiating percentage of the
601,589
RSF
of development and redevelopment projects that are expected to stabilize in
2026
.
51
Trends that may affect our future results
Currently identified key market trends and uncertainties that had or may have a negative effect on our business are discussed
below. Although we seek to minimize the risks posed by these trends and uncertainties as discussed in the mitigating factors section
below, there can be no assurance that these measures will be successful in preventing material impacts on our future results of
operations, financial position, and cash flows. Refer to “Item 1A. Risk factors” within Part I in our annual report on Form 10-K for the
year ended December 31,
2025
for discussion of additional risks we face.
New supply and reduced demand for life science space may continue to negatively affect our rental rates, occupancy, and
operating results.
•
Influx of supply
. During and after the COVID-19 pandemic, the shift toward hybrid and remote work arrangements as well as
exceptionally strong demand for life science space, driven by public health urgency and supported by historically low interest
rates, prompted certain office and other real estate investors to repurpose underutilized office spaces into laboratory facilities,
initiating a wave of new development activity across the sector. Our success and the success of other laboratory operators
prompted new and existing developers to commence speculative redevelopment and/or development laboratory projects in
anticipation of demand for such facilities. These conversion and speculative development projects have contributed to a
significant influx of new laboratory properties in our top three markets—Greater Boston, San Diego, and the San Francisco
Bay Area. Life science real estate availability in these top markets—measured as the percentage of life science RSF available
relative to total life science RSF—rose to approximately
29%
during 2025, from approximately
4%
in 2021
. This surge created
supply that materially exceeded current demand. As pandemic-driven urgency faded, the amount of available space became
the dominant factor influencing tenant activity, with absorption unable to match the influx of supply.
•
Decrease in demand
. Adding to these challenges, life science tenant demand—after reaching historically high levels in 2021—
has moderated significantly. The average tenant demand, measured by life science tenants’ RSF requirements, has declined
by more than
60%
during 2025 compared to 2021 across our top three markets: Greater Boston, San Francisco Bay Area, and
San Diego
. This reflected a shift from extraordinary tenant demand driven by pandemic-related urgency to levels more
consistent with historical pre-pandemic norms, particularly those observed during 2016-2018. Importantly, this shift occurred
amid substantially higher available supply, as discussed above, further negatively impacting occupancy and rental rates in top
markets.
Exacerbating the recent demand trend, the life science industry faced an unusual convergence of macroeconomic, regulatory,
policy, and political challenges in 2025 which persist today, all of which are critical facets of the life science industry. These
included consequential shifts in leadership at the Health and Human Services agency (“HHS”), tariff-related measures,
operational, leadership, and staff disruptions at the NIH and the FDA, threatened reductions in NIH funding of biomedical
research and proposals to limit NIH funding of indirect grant costs, heightened scrutiny of pharmaceutical pricing, and
increased global competition from China, discussed below. Collectively, these factors, including those described below,
increased uncertainty, leading tenants to defer leasing commitments and expansion decisions pending greater clarity. As a
result, absorption of available space has been notably slower.
◦
Prolonged biotech bear market and capital constraints.
The life science sector experienced the fifth consecutive year
of a broad-based biotech bear market in 2025. Life science venture capital fundraising declined to its lowest level since
2016, reducing overall levels of venture capital funds available to deploy in the future. Life science venture funds also
continued to be highly risk averse, focusing investments on clinical-stage and asset-based opportunities that may not
drive significant laboratory space needs. The initial public offering market for biotech companies has remained largely
closed, eliminating a key source of liquidity and growth capital. Elevated interest rates have further constrained access to
debt and equity financing. These factors have slowed company formation, reduced headcount growth, and delayed
laboratory expansion decisions, directly impacting leasing demand for specialized life science space.
◦
Regulatory and policy factors affecting absorption.
At the same time, the regulatory environment experienced
significant disruption. The FDA saw more than
50%
turnover in senior leadership during the first half of 2025,
accompanied by employee layoffs and delays in regulatory review decisions. Changing expectations related to clinical trial
requirements and flexibility for rare diseases with large unmet needs created additional uncertainty around development
timelines for certain regulated products. These conditions have reduced some tenants’ near-term confidence in expansion
and capital investment decisions.
Biomedical research institutions have faced increased uncertainty around federal funding policies throughout 2025. The
proposed
15%
cap on NIH institutional indirect grant spending, subsequently ruled unlawful by an appellate court, raised
concerns for biomedical research institutions about the ability to recover infrastructure and operating costs, which
materially constrained incremental real estate demand among certain federally supported entities.
52
Further, government actions aimed at reducing U.S. prescription drug prices have heightened uncertainty regarding future
returns on pharmaceutical and biotechnology investments. This has weighed on risk appetite across the sector and
constrained investment into some areas of research and development. As a result, some tenants have delayed or scaled
back expansion plans, reducing leasing activity and occupancy levels.
At the same time, global competition for life science research has intensified, with certain foreign markets, especially
China, rapidly gaining ground as biotechnology leaders through centralized funding and faster regulatory timelines.
Coupled with immigration-related restrictions implemented in the U.S. during 2025 that limit access to international
research talent, these policy actions not only affect current activities but also pose a significant threat to the long-term
viability of the U.S. biomedical industry. The cumulative effect of these developments may significantly reduce tenant
demand for U.S. life science real estate. Refer to “Item 1A. Risk factors” in this annual report on Form 10-K for more
information.
•
Impact on our business
.
The surge in supply and decrease in demand have led to industry-wide elevated vacancy rates,
slower leasing activity, pressure on rental rates, higher lease concessions, and increased competition for tenants.
Our
operating occupancy declined from
90.9%
as of December 31,
2025
to
87.7%
as of
March 31, 2026
, and we project our
operating occupancy to be approximately
87.0%
as of December 31,
2026
,
representing the midpoint of our guidance range
for occupancy percentage in North America as of December 31,
2026
.
To remain competitive, we have realized lower rental rate changes on renewed and re-leased spaces and have offered more
tenant improvement allowances or additional tenant concessions, including free rent, to retain existing tenants, or attract new
tenants. We project our rental rate changes on renewed and re-leased spaces to be approximately
(5.0)%
for the year ending
December 31,
2026
, representing the midpoint of our guidance range. Furthermore, to maintain long-term tenant relationships
and sustain occupancy levels within our core assets, our existing operating properties may require additional revenue- and
non-revenue-enhancing capital expenditures earlier than typically expected.
The table below reflects a trend of increasing revenue- and non-revenue-enhancing capital expenditures, including tenant
improvement expenditures. The table also presents the trend, on a per RSF basis, of increasing tenant improvements, leasing
commissions, and free rent concessions, and of less favorable changes in rental rates related to our renewed/re-leased
spaces, as well as decreases in our operating occupancy (dollars in thousands, except per RSF amounts):
Revenue- and
Non-Revenue-
Enhancing
Capital
Expenditures
Tenant
Improvements/
Leasing
Commissions
per RSF
Free Rent
Concessions per
Annum
(leases executed in
trailing 12 months)
Rental Rate
Changes
(on renewed/
re-leased
spaces)
Operating
Occupancy
(as of each
period end)
2024
$
273,377
$
46.89
0.7 months
16.9%
94.6%
2025
$
324,293
$
55.34
1.5 months
7.0%
90.9%
Three months ended March 31, 2026
$
164,382
$
59.92
2.0 months
(15.0)
%
87.7%
Midpoint of
2026
guidance range
$
510,000
N/A
(5.0)%
87.0%
Additionally, we have key lease expirations with expected downtime in
2026
, primarily in the Greater Boston, San Francisco
Bay Area, and San Diego markets, aggregating
747,383
RSF as of
March 31, 2026
with a weighted-average lease expiration
date of
June 2026
.
These spaces are expected to become vacant at lease expiration and re-leased to new tenants. We expect
downtime on the
747,383
RSF to be approximately
6
to
24
months on a weighted-average basis.
In addition,
we have
identified
1.5 million
RSF of key lease expirations in
2027
that are expected to have downtime of approximately
6
to
24
months
on a weighted-average basis
.
Considering elevated new laboratory supply in these markets, there can be no assurance that
we will be able to re-lease some or all of this space on acceptable terms, without significant capital expenditures, or within
anticipated time frames, even at reduced rates.
As of
March 31, 2026
, we anticipate that
1.9 million
RSF
of our projects undergoing construction will be placed into service
from
April 1, 2026
through
2028
and will generate
$185 million
in future incremental annual net operating income. These
projects are
77%
leased or under lease negotiations as of
March 31, 2026
.
Furthermore, we have additional
1.6 million
RSF
of
projects under evaluation which are
23%
leased or under lease negotiations
.
For these projects, we are evaluating business
and financial strategy, including continuing construction, repositioning for office or other non-laboratory use, selling, or pausing
development or redevelopment. If we decide to sell or pause, such actions could be dilutive to our funds from operations and
operating metrics. Alternatively, if we decide to invest limited capital, we may place some or all of these projects into
operations, which could temporarily reduce our operating occupancy until the projects are leased and occupied.
Landlord-funded tenant improvement allowances have increased significantly for first-generation space, including development
and redevelopment projects, with most space in shell condition requiring landlords to fund the full build-out cost. This trend
places additional pressure on projected returns and overall economics, and further challenges our ability to attract and secure
tenants for the remaining unleased RSF related to these projects at the expected rates, or at all, which could result in a
shortfall or delay in the commencement of the projected incremental annual net operating income.
53
Unfavorable macroeconomic and capital market conditions may continue to adversely affect the value of our real estate and
non-real estate portfolios, which could result in additional significant impairments and may impact our ability to raise capital
efficiently to further our business objectives.
The effective execution of our development and redevelopment activities is contingent on access to the capital required to fund
these projects. We expect funding for construction spending in
2026
to aggregate
$1.75 billion
at the midpoint of our
2026
guidance range for construction spending
. This includes significant remaining construction costs to complete our active
pipeline and anticipated increases in both revenue- and non-revenue-enhancing capital expenditures in our operating portfolio.
As a result, our capital plan and leverage management strategy have increased our reliance on real estate dispositions and
sales of partial interests to generate capital. However, current real estate market conditions, including lower property
valuations and increased capitalization rates, will likely adversely affect the timing and pricing of such transactions.
•
Lower property valuations and increased capitalization rates
. A portion of our projected construction spending and other uses
of capital is expected to be funded through dispositions and sales of partial interests in core, land, and non-core real estate
assets. Real estate investments are generally less liquid than many other investment types, which can present challenges in
selling our properties in a timely manner or at desirable prices, especially in an environment of oversupply.
In addition to the factors discussed above specifically affecting demand for life science space, broader real estate demand has
also been impacted by macroeconomic conditions, particularly elevated interest rates. Following the onset of the COVID-19
pandemic, the U.S. Federal Reserve reduced the federal funds target range to
0%
–
0.25%
in March 2020 and maintained that
near-zero range until March 2022. To address inflation concerns, the U.S. Federal Reserve then increased the target range
rapidly, reaching
5.25%
–
5.50%
in July 2023, where it remained for an extended period. Although the U.S. Federal Reserve
reduced the federal funds target range to
4.25%
–
4.50%
during 2024, and to
3.50%
–
3.75%
during 202
5, interest rates remain
elevated. This continues to limit access to debt and/or equity financing for prospective buyers of real estate assets. All other
aspects being equal, such challenges for buyers contribute to an excess of properties available for sale, which exerts
downward pressure on property valuations and elevates capitalization rates, adversely impacting the sales proceeds we can
generate from our real estate asset sales.
The oversupply of life science real estate assets, discussed above, combined with high interest rates and reduced market
liquidity, has contributed to a prolonged period of lower property valuations and higher capitalization rates, resulting in
significant real estate impairments and making it more challenging to execute asset sales within the expected timelines and at
favorable pricing. In
2026
, we expect to complete dispositions and sales of partial interests of approximately
$2.90 billion
at the
midpoint of our
2026
guidance range
. However, we may not be able to achieve this and/or other targets disclosed in our
2026
guidance as a result of the uncertainties discussed in this section as well as in “Item 1A. Risk factors” within “Part II – Other
information” of this quarterly report on Form 10-Q and “Item 1A. Risk factors” within Part I in our annual report on Form 10-K
for the year ended December 31,
2025
.
The table below presents total dispositions and a trend of increasing impairments of real estate and capitalization rates
associated with dispositions and sales of partial interests in our real estate assets over the last several years (dollars in
thousands), which is partly attributable to the quality of core and non-core assets sold during each period.
Aggregate Sales Price
of Dispositions and
Sales of Partial
Interests
Impairment of
Real Estate
Capitalization
Rates
(1)
Capitalization
Rates
(Cash Basis)
(1)
2024
$
1,382,453
$
223,068
7.7%
6.5%
2025
$
1,813,778
$
2,202,818
7.7%
7.5%
(2)
Three months ended March 31, 2026
$
—
$
5,499
N/A
Midpoint of
2026
guidance range
$
2,900,000
(3)
(1)
Capitalization rates are calculated only for stabilized operating assets sold. Refer to “Capitalization rates” under “
Definitions and reconciliations
”
for additional
information.
(2)
Represents the weighted-average capitalization rate for stabilized operating assets sold in 2025, which accounted for only
20%
o
f the aggregate sales price
of dispositions and sales of partial interests in 2025.
(3)
We are not able to forecast impairments or capitalization rates for future periods without unreasonable effort due to the inherent difficulty of forecasting the
timing and amount of transactions that depend on market conditions outside of our control.
For additional information about our dispositions and real estate impairments recognized during the
three months ended March
31, 2026
, refer to “
Sales of real estate assets and impairment of real estate
” in Note 3 – “Investments in real estate” to our
unaudited consolidated financial statements in Item 1.
54
For
2026
, we have established a disposition program with expected sales of approximately
$2.90 billion
at the midpoint of our
2026
guidance range for real estate dispositions and sales of partial interests.
In
2026
we are committed to dispose of certain assets classified as held for sale with an aggregate book value of
$522.5 million
as of
March 31, 2026
. To achieve the midpoint of our
2026
guidance range of
$2.90 billion
for
dispositions and
sales of partial interests, we continue to evaluate a significant number of disposition targets, including non-core operating
properties, both stabilized and unstabilized, and land parcels.
Under GAAP, real estate assets are evaluated for impairment upon indication of potential impairment:
•
For real estate assets held and used, impairments are recognized if the sum of expected future undiscounted cash
flows, including estimated proceeds from eventual disposition, is less than the carrying amount. In such cases, the
carrying amount is reduced to estimated fair value.
•
For real estate assets held for sale, impairments are recognized if fair value less costs to sell is less than the carrying
amount.
•
In evaluating potential disposition targets that do not meet the criteria for held for sale classification, we apply a
probability-weighted approach, and in each case, no impairment charge is currently required.
If circumstances change, including changes in expected cash flows, capitalization rates, or market conditions, we may incur
additional material real estate impairments in
2026
. For additional information on accounting for real estate impairments, refer
to “Impairment of long-lived assets” in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated
financial statements in Item 1.
We expect to substantially complete our large-scale non-core asset sales program in 2026. As of
March 31, 2026
,
78%
of
our
annual rental revenue is from our Megacampus platform, and we expect this percentage to continue to grow over time, in part
through our disposition program.
•
Increased cost and limited availability of capital.
Our
2026
guidance assumes a reduction of our outstanding debt by
approximately
$1.68 billion
, at the midpoint of our
2026
guidance range.
•
In February 2026, we completed tender offers to repurchase an aggregate
debt
principal amount of
$1.33 billion
across a portion of our outstanding
4.00%
Senior Notes due
2050
,
3.00%
Senior Notes due
2051
, and
3.55%
Senior
Notes due
2052
.
The tender offers were completed at an average discount of approximately
28%
, for a total cash
payment of
$952.2 million
, resulting in the extinguishment of approxim
ately $380 million of de
bt.
We funded the
$952.2 million
payment
through the
issuance of
$750.0 million
of
5.25%
unsecured senior notes due
2036
and
approximately
$200 million
of short-term borrowings
under our commercial paper program.
•
I
n
January 2026
and April 2026, we repaid, upon maturity,
$300.0 million
of 4.30% unsecured senior notes
and
$350.0 million
of 3.80% unsecured senior notes
, respectively.
These repayments,
aggreg
ating
$650 million
, were
temporarily funded through borrowings under our commercial paper program.
Although we repaid a portion of our outstanding debt during 2026, these repayments have been fully financed through the
issuance of new debt. As a result, we have not yet made progress toward our targeted
$1.68 billion
net debt reduction.
Accordingly, achievement of this target debt reduction remains dependent on our ability to generate proceeds during 2026
from planned real estate dispositions and sales of partial interests.
These expectations assume our ability to execute our planned real estate dispositions and partial interest sales on acceptable
terms. If we are unable to sell real estate assets at our targeted prices or within our expected timeframes, we may need to
reduce the projected amount of debt repayment, delay the timing of such repayment, and/or increase our reliance on additional
debt financing to fund the approximatel
y
$1.75 billion
of construction spendin
g, based on the midpoint of our
2026
guidance
range. Elevated interest rates may result in debt financing options that are costlier, less accessible, or even unavailable,
potentially limiting our ability to complete our development and redevelopment projects on schedule and thereby delaying our
expected incremental annual net operating income generation.
The table below reflects interest rates related to unsecured senior notes payable that we have issued over the last several
years and in February 2026 (dollars in thousands). There is no assurance that high debt costs will not continue into the future.
Unsecured Senior
Notes Payable Issued
Interest Rate
(1)
2024
$
1,000,000
5.57%
2025
$
550,000
5.66%
February
2026
issuance
$
750,000
5.41%
(1)
Includes amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.
55
•
Capitalized Interest.
The table below presents gross interest expense, capitalized interest, and interest expense (in thousands):
Gross Interest Expense
Capitalized Interest
Interest Expense
2024
$
516,799
$
(330,961)
$
185,838
2025
$
557,122
$
(330,424)
$
226,698
Three months ended March 31, 2026
$
134,557
$
(69,973)
$
64,584
Midpoint of
2026
guidance range
$
505,000
$
(245,000)
$
260,000
For
2026
, we expect capitalized interest of approximately
$245 million
at the midpoint of our guidance range. The decrease
compared to
2025
reflects our actions taken in response to the market conditions, including re-evaluating certain projects,
ceasing or pausing certain pre-construction activities on land and uncommitted projects to conserve capital, and disposing of
certain assets.
As a result, we expect our interest expense to increase to approximately
$260 million
(at the midpoint of our
2026
guidance range) in
2026
from
$226.7 million
in
2025
. Continued macroeconomic and capital market pressures may
necessitate further reevaluation of our plans, including temporary suspension of our construction projects, delay of future
projects, or the sale of non-income-producing properties, which could further reduce our capitalized interest and increase
interest expense.
•
Volatility in the valuation of non-real estate investments
.
We hold strategic investments in publicly traded companies and
privately held entities primarily involved in the life science industry. These investments are subject to market-and sector-
specific risks that can substantially affect their valuation. Like many other industries, the life science industry is susceptible to
macroeconomic challenges, such as ongoing economic and geopolitical uncertainty and a tighter capital environment. These
factors may lead to increased volatility in the valuation of our non-real estate investments.
In such an environment, distributions from our investments—which we may receive as dividends, as liquidation distributions
from our investments in limited partnerships, or as a result of mergers and acquisitions involving our privately held investees—
may be limited and could result in lower realized gains. Gross unrealized gains related to our non-real estate investments held
as of
March 31, 2026
,
December 31, 2025
, and
December 31, 2024
aggregated to
$191.5 million
,
$184.4 million
, and
$228.1
million
, respectively. These unrealized amounts are subject to market fluctuations and may not ultimately be realized. We may
not receive distributions from our investments or may face difficulties in monetizing our non-real estate investments at optimal
prices. There can be no assurance that we will be able to realize gains in the future. In periods with limited or no realized
gains, our FFO per share, as adjusted, may be adversely affected.
For the
three months ended March 31, 2026
,
we recognized
$18.2 million
in realized gain
s on non-real estate investments and
are
projecting realized gains of
$75 million
in
2026
at the midpoint of our guidance range.
During the
three months ended
March 31, 2026
, we also recognized impairment charges and unrealized losses that reflect continued valuation pressures. The
table below presents components of investment income (loss) on our non-real estate investments (in thousands):
Non-Real Estate Investments
Realized
Gains
Significant
Realized
Losses
Impairments
Unrealized
(Losses)
Gains
Investment
Loss
2024
$
117,214
$
—
$
(58,090)
$
(112,246)
$
(53,122)
2025
$
115,722
$
(103,329)
$
(95,716)
$
26,980
$
(56,343)
Three months ended March 31, 2026
$
18,198
$
—
$
(12,448)
$
(10,332)
$
(4,582)
Midpoint of
2026
guidance range
$
75,000
N/A
(1)
(1)
We are not able to forecast investment income (loss) of future periods without unreasonable effort and therefore do not provide the information on a forward-
looking basis. This is due to the inherent difficulty of forecasting the timing and/or amount of items that depend on market conditions outside of our control.
Unfavorable market conditions could also lead to additional impairments of our investments in privately held entities that do not
report NAV per share, as well as other‑than‑temporary impairments of our non‑real‑estate investments accounted for under the
equity method.
56
The realization of any of the foregoing risks could continue to have material adverse impacts on our revenues and operating
performance, including but not limited to our income from rentals, net operating income, results of operations, funds from operations,
operating margins, initial stabilized yields (unlevered) on new or existing construction projects, occupancy, rental rates, EPS, FFO per
share, FFO per share, as adjusted, and net cash provided by operating activities, as adjusted. These impacts have adversely affected,
and could continue to adversely affect, our Adjusted EBITDA, which in turn may continue to negatively impact our key metrics such as
Adjusted EBITDA margin, net debt and preferred stock to Adjusted EBITDA, and fixed-charge coverage ratios. This may also impact
our credit ratings and credit rating outlooks. To preserve liquidity and mitigate an increase to our net debt and preferred stock to
Adjusted EBITDA ratio resulting from declines in Adjusted EBITDA, we may seek additional capital by pursuing additional sales of real
and non-real estate assets, or through equity offerings, which could be dilutive to existing stockholders. A reduction in earnings and/or
net cash provided by operating activities, as adjusted, could potentially necessitate or make advisable a reduction in our dividends per
share, as determined by our board of directors. Any of the foregoing could further negatively affect our business and the market value
of our common stock.
•
Mitigating factors:
•
Reinforcing the Megacampus platform as our core growth engine.
We believe our Megacampus strategy represents
our most powerful competitive advantage in an oversupplied life science real estate market. Our Megacampus
ecosystems are large-scale environments designed to meet the evolving needs of the world’s leading scientific and
technological organizations, located in life science innovation hubs in close proximity to top academic and medical
research institutions. This proximity is a key driver of tenant demand. These campuses are used in two distinct ways: (i) to
house the research operations of our tenants, and (ii) to recruit and retain the best talent available from a limited pool,
which underscores why their scale, strategic design, and location are critical. With our Megacampus ecosystems, we aim
to provide a superior set of amenities, services, and access to transit. With inspiring design and people-centric amenities,
we believe these campuses enhance our tenants’ confidence in using these spaces as effective recruiting tools. In
contrast, we believe that a significant amount of the competitive supply in the market today consists of isolated facilities
that provide operational space but lack the scale and strategic design that our Megacampus ecosystems deliver.
Our Megacampus ecosystems, which offer both high visibility and a clear path for growth, are designed for scalability to
accommodate our tenants’ growth. Our future development and redevelopment projects aggregate
21.9 million
RSF
as of
March 31, 2026
, of which
77%
is concentrated within our Megacampus ecosystems. Their strategic locations and path for
growth serve as powerful incentives for tenants to lease space from us.
We believe our Megacampus strategy has enabled us to capture a greater share of available leasing demand relative to
competitors in our core life science markets, even as overall supply has increased. The strength of this strategy is
reflected in the
2026
performance metrics below, achieved despite challenging macroeconomic, regulatory, policy, and
geopolitical environments:
•
Occupancy of
87.7%
as of
March 31, 2026
:
•
Outperforms
market occupancy levels in our top
three
markets: Greater Boston, San Francisco Bay Area, and
San Diego.
•
Additional
3.2%
occupancy is expected from temporary vacancies aggregating
1.1 million
RSF (
3.2%
of total
operating RSF) as of
March 31, 2026
.
These vacant spaces are currently leased and are expected to become
occupied upon completion of building and/or tenant improvements, with a weighted‑average expected occupancy
date of
September 2026
. These spaces are primarily located in our Greater Boston, San Francisco Bay Area,
and Seattle markets and are expected to generate annual rental revenue of approximately
$68 million
upon lease
commencement.
•
93%
of development and redevelopment projects under construction that are expected to stabilize in
2026
are leased
or under lease negotiatio
n.
•
Expected incremental annual net operating income from projects anticipated to be placed into service from the
second quarter of 2026
to the end of
2028
:
•
$92 million
from deliveries in remaining quarters of
2026
.
•
$93 million
from
2027
-
2028
deliveries.
•
Strength of our brand.
As a recognized leader in the life science and real estate sectors, Alexandria has successfully
built a diverse and high-quality tenant base. Over the past three decades, we have fostered long-standing relationships
and strategic partnerships with our tenants, which have enabled us to maintain strong occupancy levels and leasing
volume, and growth in net operating income and cash flows and to effectively navigate through various economic cycles.
Key indicators of our brand strength include the following:
•
As of
March 31, 2026
,
78%
of our leasing activity during the last twelve months was from our existing tenant base.
•
As of
March 31, 2026
,
87%
of our top 20 tenant annual rental revenue was derived from investment-grade or publicly
traded large cap companies.
•
Our tenant collections have remained consistently high, averaging
99.8%
since the beginning of 2021 through
March 31, 2026
.
57
•
Prudent financial management.
Our strong and flexible balance sheet and prudent balance sheet management are key
factors in our ability to navigate macroeconomic uncertainties and capitalize on new opportunities. The strength of our
financial position is highlighted by several key indicators:
•
Our significant liquidity of
$4.17 billion
as of March 31, 2026
provides us the flexibility to address our operational
needs and to pursue strategic opportunities.
•
We expect to self-fund a large portion of our capital requirements through the following sources in
2026
:
•
$525 million
in net cash provided by operating activities, as adjusted, at the midpoint of our
2026
guidance range.
•
$120.0 million
in capital contributions to fund construction expected from our existing consolidated real estate
joint venture partners from
April 1, 2026
through
2027
and beyond
.
•
$2.90 billion
from dispositions and sales of partial interests in real estate assets at the midpoint of our
2026
guidance range.
•
As of
March 31, 2026
, our credit ratings from
S&P Global Ratings and Moody’s Ratings were
BBB+
and
Baa1
,
respectively, which rank in the
top 15%
among all publicly traded U.S. REITs.
•
N
et debt and preferred stock to Adjusted EBITDA ratio
target is
5.6x to 6.2x
for the fourth quarter of
2026
, annualized.
•
As of
March 31, 2026
, ou
r fixed-rate debt represents
89.2%
of our total deb
t,
which provides predictability in debt
servicing costs.
Since
2022
, our quarter-end fixed-rate debt has averaged
96.4%
.
•
Our debt maturity schedule is well laddered, which provides us with financial flexibility and reduces short-term
refinancing risks
.
As of
March 31, 2026
, only
9%
of our debt matures through
2028
.
•
As of
March 31, 2026
,
the weighted-average remaining term of our debt is
10.0
years
,
which is the
longest
among
S&P 500 REIT
s, and
demonstrates our strategic approach to debt management and our focus on maintaining
manageable annual debt maturities.
•
Operational excellence of our team.
Alexandria focuses on operational excellence in the direct asset management and
operations of our Labspace
®
asset base. Our asset management and operations team is composed of highly experienced,
educated, and professionally credentialed facilities specialists. This expertise, essential in ensuring a secure and efficient
environment for groundbreaking scientific research, has been cultivated and maintained over many years.
The demanding nature of laboratory-based scientific research requires strict adherence to safety standards set by local,
state, and federal regulatory bodies. Key compliance aspects include good manufacturing practices (“GMP”) and Clinical
Laboratory Improvement Amendments (“CLIA”) certifications, adherence to national biosafety level guidelines, proper
permitting and handling of hazardous waste generation and chemical storage, maintenance of safety stations, effective
management of ultra-low temperature freezers, and careful licensing and management of radioactive materials.
•
Other mitigating factors
•
Improvement in office market.
The increase in demand for premium office space since 2024, primarily driven by the
technology sector, particularly companies focused on AI, absorbed some of the market’s supply previously anticipated
for life science use and is now being repositioned back into office space. High ceilings, improved ventilation systems,
and abundant natural light, which are all features of life science real estate, have become highly desirable, appealing
to office and advanced technologies tenants. We expect this trend may lead to the exit from the life science sector of
inexperienced life science real estate developers and expedite the resolution of the oversupply impacting the sector.
•
Proactive reduction in capital spending and funding needs
.
To address higher capital costs and slower market
absorption, we implemented a disciplined reduction in construction spending. Based on the midpoint of our 2026
guidance range, our average annual construction spending is expected to decrease to approximately
$1.74 billion
for
2024–2026, representing a reduction of approximately
$1.02 billion
, or
37%
, compared to the 2021–2023 average
.
Our 2026 construction spending is primarily focused on:
•
Leasing vacant space at operating properties
•
Completing active committed construction projects
•
Limiting future pipeline pre-construction activity
This strategy supports a more self-funded capital plan while preserving flexibility for future growth opportunities.
•
Decrease in general and administrative expenses.
Over the past several years, we have implemented comprehensive
measures to reduce our expenditures across our organization, including our general and administrative expenses, by
implementing a variety of cost-control and efficiency initiatives, including, but not limited to:
•
Personnel-related matters, including:
•
Reduction in headcount over the last two years.
•
Restructuring of various compensation plans.
•
Streamlining of business processes:
•
Implementation of systems upgrades, process improvements, and smarter technology.
•
Renegotiation of contracts related to legal, technology, and operational support services, and
elimination of redundancies through better alignment and consolidation of roles.
58
As a result, we have achieved the following outcomes:
•
During the
three months ended March 31, 2026
, general and administrative expenses aggregated
$34.7 million
, wh
ich represents a
decrease
of
$7.4 million
, or
18%
, compared to the quarterly average for
2024
.
•
We expect
$76 million
of cumulative savings in
2025
and
2026
(based upon the midpoint of our guidance
range for 2026 general and administrative expenses), compared to 2024.
•
For the trailing twelve months ended
March 31, 2026
, our general and administrative expenses as a
percentage of net operating income were
6.0%
,
approximately
half
the average of other S&P 500 REITs for
2023–2025.
We believe the mitigating factors discussed above will help us manage prolonged market volatility while maintaining the
flexibility to act on strategic opportunities. Through disciplined execution of non-core asset recycling, targeted capital
allocation, continued focus on our Megacampus platform, moderated construction spending, and preservation of balance sheet
strength, we are building a resilient platform designed to deliver sustainable future growth and value creation across multiple
cycles. We believe these actions position us to emerge from the current cycle in a position of strength.
59
Operating summary
Same Property Performance:
Net Operating Income Changes
Rental Rate Changes:
Renewed/Re-Leased Space
Margins
(3)
Favorable Lease Structure
(4)
Operating
Adjusted EBITDA
Strategic Lease Structure by Owner and
Operator of Collaborative Megacampus Ecosystems
67%
66%
Increasing cash flows
Percentage of leases containing annual
rent escalations
97
%
Stable cash flows
Long-Duration Lease Terms
(5)
Percentage of triple net leases
91
%
9.9 Years
7.5 Years
Lower capex burden
Percentage of leases providing for the
recapture of capital expenditures
92
%
Top 20 Tenants
All Tenants
Net Debt and Preferred Stock
to Adjusted EBITDA
(6)
Fixed-Charge Coverage Ratio
(6)
(2)
(1)
(1)
(2)
5.6x to 6.2x
3.6x
to
4.1x
Refer to “
Same properties
” and “
Definitions and reconciliations
” in Item 2 for additional details. “
Definitions and reconciliations
” contains the definitions of “Fixed-charge
coverage ratio,” “Net debt and preferred stock to Adjusted EBITDA,”, “Net operating income”, and “Adjusted EBITDA” and their respective reconciliations from the most directly
comparable financial measures presented in accordance with GAAP.
(1)
Refer to footnote 1 under “
Same properties
” in Item 2 for additional details.
(2)
Refer to footnote 2 under “Leasing activity” in Item 2 for additional details.
(3)
For the
three months ended March 31, 2026
.
(4)
Percentages calculated based on our annual rental revenue in effect
as of March 31, 2026
.
(5)
Represents the weighted-average remaining term based on annual rental revenue in effect
as of March 31, 2026
.
(6)
Quarter annualized.
60
Stable Cash Flows From Our High-Quality, Diverse Tenant Mix
Investment-Grade or Publicly Traded Large Cap Tenants
87%
55%
of ARE’s Top 20 Tenant
Annual Rental Revenue
of ARE’s Total Annual
Rental Revenue
(1)
(2)
(3)
Percentage of ARE’s
Annual Rental Revenue
As of
March 31, 2026
. Annual rental revenue represents amounts in effect
as of March 31, 2026
. Refer to “
Definitions and reconciliations
” in Item 2 for additional information.
(1)
Represents the percentage of our annual rental revenue generated by professional services, finance, construction/real estate companies, and retail-related tenants.
(2)
76%
of our annual rental revenue from advanced technologies tenants is from investment-grade or publicly traded large cap tenants.
(3)
81%
of our annual rental revenue from biomedical institutions is from investment-grade or publicly traded large cap tenants.
61
Leasing activity
The following table summarizes our leasing activity at our properties:
Three Months Ended
Year Ended
March 31, 2026
December 31, 2025
(Dollars per RSF)
Including
Straight-Line Rent
Cash Basis
Including
Straight-Line Rent
Cash Basis
Leasing activity:
Renewed/re-leased space
(1)
Rental rate changes
(15.0)%
(2)
(15.8)%
(2)
7.0%
3.5%
New rates
$49.88
$53.43
$52.71
$53.66
Expiring rates
$58.67
$63.42
$49.27
$51.87
RSF
380,687
2,543,473
Tenant improvements/leasing commissions
$59.92
(2)
$55.34
Weighted-average lease term
8.4 years
9.0 years
Previously vacant/developed/redeveloped space leased
New rates
$53.34
$52.10
$72.30
$67.56
Previously vacant RSF
148,734
944,362
Developed/redeveloped RSF
(3)
117,935
704,821
(4)
Weighted-average lease term
14.0 years
13.8 years
Leasing activity summary (totals):
New rates
$51.30
$52.88
$60.42
$59.13
RSF
647,356
4,192,656
Weighted-average lease term
12.0 years
11.9 years
Lease expirations
(1)
Expiring rates
$56.43
$62.28
$54.22
$55.56
RSF
1,340,809
(5)
4,460,081
Leasing activity includes 100% of results for properties in North America in which we have an investment.
(1)
Excludes month-to-month leases aggregating
103,632
RSF and
58,516
RSF as of
March 31, 2026
and
December 31, 2025
, respectively.
During the
trailing twelve
months
ended
March 31, 2026
, we granted free rent concessions averaging
2.0
months
per annum.
(2)
Includes the impact of one lease aggregating
47,719
RSF at 480 Arsenal Street
in our Cambridge/Inner Suburbs submarket, which was signed to an entertainment
studio user to accommodate their expansion needs and secure a long-term extension. The reorientation of the building layout needed to accommodate the tenant also
provides flexibility to market the remaining available space to a broader range of user demand. Excluding this lease, rental rates for renewed and re-leased space for the
three months ended March 31, 2026
would have decreased by
10.1%
and
9.1%
(cash basis) and tenant improvements and leasing commissions would have been
$46.18
per RSF.
(3)
Refer to “
New
Class A/A+ development and redevelopment properties: summary of pipeline” in Item 2 for additional information, including total project costs.
(4)
Includes the largest life science lease in company history, executed in July 2025 with a long-standing multinational pharmaceutical tenant. The 16-year expansion
build-to-suit lease aggregates
466,598
RSF and is located at the Cam
pus Point by Alexandria Megacampus in our University Town Center submarket
.
Excluding
this lease, developed/redeveloped space for the year ended December 31, 2025 was
238,223
RSF.
(5)
Includes previously disclosed 2026 key lease expirations aggregating
657,492
RSF that became vacant during the
three months ended March 31, 2026
, with a
weighted-average lease expiration date of
January 2026
.
62
S
ummary of contractual lease expirations
The following table summarizes the contractual lease expirations at our properties as of
March 31, 2026
:
Year
RSF
Percentage of
Occupied RSF
Annual Rental Revenue
(per RSF)
(1)
Percentage of
Annual Rental Revenue
2026
(2)
1,485,686
4.9%
$
55.84
4.6%
2027
3,367,997
11.2%
$
56.51
10.5%
2028
3,687,608
12.3%
$
49.66
10.1%
2029
1,831,388
6.1%
$
44.65
4.5%
2030
2,446,190
8.1%
$
42.70
5.8%
2031
3,562,366
11.8%
$
54.91
10.8%
2032
886,704
2.9%
$
57.83
2.8%
2033
2,177,834
7.2%
$
50.72
6.1%
2034
2,727,148
9.1%
$
66.91
10.1%
2035
1,042,126
3.5%
$
58.19
3.4%
Thereafter
6,868,641
22.9%
$
82.42
31.3%
Contractual lease expirations for properties classified as held for sale
as of March 31, 2026
are excluded from the information on this page.
(1)
Amounts in effect
as of March 31, 2026
.
(2)
Excludes month-to-month leases aggregating
103,632
RSF
as of March 31, 2026
.
Refer to “Leasing activity” in Item 2 for additional details.
63
The following tables present our lease expirations by market for the remainder of
2026
and for
2027
, as of
March 31, 2026
:
2026
Contractual Lease Expirations (in RSF)
Market
Leased
Negotiating/
Anticipating
Remaining
Expiring
Leases
Total
(2)
Annual Rental
Revenue
(per RSF)
(1)
Greater Boston
119,822
11,894
110,339
242,055
$
42.93
San Francisco Bay Area
4,908
21,671
115,876
142,455
74.74
San Diego
—
—
104,945
104,945
57.70
Seattle
10,553
12,908
39,002
62,463
24.74
Maryland
8,155
—
48,302
56,457
26.82
Research Triangle
41,518
11,913
19,783
73,214
43.58
New York City
—
—
36,501
36,501
103.49
Texas
—
—
—
—
—
Non-cluster/other markets
—
—
20,213
20,213
57.70
Subtotal
184,956
58,386
494,961
738,303
51.86
Key lease expirations with expected downtime
17,271
81,642
648,470
747,383
(3)
59.77
Total
202,227
140,028
1,143,431
1,485,686
$
55.84
Percentage of expiring leases
14%
9%
77%
100%
2027
Contractual Lease Expirations (in RSF)
Market
Leased
Negotiating/
Anticipating
Remaining
Expiring
Leases
Total
Annual Rental
Revenue
(per RSF)
(1)
Greater Boston
50,375
24,386
110,518
185,279
$
67.27
San Francisco Bay Area
1,873
8,927
183,000
193,800
72.78
San Diego
—
62,415
335,515
397,930
45.00
Seattle
9,435
93,839
305,254
408,528
47.30
Maryland
—
—
191,188
191,188
30.63
Research Triangle
30,696
—
283,614
314,310
34.13
New York City
—
—
100,787
100,787
97.97
Texas
—
65,551
26,160
91,711
26.10
Non-cluster/other markets
—
—
—
—
—
Subtotal
92,379
255,118
1,536,036
1,883,533
49.28
Key lease expirations with expected downtime
—
—
1,484,464
1,484,464
(4)
65.64
Total
92,379
255,118
3,020,500
3,367,997
$
56.51
Percentage of expiring leases
3%
8%
89%
100%
Contractual lease expirations for properties classified as held for sale
as of March 31, 2026
are excluded from the information on this page.
(1)
Amounts in effect
as of March 31, 2026
.
(2)
Excludes month-to-month leases aggregating
103,632
RSF
as of March 31, 2026
. Refer to “Leasing activity” in Item 2 for additional details.
(3)
Represents 2026 key lease expirations with expected
downtime aggregating
747,383
RSF with a weighted-average expiration date of
June 2026
and annual rental
revenue aggregating
$44.7 million
as of March 31, 2026
.
This includes i)
137,316
RSF generating
$13.3 million
of annual rental revenues at Alexandria Stanford Life
Science District, where we are evaluating a redevelopment for advanced technology space, ii)
108,136
RSF generating
$8.1 million
of annual rental revenues at
Alexandria Center
®
at One Kendall Square, where expected downtime is primarily driven by tenant relocations to other ARE-developed properties, and iii)
99,271
RSF
generating
$7.9 million
of annual rental revenues at Alexandria Center
®
for Life Science – Eastlake, where the tenant is also relocating to another ARE-developed
proper
ty.
Additionally, we have identified prospective tenants or are in early discussions for
111,983
RS
F in our Greater Boston and San Francisco Bay Are
a markets
. We
continue to evaluate business plans and
re-leasing strategies for these projects to maximize occupancy and rental revenue. We expect weighted-average downtime to
be approximately
6
to
24
months.
(4)
Represents space with an annual rental revenue of
$97.4 million
, with a weighted-average lease expiration date of
February 2027
, and
a
weighted-average downtime of
approximately
6
to
24
months.
Of the expiring
1.5 million
RSF, we have identified prospective tenants or are in early discussions for
532,585
RSF. Compared to the
information previously reported as of December 31, 2025
, 2027 key lease expirations increased primarily due to a
232,902
-RSF lease expiration with a single tenant at
our Alexandria Center
®
for Life Science – Waltham Megacampus with
$27.0 million
of annual rental revenue, for which we no longer expect the tenant to renew.
Other
key considerations of this expiring
1.5 million
RSF include:
Progress on 2027 Key Lease Expirations
36%
61%
533
K
RSF
of ARR Relocating to
ARE Development/
Redevelopment
Projects
Average RSF
Expansion by
Relocating
Tenants
Under
Negotiation
(
36%
of
Expiring RSF)
Located on Megacampuses
(based on RSF)
Laboratory Space
(based on RSF)
64
Top 20 tenants
87%
of Top 20 Tenant Annual Rental Revenue Is From Investment-Grade
or Publicly Traded Large Cap Tenants
(1)
Our properties are leased to a high-quality and diverse group of tenants, with no individual tenant accounting for greater than
5.8%
of our annual rental revenue in effect as of
March 31, 2026
. The following table sets forth information regarding leases with our 20
largest tenants in North America based upon annual rental revenue in effect as of
March 31, 2026
(dollars in thousands, except average
market cap amounts):
Remaining
Lease
Term
(1)
(in Years)
Aggregate
RSF
Annual
Rental
Revenue
(1)
Percentage
of Annual
Rental
Revenue
(1)
Investment-Grade
Credit Ratings
Average
Market
Cap
(in billions)
Tenant
Moody’s
S&P
1
Bristol-Myers Squibb Company
5.9
1,226,762
$
107,021
5.8%
A2
A
$
102.8
2
Eli Lilly and Company
9.2
1,053,592
92,049
5.0
Aa3
A+
$
826.6
3
Moderna, Inc.
12.7
462,100
71,571
3.9
—
—
$
12.4
4
AstraZeneca PLC
5.9
611,326
55,480
3.0
A1
A+
$
255.3
5
Takeda Pharmaceutical Company Limited
10.6
386,111
41,673
2.3
Baa1
BBB+
$
48.9
6
Eikon Therapeutics, Inc.
(2)
13.2
299,638
38,907
2.1
—
—
$
0.7
7
Illumina, Inc.
5.6
792,687
29,977
1.6
Baa3
BBB
$
16.6
8
United States Government
4.4
414,499
29,334
(3)
1.6
Aaa
AA+
$
—
9
Uber Technologies, Inc.
56.5
(4)
1,009,188
27,865
1.5
Baa1
BBB
$
178.6
10
Boston Children's Hospital
11.0
309,231
26,294
1.4
Aa2
AA
$
—
11
Novartis AG
2.2
(5)
321,743
25,111
1.4
Aa3
AA-
$
273.6
12
Sanofi
4.8
267,278
22,045
1.2
Aa3
AA
$
119.9
13
Alphabet Inc.
2.1
418,600
21,837
1.2
Aa2
AA+
$
2,946.3
14
New York University
6.3
218,983
21,073
1.1
Aa2
AA-
$
—
15
Massachusetts Institute of Technology
3.8
242,428
20,529
1.1
Aaa
AAA
$
—
16
Charles River Laboratories, Inc.
9.4
238,938
20,045
1.1
—
—
$
8.1
17
Merck & Co., Inc.
7.8
308,356
19,610
1.1
Aa3
A+
$
231.2
18
Vaxcyte, Inc.
8.8
230,755
18,672
1.0
—
—
$
5.5
19
Altos Labs, Inc.
(6)
15.0
158,990
18,407
1.0
—
—
$
—
20
Amgen Inc.
9.7
317,157
18,181
1.0
Baa1
BBB+
$
167.7
Total/weighted-average
9.9
(4)
9,288,362
$
725,681
39.4%
Annual rental revenue and RSF include 100% of each property managed by us in North America. Refer to “
Annual rental revenue
” and “
Investment-grade or publicly traded large
cap tenants
” under “
Definitions and reconciliations
” in Item 2 for additional details, including our methodologies of calculating annual rental revenue from unconsolidated real
estate joint ventures and average market capitalization, respectively.
(1)
Based on total annual rental revenue in effect as of
March 31, 2026
.
(2)
Eikon Therapeutics, Inc. is a public biotechnology company led by Roger Perlmutter, a biopharmaceutical executive who previously served as an executive vice president
of Merck & Co., Inc.
As of December 31, 2025, the company held
$336 million
in cash and marketable securities.
(3)
Includes leases, which are not subject to annual appropriations, with governmental entities such as the NIH and the General Services Administration. Approximately
2%
of
the annual rental revenue derived from our leases with the United States Government is cancellable prior to the lease expiration date.
(4)
Includes (i) ground leases for land at 1455 and 1515 Third Street (two buildings aggregating
422,980
RSF) and (ii) leases at 1655 and 1725 Third Street (two buildings
aggregating
586,208
RSF) in our Mission Bay submarket owned by our unconsolidated real estate joint venture in which we have an ownership interest of 10%. Annual
rental revenue is presented using 100% of the annual rental revenue from our consolidated properties and our share of annual rental revenue from our unconsolidated real
estate joint ventures. Excluding these ground leases, the weighted-average remaining lease term for our top 20 tenants was
8.1
years
as of March 31, 2026
.
(5)
Includes one lease at 100 Technology Square at Alexandria Technology Square
®
Megacampus in our Cambridge submarket aggregating
255,441
RSF, which generates
annualized rental revenue of
$21.0 million
and expires in
March 2028
. We are actively marketing the space for re-lease.
(6)
Altos Labs, Inc. is a private biotechnology company led by Hal Barron, M.D., former Chief Scientific Officer and President, R&D at GlaxoSmithKline. Altos Labs launched
with
$3.0 billion
in private funding in 2022, and is backed by a group of prominent investors.
65
Locations of properties
Our properties are strategically located in AAA life science innovation cluster markets. The following table sets forth the total
RSF, number of properties, and annual rental revenue in effect as of
March 31, 2026
in each of our markets in North America (dollars in
thousands, except per RSF amounts):
RSF
Number of
Properties
Annual Rental Revenue
Market
Operating
Development
Redevelopment
Total
% of Total
Total
% of Total
Per RSF
Greater Boston
9,338,588
566,673
1,361,372
11,266,633
29%
63
$
697,286
38%
$
89.09
San Francisco Bay Area
6,083,765
212,657
84,157
6,380,579
16
52
332,008
18
69.11
San Diego
6,225,980
893,525
—
7,119,505
18
61
295,434
15
53.67
Seattle
2,846,292
227,577
—
3,073,869
8
39
120,494
7
48.21
Maryland
3,676,566
—
—
3,676,566
9
47
153,371
8
45.94
Research Triangle
3,435,988
—
—
3,435,988
9
36
89,401
5
27.74
New York City
727,674
—
—
727,674
2
2
66,510
4
95.46
Texas
1,651,094
—
66,350
1,717,444
4
13
37,887
2
28.04
Non-cluster/other markets
(1)
417,523
—
—
417,523
1
7
10,903
1
30.36
Properties held for sale
1,444,387
—
—
1,444,387
4
19
32,567
2
31.27
North America
35,847,857
1,900,432
1,511,879
39,260,168
100%
339
$
1,835,861
100%
$
59.91
3,412,311
Summary of occupancy percentages in North America
The following table sets forth the occupancy percentages for our operating properties and our operating and redevelopment
properties in each of our North America markets, excluding properties held for sale, as of the following dates:
Operating Properties
Operating and Redevelopment Properties
Market
3/31/26
12/31/25
3/31/25
3/31/26
12/31/25
3/31/25
Greater Boston
83.8%
(2)
86.4%
91.8%
73.1%
75.1%
78.4%
San Francisco Bay Area
87.6
(2)
90.9
90.3
86.4
89.4
86.3
San Diego
88.4
(2)
97.2
94.3
88.4
97.2
94.3
Seattle
87.8
88.4
91.5
87.8
88.4
91.5
Maryland
92.3
(3)
93.6
94.1
92.3
93.6
94.1
Research Triangle
93.8
(4)
95.2
93.4
93.8
95.2
93.4
New York City
95.8
96.4
87.6
95.8
96.4
87.6
Texas
81.8
79.9
82.1
78.7
76.5
78.9
Subtotal
87.8
90.9
91.8
84.0
86.9
87.1
Canada
N/A
(1)
N/A
(1)
94.6
N/A
N/A
82.4
Non-cluster/other markets
86.0
91.2
73.0
86.0
91.2
73.0
North America
87.7%
(5)
90.9%
91.7%
84.1%
86.9%
86.9%
(1)
10
properties in Canada
were classified as held for sale during the three months ended December 31, 2025 and the
one
remaining property in Canada is now included
in our non-cluster market.
(2)
Decline in occupancy since
December 31, 2025
was primarily attributable to previously disclosed key lease expirations with expected downtime, including:
•
Greater Boston:
45,636
RSF at Alexandria Center
®
at Kendall Square in our Cambridge submarket and
52,467
RSF in our Route 128 submarket.
•
San Francisco Bay Area:
78,962
RSF at Alexandria Stanford Life Science District in our Greater Stanford submarket, where we are evaluating a redevelopment for
advanced technology use, and
42,299
RSF in our South San Francisco submarket which is currently under negotiation.
•
San Diego:
•
163,648
RSF at a property in our University Town Center submarket, for which we have executed a letter of intent to re-lease the entire premises;
•
118,225
RSF at One Alexandria Square in our Torrey Pines submarket. Of this space,
58,282
RSF has already been re-leased, with occupancy expected to
phase in commencing during the fourth quarter of 2026; and
•
83,354
RSF at 5810 and 5820 Nancy Ridge Drive in our Sorrento Mesa submarket which has been re-leased, with occupancy expected to commence during
the fourth quarter of 2026.
(3)
Decline in occupancy was primarily driven by the expiration of one private biotechnology lease aggregating
30,161
RSF in our Rockville submarket.
(4)
Decline in occupancy was primarily due to
30,667
RSF of vacancy from a tenant winding down operations in the Research Triangle submarket.
(5)
Includes temporary vacancies as of
March 31, 2026
aggregating
1.1 million
RSF, or
3.2%
of total operating RSF, primarily in the Greater Boston, San Francisco Bay
Area, and Seattle markets, which are leased and expected to be occupied upon completion of building and/or tenant improvements. The weighted-average expected
delivery date is approximately
September 2026
, with expected annual rental revenue of approximately
$68 million
.
66
Investments in real estate
A key component of our business model is our disciplined allocation of capital to the development and redevelopment of
new
Class A/A+ properties, and property enhancements identified during the underwriting of certain acquired properties, primarily located in
collaborative Megacampus ecosystems in AAA life science innovation clusters. These projects are focused on providing high-quality,
generic, and reusable spaces that meet the real estate requirements of a wide range of tenants. Upon completion, each development or
redevelopment project is expected to generate increases in rental income, net operating income, and cash flows. Our development and
redevelopment projects are generally in locations that are highly desirable to high-quality entities, which we believe may result in higher
occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. Our pre-construction
activities are undertaken in order to prepare the property for its intended use and include entitlements, permitting, design, site work, and
other activities preceding commencement of construction of aboveground building improvements.
Our investments in real estate consisted of the following as of
March 31, 2026
(dollars in thousands):
Development and Redevelopment
Under Construction
Operating
2Q26–4Q26
Stabilization
2027–2028
Stabilization
Evaluating
Business
and
Financial
Strategy
Future
Subtotal
Total
Square footage
Operating
34,403,470
—
—
—
—
—
34,403,470
Future Class A/A+ development and
redevelopment properties
—
601,589
1,258,004
1,552,718
20,014,546
23,426,857
23,426,857
Future development and redevelopment square
feet currently included in rental properties
(1)
—
—
—
—
(1,516,872)
(1,516,872)
(1,516,872)
Total square footage, excluding properties held for
sale
34,403,470
601,589
1,258,004
1,552,718
18,497,674
21,909,985
56,313,455
Properties held for sale
1,444,387
—
—
—
1,619,425
1,619,425
3,063,812
Total square footage
35,847,857
601,589
1,258,004
1,552,718
20,117,099
23,529,410
59,377,267
Investments in real estate
Gross book value as of
March 31, 2026
(2)
$
28,135,300
$
629,966
$
1,130,851
$
1,356,515
$
3,971,142
$
7,088,474
(3)
$
35,223,774
Properties held for sale
423,335
—
—
—
230,905
230,905
654,240
Total gross investment in real estate, excluding
properties held for sale
$
27,711,965
$
629,966
$
1,130,851
$
1,356,515
$
3,740,237
$
6,857,569
$
34,569,534
20%
Development/
Redevelopment
Under Construction
Land/Future
Development
17%
11%–16%
Non-Income-Producing Assets
(4)
as a Percentage of Gross Assets
(1)
Refer to “
Investments in real estate
” under “
Definitions and reconciliations
” in Item 2
for additional details, including future development and redevelopment square feet
currently included in rental properties.
(2)
Balances exclude accumulated depreciation and our share of the cost basis associated with our properties held by our unconsolidated real estate joint ventures, which is
classified as investments in unconsolidated real estate joint ventures in our consolidated balance sheet.
(3)
Our share of investment in our development and redevelopment pipeline
as of March 31, 2026 is
$6.45 billion
.
(4)
Excludes properties classified as held for sale, of which land parcels represented approximately
1%
of total non-income-producing assets as of December 31, 2024 and
2025
.
67
Dispositions and sales of partial interests
Our completed dispositions and sales of partial interests of real estate assets during the
three months ended March 31, 2026
and pending dispositions as of the date of this report
consisted of the following (dollars in thousands):
Price
(Our Share)
Gain on Sales of
Real Estate
Property
Completed in April 2026
$
2,250
$
—
Our share of pending dispositions subject to non-refundable deposits, signed letters of intent, and/or purchase and sale agreement negotiations
149,106
Completed and pending 2026 dispositions as of April 27, 2026
151,356
Dispositions and sales of partial interests identified and in process
(1)
2,181,275
Additional projected
567,369
$
2,900,000
2026 guidance range for dispositions and sales of partial interests
Midpoint
$
2,900,000
Weighted-average projected disposition date
August 2026
(1) Consists of assets classified as held for sale as of March 31, 2026, and projected sales of noncontrolling ownership interests in real estate assets for which consolidation is expected to continue.
68
New
Class A/A+ development and redevelopment properties
INCREMENTAL ANNUAL NET OPERATING INCOME
GROWTH EXPECTED FROM ALEXANDRIA’S
DEVELOPMENT AND REDEVELOPMENT DELIVERIES
Near-Term
Deliveries
Intermediate-Term
Deliveries
2Q26
–
4Q26
2027
–
2028
$92M
$93M
93%
Leased/Negotiating
68%
Leased/Negotiating
601,589
RSF
1.3 million
RSF
(1)
(2)
(3)
(4)
For the definition of “Net operating income” and a reconciliation from the most directly comparable GAAP measure, refer to the “
Definitions and reconciliations
”
in Item 2.
(1)
Includes expected partial deliveries through
2026
from projects expected to stabilize in
2027
-
2028
, including speculative future leasing that is not yet fully committed. Our share of incremental annual net operating income from
projects expected to be placed into service primarily commencing through
2026
is projected to be
$70 million
. Refer to the initial and stabilized occupancy years under “New Class A/A+ development and redevelopment properties:
under construction
” in Item 2 for additional details.
(2)
Our share of incremental annual net operating income from projects expected to stabilize in
2027
-
2028
is projected to be
$60 million
.
(3)
Represents the current leased/negotiating percentage of development and redevelopment projects that are expected to stabilize through the end of
2026
.
(4)
Represents the RSF related to projects expected to stabilize in
2026
. Does not include RSF for partial deliveries through
2026
from projects expected to stabilize in
2027
-
2028
.
69
New Class A/A+ development and redevelopment properties: recent deliveries
99 Coolidge Avenue
10075 Barnes Canyon Road
8800 Technology Forest Place
Greater Boston/
Cambridge/Inner Suburbs
San Diego/Sorrento Mesa
Texas/Greater Houston
146,147
RSF
253,079
RSF
57,042
RSF
100%
Occupancy
80%
Occupancy
100%
Occupancy
The following table presents development and redevelopment of new Class A/A+ projects placed into service during the
three months ended March 31, 2026
(dollars in thousands):
Property/Market/Submarket
1Q26
Delivery
Date
(1)
Our
Ownership
Interest
RSF Placed in Service
Occupancy
Percentage
(2)
Total Project
Unlevered Yields
Prior to
1/1/26
1Q26
Total
Initial
Stabilized
Initial
Stabilized
(Cash Basis)
RSF
Investment
Development projects
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs
1/27/26
100%
129,413
16,734
146,147
100%
320,809
$
444,000
6.0%
6.8%
10075 Barnes Canyon Road/San Diego/Sorrento Mesa
3/31/26
50.0%
171,469
81,610
(3)
253,079
80%
253,079
314,000
5.5
5.7
Redevelopment projects
8800 Technology Forest Place/Texas/Greater Houston
2/5/26
100%
50,094
6,948
57,042
100%
123,392
112,000
6.3
6.0
Weighted average/total
1/28/26
350,976
105,292
456,268
697,280
$
870,000
5.9%
6.3%
(1)
Represents the average delivery date for deliveries that occurred during the three months ended
March 31, 2026
, weighted by annual rental revenue.
(2)
Occupancy reflects total operating RSF placed in service as of each respective delivery date when the space was placed into service. Subsequent occupancy changes are not reflected.
(3)
Includes
50,531
RSF
that were vacant and/or unleased at delivery.
70
New Class A/A+ development and redevelopment properties: under construction
99 Coolidge Avenue
50 and 60 Sylvan Road
(1)
1450 Owens Street
Greater Boston/
Cambridge/Inner Suburbs
Greater Boston/Route 128
San Francisco Bay Area/
Mission Bay
174,662
RSF
267,015
RSF
212,657
RSF
84%
Leased/Negotiating
74%
Leased/Negotiating
51%
Leased/Negotiating
269 East Grand Avenue
4135 Campus Point Court
10200 Campus Point Drive
701 Dexter Avenue North
San Francisco Bay Area/
South San Francisco
San Diego/
University Town Center
San Diego/
University Town Center
Seattle/Lake Union
84,157
RSF
426,927
RSF
466,598
RSF
227,577
RSF
40%
Leased/Negotiating
100%
Leased
100%
Leased
23%
Leased/Negotiating
(1)
Image represents 60 Sylvan Road on the Alexandria Center
®
for Life Science – Waltham Megacampus. The project is expected to capture demand in our Route 128 submarket.
71
New Class A/A+ development and redevelopment properties: under construction (continued)
The following tables set forth a summary of our new Class A/A+ development and redevelopment properties under construction as of
March 31, 2026
(dollars in thousands):
Property/Market/Submarket
Located
on Mega-
campus
Square Footage
Percentage
Occupancy
(1)
Dev/
Redev
In Service
CIP
Total
Leased
Leased/
Negotiating
Initial
Stabilized
Under construction
2Q26–4Q26 stabilization
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs
X
Dev
146,147
174,662
320,809
84%
84%
4Q23
4Q26
4135 Campus Point Court/San Diego/University Town Center
X
Dev
—
426,927
426,927
100
100
3Q26
3Q26
146,147
601,589
747,736
93
93
2027–2028 stabilization
50 and 60 Sylvan Road/Greater Boston/Route 128
X
Redev
—
267,015
267,015
74
74
4Q26
2027
1450 Owens Street/San Francisco Bay Area/Mission Bay
X
Dev
—
212,657
212,657
51
51
2027
2027
269 East Grand Avenue/San Francisco Bay Area/South San Francisco
X
Redev
—
84,157
84,157
40
40
2H26
2027
10200 Campus Point Drive/San Diego/University Town Center
(2)
X
Dev
—
466,598
466,598
100
100
2028
2028
701 Dexter Avenue North/Seattle/Lake Union
X
Dev
—
227,577
227,577
23
23
3Q26
2027
—
1,258,004
1,258,004
68
68
Total
146,147
1,859,593
2,005,740
77%
77%
Evaluating business and financial strategy with earliest potential lab
delivery in 2028
(3)
311 Arsenal Street/Greater Boston/Cambridge/Inner Suburbs
X
Redev
56,904
333,758
390,662
9%
28%
421 Park Drive/Greater Boston/Fenway
X
Dev
—
392,011
392,011
13
13
40 Sylvan Road/Greater Boston/Route 128
X
Redev
—
329,049
329,049
—
—
3000 Minuteman Road/Greater Boston/Other
X
Redev
—
431,550
431,550
—
37
8800 Technology Forest Place/Texas/Greater Houston
Redev
57,042
66,350
123,392
46
46
113,946
1,552,718
1,666,664
9%
23%
(1)
Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over time.
(2)
Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a
57.2%
ownership interest.
The project is fully leased to a longtime multinational pharmaceutical tenant that
currently occupies
one building within the Megacampus aggregating
52,853
RSF
, which generated annual rental revenue of
$4.1 million
as of
March 31, 2026
.
The tenant is expected to vacate this building during 2028. We expect to fund
the majority of future construction costs at the Megacampus until our ownership interest increases to
75%
, after which future capital would be contributed pro rata with our joint venture partner
.
(3)
We are evaluating multiple options, including whether to continue construction of laboratory improvements, pause construction, pursue lower-investment construction alternatives (including a pivot to advanced technology use), or
disposition, based upon future leasing interest. Under a lower-investment, we would expect lower rent and tenant improvement requirements, and we would evaluate whether all or a portion of the property would be placed back into
operation. If the properties are completed as laboratory/office, we do not expect significant deliveries until 2028 at the earliest.
72
New Class A/A+ development and redevelopment properties: under construction (continued)
Our
Ownership
Interest
At 100%
Unlevered Yields
Property/Market/Submarket
In Service
CIP
Cost to
Complete
Total at
Completion
Initial
Stabilized
Initial Stabilized
(Cash Basis)
Under construction
2Q26–4Q26 stabilization with
93%
leased/negotiating
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs
100%
$
203,361
$
185,307
$
55,332
$
444,000
6.0%
6.8%
4135 Campus Point Court/San Diego/University Town Center
57.2%
—
444,659
79,341
524,000
9.8%
6.2%
203,361
629,966
2027–2028 stabilization with
68%
leased/negotiating
(1)
50 and 60 Sylvan Road/Greater Boston/Route 128
100%
—
360,504
TBD
1450 Owens Street/San Francisco Bay Area/Mission Bay
25.0%
—
251,678
269 East Grand Avenue/San Francisco Bay Area/South San Francisco
100%
—
121,604
10200 Campus Point Drive/San Diego/University Town Center
(2)
57.2%
—
76,310
583,690
660,000
7.3%
6.5%
701 Dexter Avenue North/Seattle/Lake Union
100%
—
320,755
TBD
—
1,130,851
Total
$
203,361
$
1,760,817
$
1,020,000
(3)
$
2,990,000
(3)
Our share of investment
(3)(4)
$
200,000
$
1,350,000
$
680,000
$
2,230,000
Evaluating business and financial strategy with earliest potential lab
delivery in 2028
(5)
311 Arsenal Street/Greater Boston/Cambridge/Inner Suburbs
100%
$
28,081
$
310,025
TBD
421 Park Drive/Greater Boston/Fenway
100%
—
606,090
40 Sylvan Road/Greater Boston/Route 128
100%
—
229,568
3000 Minuteman Road/Greater Boston/Other
100%
—
168,783
8800 Technology Forest Place/Texas/Greater Houston
100%
65,564
42,049
$
93,645
$
1,356,515
Refer to “
Initial stabilized yield (unlevered)
” under “
Definitions and reconciliations
” in Item 2 for additional information.
(1)
We expect to provide total estimated costs and related yields for each project over the next several quarters.
(2)
Refer to footnote 2 on the prior page for additional details.
(3)
Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD.
(4)
Represents our share of investment based on our current ownership percentage upon completion of development or redevelopment projects. Our share of investment will be adjusted as our ownership percentage increases at the
Campus
Point
project.
(5)
Refer to footnote 3 on the prior page for additional details.
73
New Class A/A+ development and redevelopment properties: summary of pipeline
77%
of Our Total Development and Redevelopment Pipeline RSF
Is Within Our Megacampus Ecosystems
The following table summarizes the key information for all our development and redevelopment projects in North America as of
March 31, 2026
(dollars in thousands):
Market
Property/Submarket
Our
Ownership
Interest
Book Value
Development and Redevelopment
Square Footage
Under
Construction
Future
Total
(1)
Greater Boston
Megacampus: The Arsenal on the Charles/Cambridge/Inner Suburbs
100%
$
322,671
333,758
34,157
367,915
311 Arsenal Street
Megacampus: 480 Arsenal Way and 446, 458, and 500 Arsenal Street, and 99 Coolidge Avenue/Cambridge/
Inner Suburbs
100%
209,508
174,662
560,000
734,662
446, 458, and 500 Arsenal Street, and 99 Coolidge Avenue
Megacampus: Alexandria Center
®
for Life Science – Fenway/Fenway
100%
606,090
392,011
—
392,011
421 Park Drive
Megacampus: Alexandria Center
®
for Life Science – Waltham/Route 128
100%
655,867
596,064
515,000
1,111,064
40, 50, and 60 Sylvan Road, and 35 Gatehouse Drive
Megacampus: 30, 200, and 3000 Minuteman Road/Other
100%
194,127
431,550
350,000
781,550
3000 Minuteman Road
Megacampus: Alexandria Technology Square
®
/Cambridge
100%
8,858
—
100,000
100,000
10 Necco Street/Seaport Innovation District
100%
107,101
—
175,000
175,000
215 Presidential Way/Route 128
100%
6,816
—
112,000
112,000
Other development and redevelopment projects
100%
165,576
—
740,000
740,000
$
2,276,614
1,928,045
2,586,157
4,514,202
Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional information.
(1)
Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have
future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “Investments in real estate” under
“Definitions and reconciliations” in Item 2 for additional information, including development and redevelopment square feet currently included in rental properties.
74
New Class A/A+ development and redevelopment properties: summary of pipeline (continued)
Market
Property/Submarket
Our
Ownership
Interest
Book Value
Development and Redevelopment
Square Footage
Under
Construction
Future
Total
(1)
San Francisco Bay Area
Megacampus: Alexandria Center
®
for Science and Technology – Mission Bay/Mission Bay
25.0%
$
251,678
212,657
—
212,657
1450 Owens Street
Megacampus: Alexandria Center
®
for Advanced Technologies – South San Francisco/South San Francisco
100%
128,259
84,157
90,000
174,157
211
(2)
and 269 East Grand Avenue
Megacampus: Alexandria Center
®
for Advanced Technologies – Tanforan/South San Francisco
100%
443,324
—
1,930,000
1,930,000
1122, 1150, and 1178 El Camino Real
Alexandria Center
®
for Life Science – Millbrae/South San Francisco
48.6%
162,361
—
348,401
348,401
201 and 231 Adrian Road and 30 Rollins Road
Megacampus: Alexandria Center
®
for Life Science – San Carlos/Greater Stanford
100%
493,425
—
1,497,830
1,497,830
960 Industrial Road, 987 and 1075 Commercial Street, and 888 Bransten Road
2100, 2200, 2300, and 2400 Geng Road/Greater Stanford
100%
128,360
—
240,000
240,000
1,607,407
296,814
4,106,231
4,403,045
San Diego
Megacampus: Campus Point by Alexandria/University Town Center
57.2%
(3)
709,266
893,525
866,816
1,760,341
10010
(4)
, 10140
(4)
, and 10200 Campus Point Drive and 4135, 4165, 4224, and 4275
(4)
Campus Point Court
11255 and 11355 North Torrey Pines Road/Torrey Pines
100%
163,973
—
215,000
215,000
Megacampus: One Alexandria Square/Torrey Pines
100%
69,826
—
125,280
125,280
10975 and 10995 Torreyana Road
Megacampus: 5200 Illumina Way/University Town Center
51.0%
17,939
—
451,832
451,832
9625 Towne Centre Drive/University Town Center
30.0%
837
—
100,000
100,000
Megacampus: Sequence District by Alexandria/Sorrento Mesa
100%
49,696
—
1,661,915
1,661,915
6290, 6310, 6340, 6350, and 6450 Sequence Drive
Megacampus: SD Tech by Alexandria/Sorrento Mesa
50.0%
127,187
—
493,845
493,845
9805 Scranton Road and 10065 Barnes Canyon Road
4075 Sorrento Valley Boulevard/Sorrento Valley
100%
29,598
—
144,000
144,000
Other development and redevelopment projects
(2)
78,404
—
475,000
475,000
$
1,246,726
893,525
4,533,688
5,427,213
Refer to “Megacampus” under “
Definitions and reconciliations
” in Item 2 for additional information.
(1)
Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have
future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “
Investments in real estate
” under
“
Definitions and reconciliations
” in Item 2 for additional information, including development and redevelopment square feet currently included in rental properties.
(2)
Includes a property in which we own a partial interest through a real estate joint venture. Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for
additional details.
(3)
The noncontrolling interest share of our real estate joint venture partner is anticipated to decrease to
25%
, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases to
75%
, after
which future capital would be contributed pro rata with our partner.
(4)
We have a 100% interest in this property.
75
New Class A/A+ development and redevelopment properties: summary of pipeline (continued)
Market
Property/Submarket
Our
Ownership
Interest
Book Value
Development and Redevelopment
Square Footage
Under
Construction
Future
Total
(1)
Seattle
Megacampus: Alexandria Center
®
for Advanced Technologies – South Lake Union/Lake Union
(2)
$
617,648
227,577
1,057,400
1,284,977
601 and 701 Dexter Avenue North and 800 Mercer Street
1010 4th Avenue South/SoDo
100%
63,523
—
544,825
544,825
410 West Harrison Street/Elliott Bay
100%
25,224
—
91,000
91,000
Megacampus: Alexandria Center
®
for Advanced Technologies – Canyon Park/Bothell
100%
20,692
—
230,000
230,000
21660 20th Avenue Southeast
Other development and redevelopment projects
100%
157,385
—
706,087
706,087
884,472
227,577
2,629,312
2,856,889
Maryland
Megacampus: Alexandria Center
®
for Life Science – Shady Grove/Rockville
100%
28,803
—
296,000
296,000
9830 Darnestown Road
28,803
—
296,000
296,000
Research Triangle
Megacampus: Alexandria Center
®
for Life Science – Durham/Research Triangle
100%
167,871
—
2,060,000
2,060,000
Megacampus: Alexandria Center
®
for Advanced Technologies and AgTech – Research Triangle/Research
Triangle
100%
115,384
—
1,170,000
1,170,000
4 and 12 Davis Drive
Megacampus: Alexandria Center
®
for Sustainable Technologies/Research Triangle
100%
56,960
—
750,000
750,000
120 TW Alexander Drive, 2752 East NC Highway 54, and 10 South Triangle Drive
Other development and redevelopment projects
100%
1,647
—
25,000
25,000
341,862
—
4,005,000
4,005,000
New York City
Megacampus: Alexandria Center
®
for Life Science – New York City/New York City
100%
180,617
—
550,000
(3)
550,000
$
180,617
—
550,000
550,000
Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional information.
(1)
Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have
inherent future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property. Refer to “Investments in real estate” under “Definitions and reconciliations”
for additional information, including development and redevelopment square feet currently included in rental properties.
(2)
We have a
100%
interest in 601 and 701 Dexter Avenue North aggregating
415,977
RSF and a
60%
interest in the future development project at 800 Mercer Street aggregating
869,000
RSF.
(3)
During the three months ended September 30, 2024, we filed a lawsuit against the New York City Health + Hospitals Corporation and the New York City Economic Development Corporation for fraud and breach of contract concerning our
option to ground lease a land parcel to develop a future world-class life science building within the Alexandria Center
®
for Life Science – New York City Megacampus. Refer to “Legal proceedings” in Item 1 under Part II – Other Information
for additional details.
76
New Class A/A+ development and redevelopment properties: summary of pipeline (continued)
Market
Property/Submarket
Our
Ownership
Interest
Book Value
Development and Redevelopment
Square Footage
Under
Construction
Future
Total
(1)
Texas
Alexandria Center
®
for Advanced Technologies at The Woodlands/Greater Houston
100%
$
45,105
66,350
116,405
182,755
8800 Technology Forest Place
1001 Trinity Street and 1020 Red River Street/Austin
100%
137,652
—
250,010
250,010
Other development and redevelopment projects
100%
60,808
—
344,000
344,000
243,565
66,350
710,415
776,765
Other development and redevelopment projects
100%
47,503
—
597,743
597,743
Total pipeline as of
March 31, 2026
, excluding properties held for sale
6,857,569
3,412,311
20,014,546
23,426,857
Properties held for sale
230,905
—
1,619,425
1,619,425
Total pipeline as of
March 31, 2026
$
7,088,474
(2)
3,412,311
21,633,971
25,046,282
Refer to “Megacampus” under “
Definitions and reconciliations
” in Item 2 for additional information.
(1)
Total square footage includes
1,516,872
RSF
of buildings currently in operation that we expect to demolish or redevelop and commence future construction subject to market conditions and leasing. Refer to “
Investments in real estate
”
under “
Definitions and reconciliations
” in Item 2 for additional information, including development and redevelopment square feet currently included in rental properties.
(2)
Includes
$3.12 billion
of projects that are currently under construction.
77
Results of operations
Same properties
We supplement an evaluation of our results of operations with an evaluation of operating performance of certain of our
properties, referred to as “Same Properties.” For additional information on the determination of our Same Properties portfolio, refer to
“
Same property comparisons
” under “
Definitions and reconciliations
” in Item 2. The following table presents information regarding our
Same Properties for the
three months ended March 31, 2026
:
Three Months Ended
March 31, 2026
Percentage change in net operating income over comparable period from prior year
(11.9)%
(1)
Percentage change in net operating income (cash basis) over comparable period from prior year
(11.7)%
(1)
Operating margin
65%
Number of Same Properties
294
RSF
31,965,127
Occupancy – current-period average
88.9%
Occupancy – same-period prior-year average
94.0%
(1)
The quarter-over-quarter decline was due to a decrease in same property occupancy, primarily driven by the previously disclosed 2026 key lease expirations
aggregating
657,492
RSF that became vacant during the three months ended March 31, 2026, with a weighted-average lease expiration date of
January 2026
, and by
vacancy during the three months ended December 31, 2025 at one property aggregating
170,618
RSF at Alexandria Center
®
for Advanced Technologies – South San
Francisco in our South San Francisco submarket. We expect our same property performance to improve in the second half of 2026, primarily due to changes in same
property occupancy. This includes the anticipated delivery of
1.1 million
RSF of
vacant space that was leased but not yet delivered as of March 31, 2026, which has a
weighted-average expected delivery date of approximately
September 2026
, and is expected to generate annual rental revenue of approximately
$68 million
.
The following table reconciles the number of Same Properties to total properties for the
three months ended March 31, 2026
:
Development and redevelopment – under construction
Properties
99 Coolidge Avenue
1
1450 Owens Street
1
421 Park Drive
1
4135 Campus Point Court
1
701 Dexter Avenue North
1
10200 Campus Point Drive
1
40, 50, and 60 Sylvan Road
3
269 East Grand Avenue
1
8800 Technology Forest Place
1
311 Arsenal Street
1
3000 Minuteman Road
2
14
Development – placed into service after
January 1, 2025
230 Harriet Tubman Way
1
500 North Beacon Street and 4 Kingsbury Avenue
2
10935, 10945, and 10955 Alexandria Way
3
10075 Barnes Canyon Road
1
7
Acquisitions after
January 1, 2025
Other
2
2
Unconsolidated real estate JVs
3
Properties held for sale
19
Total properties excluded from Same Properties
45
Same Properties
294
Total properties in North America as of
March 31, 2026
339
78
Comparison of results for the three months ended
March 31, 2026
to the three months ended
March 31, 2025
The following table presents a comparison of the components of net operating income for our Same Properties and Non-Same
Properties for the three months ended
March 31, 2026
, compared to the three months ended
March 31, 2025
(dollars in thousands).
Refer to “
Definitions and reconciliations
” in Item 2 for definitions of “
Tenant recoveries
” and “Net operating income” and their
reconciliations from the most directly comparable financial measures presented in accordance with GAAP, income from rentals and net
income, respectively.
Three Months Ended March 31,
2026
2025
$ Change
% Change
Income from rentals:
Same Properties
$
431,442
$
473,233
$
(41,791)
(8.8)
%
Non-Same Properties
43,344
78,879
(35,535)
(45.1)
Rental revenues
474,786
552,112
(77,326)
(14.0)
Same Properties
166,149
165,419
730
0.4
Non-Same Properties
12,078
25,644
(13,566)
(52.9)
Tenant recoveries
178,227
191,063
(12,836)
(6.7)
Income from rentals
653,013
743,175
(90,162)
(12.1)
Same Properties
250
303
(53)
(17.5)
Non-Same Properties
17,759
14,680
3,079
21.0
Other income
18,009
14,983
3,026
20.2
Same Properties
597,841
638,955
(41,114)
(6.4)
Non-Same Properties
73,181
119,203
(46,022)
(38.6)
Total revenues
671,022
758,158
(87,136)
(11.5)
Same Properties
208,056
196,587
11,469
5.8
Non-Same Properties
16,086
29,808
(13,722)
(46.0)
Rental operations
224,142
226,395
(2,253)
(1.0)
Same Properties
389,785
442,368
(52,583)
(11.9)
Non-Same Properties
57,095
89,395
(32,300)
(36.1)
Net operating income
$
446,880
$
531,763
$
(84,883)
(16.0)
%
Net operating income – Same Properties
$
389,785
$
442,368
$
(52,583)
(11.9)
%
Straight-line rent revenue
(13,114)
(15,469)
2,355
(15.2)
Amortization of acquired below-market leases and deferred
revenue related to tenant-funded and -built landlord
improvements
(10,063)
(11,558)
1,495
(12.9)
Net operating income – Same Properties (cash basis)
$
366,608
$
415,341
$
(48,733)
(11.7)
%
79
Income from rentals
Total income from rentals for the
three months ended March 31, 2026
decreased
by
$90.2 million
, or
12.1%
, to
$653.0 million
,
compared to
$743.2 million
for the
three months ended March 31, 2025
,
due to a
decrease
in rental revenues, as discussed below.
Rental revenues
Total rental revenues for the
three months ended March 31, 2026
decreased
by
$77.3 million
, or
14.0%
, to
$474.8 million
,
compared to
$552.1 million
for the
three months ended March 31, 2025
.
The
decrease
was related to dispositions of real estate assets
within our Non-Same Properties since
January 1, 2025
and a decrease in Same Properties’ average occupancy, as discussed below.
Same Properties’ rental revenues for the
three months ended March 31, 2026
decreased
by
$41.8 million
, or
8.8%
, to
$431.4 million
, compared to
$473.2 million
for the
three months ended March 31, 2025
. This
decrease is primarily attributable to a
decrease
in Same Properties’ average occupancy to
88.9%
for the
three months ended March 31, 2026
from
94.0%
for the
three
months ended March 31, 2025
. This decline includes the impact of key lease expirations during the first quarter of 2026, including
: i)
45,636
RSF at Alexandria Center
®
at Kendall Square Megacampus in our Cambridge submarket, ii)
163,648
RSF at 9625 Towne
Center Drive in our University Town Center submarket, and iii)
118,225
RSF at One Alexandria Square Megacampus in our Torrey
Pines subma
rket
. T
he decrease was further impacted by vacancy at one property aggregating
170,618
RSF at Alexandria Center
®
for
Advanced Technologies – South San Francisco Megacampus in our South San Francisco submarket during the three months ended
December 31, 2025, which has been re-leased with occupancy expected to commence during the second half of 2026.
Tenant recoveries
Tenant recoveries for the
three months ended March 31, 2026
decreased
by
$12.8 million
, or
6.7%
, to
$178.2 million
,
compared to
$191.1 million
for the
three months ended March 31, 2025
, primarily in connection with dispositions of real estate assets
within our Non-Same Properties since
January 1, 2025
.
The decrease in Non-Same Properties tenant recoveries was partially offset by the
increase
of
$730 thousand
, or
0.4%
, to
$166.1 million
in
Same Properties’ tenant recoveries for the
three months ended March 31, 2026
, compared to
$165.4 million
for the
three months ended March 31, 2025
.
Tenant recoveries for our Same Properties increased only modestly during the period despite higher operating costs primarily
due to the decrease in Same Property occupancy to
88.9%
as of March 31, 2026, from
94.0%
as of March 31, 2025, which reduced the
proportion of expenses recoverable from tenants.
As of
March 31, 2026
,
91%
of our leases (on an annual rental revenue basis)
were
triple net leases, which require tenants to pay substantially all real estate taxes, insurance, utilities, repairs and maintenance, common
area expenses, and other operating expenses (including increases thereto) in addition to base rent.
Rental operations
Total rental operating expenses for the
three months ended March 31, 2026
decreased
by
$2.3 million
, or
1.0%
, to
$224.1 million
, compared to
$226.4 million
for the
three months ended March 31, 2025
.
The
decrease
was primarily due to the
decrease
in Non-Same Properties’ rental operating expenses of
$13.7 million
primarily resulting from the real estate dispositions since
January 1, 2025
, partially offset by higher rental operating expenses related to our Same Properties, as discussed below.
Same Properties’ rental operating expenses
increased
by
$11.5 million
, or
5.8%
, to
$208.1 million
during the
three months
ended March 31, 2026
, compared to
$196.6 million
for the
three months ended March 31, 2025
, primarily due to:
(i)
a
$4.5 million
increase in utilities expenses, reflecting increases in electricity rates in our Maryland market, our assumption of utilities costs for certain
vacant spaces that were previously paid directly by tenants, primarily in our San Diego market, and increased electric and gas
consumption in our Greater Boston market due to a more severe winter in 2026, (ii) a
$3.8 million
increase in property taxes, primarily
resulting from a 22% commercial tax rate increase in Cambridge, effective in 2026, as well as changes in leasing arrangements with
certain new tenants in our San Francisco Bay Area market under which we pay property taxes and are reimbursed by tenants,
compared to previous leases where tenants paid taxes directly, and (iii) a
$3.6 million
increase in repairs and maintenance expenses,
reflecting more severe winter conditions in our Greater Boston, Maryland, and Research Triangle market
s.
Depreciation and amortization
Depreciation and amortization expense for the
three months ended March 31, 2026
decreased
by
$36.6 million
, or
10.7%
, to
$305.4 million
, compared to
$342.1 million
for the
three months ended March 31, 2025
.
The
decrease
was primarily as a result of real
estate dispositions of real estate assets since
January 1, 2025
.
80
Impairment of real estate
During the
three months ended March 31, 2026
, we recognized impairment charges aggregating
$5.5 million
, classified in
impairment of real estate in our consolidated statement of operations.
Th
e impairment primarily reflects an incremental charge
recognized in connection with the amendment of the sales agreement for our Canada portfolio
, which was classified as held for sale as
of December 31, 2025. We expect to complete the sale in 2026.
During the
three months ended March 31, 2025
, we recognized real estate impairment charges aggregating
$32.2 million
,
related to a ground lease entered into in 2021 for a future development site in our San Francisco Bay Area market.
General and administrative expenses
G
eneral and administrative expenses for the
three months ended March 31, 2026
increased
by
$4.0 million
, or
13.1%
, to
$34.7 million
, compared to
$30.7 million
for the
three months ended March 31, 2025
. The increase primarily reflects the timing of the
restructuring of compensation plans and other cost-control and efficiency initiatives during the
three months ended March 31, 2025
.
Notwithstanding this anticipated increase compared to
three months ended March 31, 2025
, general and administrative
expenses for the three months ended March 31, 2026 decreased by
$12.4 million
, or
26.3%
, compared to
$47.1 million
for the three
months ended March 31, 2024,
reflecting the continued benefit from cost‑efficiency initiatives implemented in prior periods. Based on
the midpoint of our 2026 guidance range, we continue to expect approximately
$76 million
of cumulative general and administrative
expense savings in 2025 and 2026 compared to 202
4.
As a percentage of net operating income, our general and administrative expenses for
the trailing twelve months ended
March 31, 2026
and
2025
were
6.0%
and
6.9%
, respectivel
y
.
Interest expense
Interest expense for the
three months ended March 31, 2026
and
2025
consisted of the following (dollars in thousands):
Three Months Ended March 31,
Component
2026
2025
Change
Gross interest
$
134,557
$
130,941
$
3,616
Capitalized interest
(69,973)
(80,065)
10,092
Interest expense
$
64,584
$
50,876
$
13,708
Average debt balance outstanding
(1)
$
12,901,002
$
12,815,953
$
85,049
Weighted-average annual interest rate
(2)
4.2%
4.1%
0.1%
(1)
Represents the average debt balance outstanding during the respective periods.
(2)
Represents annualized total interest incurred divided by the average debt balance outstanding during the respective periods.
81
The net change in interest expense during the
three months ended March 31, 2026
, compared to the
three months ended
March 31, 2025
, resulted from the following (dollars in thousands):
Component
Interest Rate
(1)
Effective Date
Change
Increases in interest incurred due to:
Issuances of debt:
$550 million of unsecured senior notes payable due 2035
5.66%
February 2025
$
3,544
$750 million of unsecured senior notes payable due 2036
5.41%
February 2026
3,956
Higher average outstanding balances under commercial paper program and/or
unsecured senior line of credit
13,173
Total increases
20,673
Decreases in interest incurred due to:
Repayments of debt:
Repaid
$525 million
of $1 billion of unsecured senior notes due 2052
3.64%
February 2026
(2,537)
Repaid
$498 million
of $850 million of unsecured senior notes due 2051
3.09%
February 2026
(2,036)
Repaid
$309 million
of $700 million of unsecured senior notes due 2050
3.91%
February 2026
(1,678)
$300 million of unsecured senior notes payable due 2026
4.50%
January 2026
(2,748)
$600 million of unsecured senior notes payable due 2025
3.62%
April 2025
(5,219)
Secured notes payable
7.18%
August 2025
(2,658)
Other decrease in interest
(181)
Total decreases
(17,057)
Change in gross interest
3,616
Decrease in capitalized interest
10,092
Total change in interest expense
$
13,708
(1)
Represents the weighted-average interest rate as of the end of the applicable period, including amortization of loan fees, amortization of debt premiums (discounts), and
other bank fees.
Investment loss
During the
three months ended March 31, 2026
, we recognized investment
loss
aggregating
$4.6 million
, which consisted of
$18.2 million
of realized
gains
,
$10.3 million
of unrealized
losses
, and
$12.4 million
of impairment charges
.
During the
three months ended March 31, 2025
, we recognized investment
loss
aggregating
$50.0 million
,
which consisted of
$29.3 million
of realized
gains
,
$68.1 million
of unrealized
losses
, and
$11.2 million
of impairment charges
.
For more information about our investments, refer to Note 7 – “Investments” and “
Investments
” in Note 2 – “Summary of
significant accounting policies” to our unaudited consolidated financial statements in Item 1.
Gain on early extinguishment of debt
During the
three months ended March 31, 2026
, we recognized a gain on early extinguishment of debt aggregating
$366.4 million
, net of the write-off of unamortized debt issuance costs and other transaction-related costs,
related to the completion of
the February 20
26 tender offers to repurchase
$1.33 billion
of debt principal across a portion of our outstanding
4.00%
Senior Notes
due
2050
,
3.00%
Senior Notes due
2051
, and
3.55%
Senior Notes due
2052
for
$952.2 million
.
Other comprehensive (loss) income
Other comprehensive (loss) income primarily comprised unrealized foreign currency translation gains or losses related to our
operations in Canada. Total other comprehensive
loss
for the
three months ended March 31, 2026
aggregating
$1.5 million
included
$4.9 million
of cumulative translation
loss
related to our operations in Canada, resulting from the CAD’s weakening against the USD
during this period and partially offset by
$3.3 million
of unrealized gains
related to the change in the fair value of our cross-currency
swap agreements, resulting from the Canadian dollar’s strengthening since the execution of these agreements on
July 29, 2025 through
March 31, 2026
.
Refer to Note 11 – “Hedge Agreements” to our unaudited consolidated financial statements in Item 1 for additional
information.
Total other comprehensive
income
of
$50 thousand
for the
three months ended March 31, 2025
is primarily due to unrealized
foreign currency translation gains related to our operations in Canada.
82
Summary of capital expenditures
Our construction spending for the
three months ended March 31, 2026
and projected spending for the year ending
December
31, 2026
consisted of the following (in thousands):
Three Months
Ended March 31,
2026
Projected Midpoint for
Year Ending
December 31, 2026
Construction of Class A/A+ properties:
Active construction projects
Development and redevelopment under construction
(1)
$
184,054
$
1,445,000
Future pipeline pre-construction
Primarily Megacampus expansion pre-construction work (entitlement,
design, and site work)
56,610
210,000
(2)
Revenue- and non-revenue-enhancing capital expenditures
(3)
164,382
510,000
(4)
Construction spending (before contributions from noncontrolling interests or
tenants)
405,046
2,165,000
Contributions from noncontrolling interests (consolidated real estate joint
ventures)
(23,804)
(100,000)
(5)
Tenant-funded and -built landlord improvements
(2,694)
(315,000)
Total construction spending
$
378,548
$
1,750,000
2026
guidance range for construction spending
$1,500,000 – $2,000,000
(1)
Includes smaller conversions to laboratory space through redevelopment.
(2)
Approximately 75% represents capitalized costs.
(3)
Represents revenue- and non-revenue-enhancing capital expenditures before contributions from noncontrolling interests and tenant-funded and tenant-built landlord
improvements.
(4)
The top two revenue- and non-revenue-enhancing capital expenditure projects in
2026
represent approximately
58%
of the total spending within this category. The first
project relates to a property located at the Alexandria Center
®
for Advanced Technologies – South San Francisco Megacampus in our South San Francisco submarket,
which is leased to a new tenant and is undergoing its first major renovation in
12
years. The second project relates to two properties at the Alexandria Technology
Square
®
Megacampus in our Cambridge submarket, which are undergoing their first major renovation in
16
y
ears.
(5)
Represents contractual capital commitments from existing consolidated real estate joint venture partners to fund construction.
Projected capital contributions from partners in consolidated real estate joint ventures to fund construction
The following table summarizes projected capital contributions from partners in our existing consolidated joint ventures to fund
construction through
2027
and beyond (in thousands):
Projected timing
Amount
(1)
April 1, 2026
through
December 31, 2026
$
76,000
2027
and beyond
44,000
Total
$
120,000
(1)
Amounts represent reductions to our consolidated construction spending.
83
Average real estate basis used for capitalization of interest
Our construction spending includes capitalized interest. The table below provides key categories of interest capitalized during
the
three months ended March 31, 2026
(in thousands):
Average Real Estate Basis Capitalized
Amount
Percentage
Construction of Class A/A+ properties:
Development and redevelopment of projects under construction and repositioning
projects:
2026 stabilization
$
330,399
2027–2028 stabilization
768,594
Evaluating business and financial strategy
(1)
1,277,710
Repositioning and smaller redevelopment projects
(2)
1,538,022
3,914,725
57%
Land/future development projects with critical key pre-construction milestones through:
2026
(3)
1,159,948
2027
(3)
567,606
2028 and beyond
(4)
1,217,819
2,945,373
43
Total average real estate basis capitalized
(5)
$
6,860,098
100%
(1)
I
ncludes projects aggregating
1.6 million
RSF
for which we are evaluating business and financial strategy and that are expected to reach anticipated construction or
delivery milestones, on a weighted-average real estate investment basis by
March 2027
. We are evaluating multiple options, including whether to continue construction
of laboratory improvements, pause construction, pursue lower-investment construction alternatives (including a pivot to advanced technology use), or disposition. Upon
achievement of these milestones, if we choose not to pursue future construction or other activities, capitalized interest and other project costs may no longer qualify for
capitalization. Refer to “New Class A/A+ development and redevelopment properties: under construction” in Item 2 for additional information.
(2)
Includes the real estate basis related to the
1.1 million
RSF of vacant space as of
March 31, 2026
that is leased with future delivery. The weighted-average expected
delivery date is approximately
September 2026
.
(3)
Includes future pipeline projects that are expected to reach anticipated pre-construction milestones, including various phases of entitlement, design, site work, and other
activities necessary to begin aboveground vertical construction, on a weighted-average real estate investment basis by
August 2026
and
April 2027
, for the 2026 and
2027 milestones, respectively. At each milestone date, we will evaluate whether to proceed with additional pre-construction and/or construction activities based on
leasing demand and/or market conditions, pause future investments, or consider for potential disposition.
(4)
Includes future Megacampus development projects at Alexandria Center
®
for Advanced Technologies – Tanforan in our South San Francisco submarket and Alexandria
Center
®
for Life Science – San Carlos in our
Greater Stanford submarket
, which represents approximately
68%
of the total average capitalized real estate basis with
2028 and beyond milestones during the
three months ended March 31, 2026
. These projects are located at transit-friendly sites with future access to exceptional
amenities.
(5)
In addition to capitalized interest, we incur additional capitalized project costs, including property taxes, insurance, payroll, and other costs directly related and essential
to the construction of Class A/A+ properties. If we cease activities necessary to prepare a project for its intended use, costs related to such project are expensed as
incurred. Annualized capitalized operating expenses and payroll represent approximately
2%
and
1%
, respectively, of the total average real estate basis subject to
capitalization for the
three months ended March 31, 2026
.
84
Projected results
Our
2026
guidance includes certain forward-looking non-GAAP financial measures, such as funds from operations as adjusted, net debt and preferred stock to Adjusted EBITDA –
fourth quarter of
2026
annualized, fixed-charge coverage ratio – fourth quarter of
2026
annualized, and net cash provided by operating activities, as adjusted, that differ from measures
calculated in accordance with GAAP. These non-GAAP measures are in addition to, and not a substitute for or superior to, financial measures prepared in accordance with GAAP and should
be considered in conjunction with our GAAP financial measures. We are unable to provide corresponding GAAP measures on a forward-looking basis, or a reconciliation from these GAAP
measures to the non-GAAP measures on a forward-looking basis, as we are not able to forecast the net income or loss of future periods without unreasonable effort. This is due to the
inherent difficulty of forecasting the timing and/or amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and financing
decisions, as well as quarterly and annual components such as gain on sales of real estate, impairments of real estate and non-real estate investments, and unrealized gains or losses on
non-real estate investments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would be potentially misleading for our investors. Refer to
“Definitions and reconciliations” included in Item 2 for additional details about these non-GAAP measures.
Projected
2026
Funds From Operations per Share Attributable to Alexandria’s Common Stockholders –
Diluted
As of 4/27/26
As of 1/26/26
Key Changes
Funds from operations per share and funds from operations per share, as adjusted
(1)
$6.30 to $6.50
$6.25 to $6.55
No change to midpoint;
range narrowed by
10 cents
Midpoint
$6.40
$6.40
Key Credit Metric Targets
As of 4/27/26
As of 1/26/26
Key Changes
Net debt and preferred stock to Adjusted EBITDA – fourth quarter of
2026
annualized
5.6x to 6.2x
5.6x to 6.2x
No Change
Fixed-charge coverage ratio – fourth quarter of
2026
annualized
3.6x to 4.1x
3.6x to 4.1x
Refer to “
Definitions and reconciliations
” in Item 2 for additional details on key credit metrics.
(1)
Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” under “Definitions and reconciliations” in Item 2 for additional details.
85
Capital resources
We expect that our principal liquidity needs for the year ending
December 31, 2026
will be satisfied by the following multiple sources of capital, as shown in the table below. There
can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.
Key Sources and Uses of Capital
(In millions)
As of 4/27/26
Certain
Completed
Items
As of 1/26/26
Midpoint
Range
Midpoint
Sources of capital:
Reduction in debt
$
(1,075)
$
(2,275)
$
(1,675)
See below
$
(1,675)
Net cash provided by operating activities, as adjusted
475
575
525
525
Dispositions and sales of partial interests
(1)
2,100
3,700
2,900
(1)
2,900
Total sources of capital
$
1,500
$
2,000
$
1,750
$
1,750
Uses of capital:
Construction
$
1,500
$
2,000
$
1,750
$
1,750
Total uses of capital
$
1,500
$
2,000
$
1,750
$
1,750
Reduction in debt (included above):
Repayment of secured notes payable with 2026 maturities
(2)
$
(650)
$
(650)
$
(650)
$
(650)
(650)
Tender offers for partial principal repayments of unsecured senior notes payable
(3)
(952)
(952)
(952)
$
(952)
—
Issuance of unsecured senior notes payable
(3)
750
750
750
$
750
—
Unsecured senior line of credit, commercial paper program, and other
(223)
(1,423)
(823)
(1,025)
Reduction in debt
$
(1,075)
$
(2,275)
$
(1,675)
$
(1,675)
(1)
We expect our dispositions and sales of partial interests for the year ending December 31, 2026 to consist of land, non-core assets, and core assets (primarily sales of partial interests). As of the date of this report, our share of pending
dispositions subject to non-refundable deposits, signed letters of intent, or purchase and sale agreement negotiations aggregated
$149.1 million
.
We have an additional
$2.18 billion
of dispositions and sales of partial interests identified and
in process.
(2)
In
January 2026
and
April 2026
, we repaid, upon maturity,
$300.0 million
of
4.30%
unsecured senior notes payable and
$350.0 million
of
3.80%
unsecured senior notes payable, respectively. These repayments were funded temporarily with
borrowings under our commercial paper program, which will be repaid through planned dispositions and sales of partial interests included in our 2026 guidance.
No
gain or loss was incurred in connection with these repayments.
(3)
In February 2026, we completed tender offers to repurchase debt principal aggregating
$1.33 billion
across a portion of our outstanding
4.00%
Senior Notes due
2050
,
3.00%
Senior Notes due
2051
, and
3.55%
Senior Notes due
2052
for
$952.2 million
and recognized a gain on early extinguishment of debt of
$366.4 million
, including the write-off of unamortized debt issuance costs and other transaction-related costs. The tender offers were primarily funded through the
issuance of
$750.0 million
unsecured senior notes payable, due
2036
, with an interest rate of
5.25%
.
Refer to Note 10 – “Secured and unsecured senior debt” in Item 1 for additional information.
The key assumptions behind the sources and uses of capital in the table above include favorable real estate transaction and capital market environments, performance of our core
operating properties, lease-up and delivery of current and future development and redevelopment projects, and leasing activity. Our expected sources and uses of capital are subject to a
number of variables and uncertainties, including those discussed as “Forward-looking statements” under Part I; “Item 1A. Risk factors”; and “Item 7. Management’s discussion and analysis of
financial condition and results of operations” in our annual report on Form 10-K for the year ended
December 31, 2025
; as well as in “Item 2. Trends that may affect our future results” within
“Part II – Other information” of this quarterly report on Form 10-Q. We expect to update our forecast for key sources and uses of capital on a quarterly basis.
Refer to “Key assumptions” on the following page.
86
Key Assumptions
(1)
(Dollars in millions)
As of 4/27/26
As of 1/26/26
Key Changes
to Midpoint
Low
High
Low
High
Occupancy of operating properties as of
December 31, 2026
86.2%
(2)
87.8%
(2)
87.7%
89.3%
150
bps reduction
(3)
Same property performance:
Net operating income
(10.5)%
(2)
(8.5)%
(2)
(9.5)%
(7.5)%
100
bps reduction
(3)
Net operating income (cash basis)
(10.5)%
(2)
(8.5)%
(2)
(9.5)%
(7.5)%
100
bps reduction
(3)
Lease renewals and re-leasing of space:
Rental rate changes
(9.0)%
(1.0)%
(2.0)%
6.0%
700
bps reduction
(4)
Rental rate changes (cash basis)
(15.0)%
(7.0)%
(12.0)%
(4.0)%
300
bps reduction
(4)
Straight-line rent revenue
$
55
$
85
$
65
$
95
$10 million
reduction
(4)
General and administrative expenses
$
134
$
154
$
134
$
154
No Change
Capitalization of interest
$
225
$
265
$
225
$
275
$5 million
reduction
(5)
Interest expense
$
240
$
280
$
230
$
280
$5 million
increase
(5)
Realized gains on non-real estate investments
(6)
$
60
$
90
$
60
$
90
No Change
(1)
Our assumptions presented in the table above are subject to a number of variables and uncertainties, including those discussed as “Forward-looking statements” under Part I; “Item 1A. Risk factors”; and “Item 7. Management’s discussion
and analysis of financial condition and results of operations” in our annual report on Form 10-K for the year ended
December 31, 2025
, as well as in “Item 2. Trends that may affect our future results” within “Part II – Other information” of this
quarterly report on Form 10-Q. To the extent our full-year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.
(2)
Our guidance for operating occupancy percentage as of December 31, 2026 and for same property performance net operating income changes assumes an approximat
e 1% and 2% benefit, respective
ly, related to a range of assets with
vacancy that could potentially be sold during 2026 and/or qualify for designation as held for sale by December 31, 2026, but that had not yet met such criteria as of March 31, 2026. Refer to the chart below for key drivers of the changes to
certain key projected operating metrics and assumptions included in our 2026 guidance.
(3)
Decline primarily relates to changes to a range of properties that could potentially be sold during 2026 that were assumed in our prior guidance. Refer to the chart below.
(4)
Decline primarily related to the re-lease of two spaces subject to tenant wind-downs. Refer to the chart below.
(5)
The
$5 million
reduction and corresponding
$5 million
increase to the midpoints of our guidance ranges for 2026
capitalized interest and 2026 interest expense, respectively, are primarily driven by the anticipated earlier completion of
certain milestones on several projects. Refer to the discussion of fourth quarter of 2026 FFO per share – diluted, as adjusted and “Capitalized interest” item on the following page, and “Average real estate basis used for capitalization of
interest” in Item 2 for additional details.
(6)
Represents realized gains and losses included in funds from operations per share – diluted, as adjusted. Excludes unrealized gains and losses and significant gains and impairments realized on non-real estate investments, if any. Refer to
Note 7 – “Investments” to our unaudited consolidated financial statements in Item 1 for additional details.
Occupancy of Operating Properties
Same Property Performance
Lease Renewals and
Re-leasing of Space
Straight-Line
Rent Revenue
Key Drivers of Changes to Certain 2026 Projected
Operating Metrics and Assumptions
As of
December 31, 2026
Benefit From
Potential Held
For Sale
Assets
(1)
Net Operating
Income Changes
(Cash Basis)
Net Operating
Income Changes
Benefit From
Potential
Held For
Sale Assets
(1)
Rental Rate
Changes
Rental Rate
Changes
(Cash Basis)
Guidance ranges as of 1/26/26
87.7%
to
89.3%
2%
(9.5)%
to
(7.5)%
(9.5)%
to
(7.5)%
3%
(2.0)%
to
6.0%
(12.0)%
to
(4.0)%
$65M
to
$95M
Changes to range of properties that could potentially be sold
during 2026 that were assumed in prior 2026 guidance
(1)
(1.3)
(1)
(1.0)
(1.0)
(1)
—
—
—
Primarily related to the re-lease of two spaces subject to
tenant wind-downs
(2)
(0.2)
—
—
—
—
(7.0)
(3.0)
(10)
(3)
Total changes to 2026 guidance midpoints
(1.5)
(1)
(1.0)
(1.0)
(1)
(7.0)
(3.0)
(10)
Guidance ranges as of 4/27/26
86.2%
to
87.8%
1%
(10.5)%
to
(8.5)%
(10.5)%
to
(8.5)%
2%
(9.0)%
to
(1.0)%
(15.0)%
to
(7.0)%
$55M
to
$85M
(1)
Our prior guidance for occupancy percentage as of December 31, 2026 and 2026 same property performance net operating income changes assumed a benefit of approximately 2% and 3%, respectively, related to a range of assets with
vacancy that could potentially be sold in 2026 and/or qualify for classification as held for sale by December 31, 2026 but had not yet met such criteria as of December 31, 2025. Our updated guidance for these metrics assumes a reduced
benefit of approximately 1% and 2%, respectively, related to a range of assets with vacancy that could potentially be sold during 2026 and/or qualify for classification as held for sale by December 31, 2026, primarily due to our revised
expectation that we may no longer sell as many assets with significant vacancy driven, in part, by positive leasing prospects for certain spaces that are currently vacant.
(2)
Includes the impacts of i) one lease aggregating
81,220
RSF in our Torrey Pines submarket, for which we proactively addressed a tenant wind-down by terminating the existing lease and executing a new lease in April 2026 with a growth-
stage life science company advancing next-generation therapeutics to accommodate their expansion needs within our portfolio, with expected delivery in early 2027 following the completion of tenant improvements, and ii) one lease
aggregating
47,719
RSF at 480 Arsenal Street in our Cambridge/Inner Suburbs submarket, with the space re-leased during the
three months ended March 31, 2026
.
Refer to "Leasing activity" in Item 2 for additional details.
(3)
Primarily attributable to the write-off of a deferred rent receivable in April 2026 of approximately $5 million in connection with the lease termination and a payment of $10.5 million from a tenant in our Torrey Pines submarket discussed in
footnote 2 above
.
87
Fourth quarter of 2026 FFO per share – diluted, as adjusted
•
On December 3, 2025, we provided guidance for our projected fourth quarter of 2026 FFO per share – diluted, as adjusted, to be within a range of $
1.40 to $1.60 as part of
our path forward. The decline in our quarterly FFO from first quarter of 2026 to fourth quarter of 2026 is due, in part, to projected dispositions and partial interest sales of
land, non-core, and core properties aggregatin
g
$2.9 billion
at our guidance midpoint, currently with a
weighted-average projected completion date in
August 2026
.
•
As of April 27, 2026, we continue to refine this guidance and currently expect to be within a range of $1.40 to $1.50. The updated range reflects an assumption for lower
capitalized interest, and a corresponding increase in interest expense, in the fourth quarter of 2026 due to earlier than anticipated completion of construction/pre-
construction milestones on several projects (refer to the “Capitalized interest” item below for additional details).
$1.40 – $
1
.50
1)
Potential tenant wind-downs
•
Our 2026 guidance includes a $25 million to $30 million reduction in funds from operations for potential tenant wind-downs, of which approximately $6 million was
recognized during the
three months ended March 31, 2026
.
•
Based upon current market conditions, we estimate at least a similar level of reduction in funds from operations may be necessary through 2026 and beyond.
2)
Development-related other income
•
During the
three months ended March 31, 2026
,
we recognized development fees and other related revenues of
approximately
$2.5 million
, most
of which are expected to
cease by the end of 2026 as we complete the respective projects.
3)
Development and redevelopment projects under business and financial strategy evaluation
•
We have
five
development and redevelopment projects for which the business and financial strategies continue to be evaluated, including whether to continue construction
of laboratory improvements, pause construction, pursue lower-investment construction alternatives (including a pivot to advanced technology use), or disposition. Refer to
“New Class A/A+ development and redevelopment properties: under construction” in Item 2 for additional details.
◦
If we elect to continue to pursue construction of laboratory improvements for these projects,
the earliest deliveries of these projects are in 2028
.
◦
If we elect to pursue lower-investment construction alternatives (including a pivot to advanced technology use), these projects could deliver earlier than 2028. The
incremental capital required for alternative use construction, and corresponding rental rates earned, is generally lower compared to laboratory improvements.
4)
Capitalized interest
•
For the
three months ended March 31, 2026
, average real estate basis capitalized
of
$6.86 billion
comprised t
he following:
•
$2.64 billion
of active development and redevelopment of projects
under construction
that are expected to stabilize through 2028 and are
77%
leased
and repositioning
projects;
•
$1.28 billion
of development and redevelopment projects for which we are evaluating the business and financial strategy with weighted-average critical key construction
milestones by
March 2027
;
88
•
$1.16 billion
of land with weighted-average critical key pre-construction milestones by
August 2026
;
•
$567.6 million
of land with weighted-average critical key pre-construction milestones by
April 2027
; and
•
$1.22 billion
of land with critical key pre-construction milestones through 2028 and beyond.
•
At each milestone date, we evaluate, on an asset-by-asset basis, whether to (i) proceed with additional pre-construction and/or construction activities based on leasing
demand and/or market conditions, (ii) pause future investments, or (iii) consider the potential dispositions of these real estate assets. If we cease activities necessary to
prepare a project for its intended use, costs related to such project, including interest, payroll, property taxes, insurance, and other costs directly related and essential to the
construction of Class A/A+ properties, are expensed as incurred. Annualized capitalized operating expenses and payroll represent approximately
2%
and
1%
, r
espectively,
of the total average real estate basis subject to capitalization for the
three months ended March 31, 2026
.
•
We expect average real estate basis capitalized to decrease from
$6.86 billion
f
or the
three months ended March 31, 2026
to a range from
$3.8 billion
to
$5.3 billion
for the
fourth quarter of 2026, driven by potential dispositions, deliveries of development and redevelopment, and pauses in construction/pre-construction activities. The estimated
range for the fourth quarter of 2026 represents a
$200 million reduction (at the midpoint) in the projected range from $4.0 billion to $5.5 billion initially disclosed on
December 3, 2025. Refer to “Average real estate basis used for capitalization of interest” in Item 2 for additional details.
5)
Key lease expirations
•
We estimate
1.5 million
RSF of leases expiring in 2027, with approximately
$97.4 million
of annual rental revenue
, to have
6
to
24
months of downtime on a weighted-
average basis.
These expirations have a weighted-average contractual lease expiration date of
February 2027
. 2027 expirations increased from the prior quarter primarily
due to one expiration of a
232,902
RSF single-tenant lease at our Alexandria Center
®
for Life Science – Waltham Megacampus with approximately
$27.0 million
of annual
rental revenue, for which we no longer expect the tenant to rene
w. While our initial acquisition underwriting assumed this tenant would eventually relocate to another
submarket, the relocation by the tenant is expected to occur earlier than previously anticipated. Refer to “Summary of contractual lease expirations” in the Item 2 for
additional details.
6)
Construction spending
•
We are currently evaluating our future construction spending estimates beyond 2026, and a number of factors could cause our preliminary estimates for the period beyond
2026 to change as we refine our estimates over the course of the year. We estimate our annual construction spending beyond 2026 could decline by approximately $500
million, subject to market conditions, and is expected to primarily focus on, i) construction spending required to complete our development and redevelopment projects that
are expected to stabilize through 2028 and are
77%
leased, and ii) revenue- and non-revenue-enhancing capital expenditures, in order to secure leasing of vacant space
and renewals and re-leasing of space at our operating properties.
We expect to introduce 2027 guidance and related assumptions at our Investor Day on December 2, 2026, consistent with our historical practice.
89
Consolidated and unconsolidated real estate joint ventures
We present components of balance sheet and operating results information for the noncontrolling interest share of our
consolidated real estate joint ventures and for our share of investments in unconsolidated real estate joint ventures to help investors
estimate balance sheet and operating results information related to our partially owned entities. These amounts are estimated by
computing, for each joint venture that we consolidate in our financial statements, the noncontrolling interest percentage of each financial
item to arrive at the cumulative noncontrolling interest share of each component presented. In addition, for our real estate joint ventures
that we do not control and do not consolidate, we apply our economic ownership percentage to the unconsolidated real estate joint
ventures to arrive at our proportionate share of each component presented. Refer to Note 4 – “Consolidated and unconsolidated real
estate joint ventures” to our unaudited consolidated financial statements in Item 1 for further discussion.
Consolidated Real Estate Joint Ventures
Property/Market/Submarket
Noncontrolling
Interest Share
Operating RSF
at 100%
50 and 60 Binney Street/Greater Boston/Cambridge/Inner Suburbs
66.0%
532,395
75/125 Binney Street/Greater Boston/Cambridge/Inner Suburbs
60.0%
388,270
100 and 225 Binney Street and 300 Third Street/Greater Boston/Cambridge/Inner Suburbs
70.0%
870,641
15 Necco Street/Greater Boston/Seaport Innovation District
43.3%
345,996
Alexandria Center
®
for Science and Technology – Mission Bay/San Francisco Bay Area/
Mission Bay
(1)
75.0%
550,851
211 and 213 East Grand Avenue/San Francisco Bay Area/South San Francisco
70.0%
300,930
500 Forbes Boulevard/San Francisco Bay Area/South San Francisco
90.0%
155,685
Alexandria Center
®
for Life Science – Millbrae/San Francisco Bay Area/South San Francisco
51.4%
285,346
3215 Merryfield Row/San Diego/Torrey Pines
70.0%
170,523
Campus Point by Alexandria/San Diego/University Town Center
(2)(3)
42.8%
(4)
1,159,770
5200 Illumina Way/San Diego/University Town Center
49.0%
792,687
9625 Towne Centre Drive/San Diego/University Town Center
70.0%
163,648
SD Tech by Alexandria/San Diego/Sorrento Mesa
(2)(5)
50.0%
1,051,752
Summers Ridge Science Park/San Diego/Sorrento Mesa
(6)
70.0%
316,531
1201 and 1208 Eastlake Avenue East/Seattle/Lake Union
70.0%
206,134
400 Dexter Avenue North/Seattle/Lake Union
70.0%
290,754
800 Mercer Street/Seattle/Lake Union
40.0%
—
(2)
Unconsolidated Real Estate Joint Ventures
Property/Market/Submarket
Our Ownership
Share
Operating RSF
at 100%
1655 and 1725 Third Street/San Francisco Bay Area/Mission Bay
10.0%
586,208
101 West Dickman Street/Maryland/Beltsville
58.4%
(7)
135,958
Refer to “Joint venture financial information” under “Definitions and reconciliations” in Item 2 for additional
(1)
Includes 1450, 1500, and 1700 Owens Street and 455 Mission Bay Boulevard South.
(2)
Includes properties currently under construction or in our future development and redevelopment pipeline. Refer to “New Class A/A+ development and redevelopment
properties” in Item 2 for additional details.
(3)
Includes 10200, 10290, and 10300 Campus Point Drive and 4135, 4155, 4165, 4224, and 4242 Campus Point Court.
(4)
The noncontrolling interest share of our real estate joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs
at the campus until our ownership interest increases to 75%, after which future capital would be contributed pro rata with our partner.
Refer to “New Class A/A+
development and redevelopment properties
: under construction
” in Item 2 for additional details.
(5)
Includes 9605, 9645, 9675, 9725, 9735, 9805, 9808, 9855, and 9868 Scranton Road and 10055, 10065, and 10075 Barnes Canyon Road.
(6)
Includes 9965, 9975, 9985, and 9995 Summers Ridge Road.
(7)
Represents a joint venture with a local real estate operator in which our joint venture partner manages the day-to-day activities that significantly affect the economic
performance of the joint venture.
90
The following table presents key terms related to our unconsolidated real estate joint ventures’ secured loans as of
March 31,
2026
(dollars in thousands):
Maturity Date
Stated Rate
Interest
Rate
(1)
At 100%
Our
Share
Unconsolidated Joint Venture
Aggregate
Commitment
Debt Balance
(2)
101 West Dickman Street
10/29/26
SOFR+1.95%
(3)
5.68%
$
26,750
$
19,048
58.4%
1655 and 1725 Third Street
2/10/35
6.37%
6.44%
500,000
496,967
10.0%
$
526,750
$
516,015
(1)
Includes interest expense and amortization of loan fees.
(2)
Represents outstanding principal, net of unamortized deferred financing costs,
as of March 31, 2026
.
(3)
This loan is subject to a fixed SOFR floor of 0.75%.
The following tables present information related to the operating results and financial positions of our consolidated and
unconsolidated real estate joint ventures as of and for the
three months ended March 31, 2026
(in thousands):
Three Months Ended March 31, 2026
Noncontrolling Interest
Share of Consolidated Real
Estate Joint Ventures
Our Share of
Unconsolidated
Real Estate Joint Ventures
Total revenues
$
97,212
$
3,006
Rental operations
(30,677)
(1,191)
66,535
1,815
General and administrative
(622)
(22)
Interest
(63)
(1,026)
Depreciation and amortization of real estate assets
(29,473)
(914)
Fixed returns allocated to redeemable noncontrolling interest
(1)
347
—
$
36,724
$
(147)
Straight-line rent and below-market lease revenue
$
2,981
$
197
Funds from operations
(2)
$
66,197
$
767
Refer to “Joint venture financial information” under “Definitions and reconciliations” in Item 2 for additional details.
(1)
Represents an allocation of joint venture earnings to redeemable noncontrolling interest for a property in the
San Francisco Bay Area market.
This redeemable
noncontrolling interest earns a fixed return on their investment and does not participate in the operating results of the property.
(2)
Refer to “
Funds from operations and funds from operations, as adjusted, attributable to Alexandria Real Estate Equities, Inc.’s common stockholders
” under “
Definitions
and reconciliations
” in Item 2 for the definition and its reconciliation from the most directly comparable financial measure presented in accordance with GAAP.
As of March 31, 2026
Noncontrolling Interest
Share of Consolidated
Real Estate Joint Ventures
Our Share of
Unconsolidated
Real Estate Joint Ventures
Investments in real estate
$
3,261,264
$
88,793
Cash, cash equivalents, and restricted cash
111,509
1,648
Other assets
411,563
10,686
Secured notes payable
—
(60,821)
Other liabilities
(154,688)
(9,786)
Redeemable noncontrolling interests
(9,234)
—
$
3,620,414
$
30,520
During the
three months ended March 31, 2026
and
2025
, our consolidated real estate joint ventures distributed an aggregate
of
$60.1 million
and
$66.0 million
, respectively, to our joint venture partners. Refer to our consolidated statements of cash flows and
Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for
additional information.
91
Investments
We hold investments in publicly traded companies and privately held entities primarily involved in the life science industry. The
tables below summarize components of our investment income (loss) and non-real estate investments (in thousands). Refer to Note 7 –
“Investments” to our unaudited consolidated financial statements in Item 1 for additional information.
Three Months Ended
March 31, 2026
March 31, 2025
Realized gains:
Realized gains
$
18,198
$
29,333
Impairment of non-real estate investments
(12,448)
(1)
(11,180)
5,750
18,153
Unrealized losses
(10,332)
(2)
(68,145)
(3)
Investment loss
$
(4,582)
$
(49,992)
March 31, 2026
December 31, 2025
Investments
Cost
Unrealized
Gains
Unrealized
Losses
Carrying
Amount
Carrying
Amount
Publicly traded companies
$
83,916
$
34,674
$
(16,514)
$
102,076
$
94,928
Entities that report NAV
471,058
102,050
(38,132)
534,976
512,376
Entities that do not report NAV:
Entities with observable price changes
82,128
54,780
(10,991)
125,917
123,238
Entities without observable price changes
405,567
—
—
405,567
413,324
Investments accounted for under the equity method
N/A
N/A
N/A
367,883
357,383
March 31, 2026
$
1,042,669
(4)
$
191,504
$
(65,637)
$
1,536,419
$
1,501,249
December 31, 2025
$
1,010,488
$
184,434
$
(51,056)
$
1,501,249
Public/Private Mix (Cost)
Tenant/Non-Tenant Mix (Cost)
6%
Public
17%
Tenant
94%
Private
83%
Non-Tenant
(1)
Primarily related to
two
non-real estate investments
in privately held entities that do not report NAV.
(2)
Primarily relates to the accounting reclassifications of unrealized gains recognized in prior periods into realized gains upon our realization of investments during the
three
months ended March 31, 2026
.
(3)
Primarily relates to the decrease in fair values of our investments in publicly traded entities and privately held entities that report N
AV du
ring the
three months ended
March 31, 2025
.
(4)
Represents
2.6%
of gross assets as of
March 31, 2026
. Refer to “
Gross assets
” under “
Definitions and reconciliations
” in Item 2 for additional details.
92
Liquidity
Liquidity
Limited Outstanding Borrowings and
Significant Availability on
Unsecured Senior Line of Credit
$4.2B
(in millions)
(In millions)
Availability under our unsecured senior line of credit, net of
amounts outstanding under our commercial paper program
$
3,645
Cash, cash equivalents, and restricted cash
423
Investments in publicly traded companies
102
Liquidity as of
March 31, 2026
$
4,170
We expect to meet certain long-term liquidity requirements, such as requirements for development, redevelopment, other
construction projects, capital improvements, tenant improvements, property acquisitions, equity repurchases, leasing costs, revenue-
and non-revenue-enhancing capital expenditures, scheduled debt maturities, distributions to noncontrolling interests, and payment of
dividends through net cash provided by operating activities, as adjusted, periodic asset dispositions, strategic real estate joint ventures,
long-term secured and unsecured indebtedness, borrowings under our unsecured senior line of credit, issuances under our commercial
paper program, and issuances of additional debt and/or equity securities.
We also expect to continue meeting our short-term liquidity and capital requirements, as further detailed in this section,
generally through our working capital and net cash provided by operating activities, as adjusted. We believe that the net cash provided
by operating activities, as adjusted, will continue to be sufficient to enable us to make the distributions necessary to continue qualifying
as a REIT.
For additional information on our liquidity requirements related to our contractual obligations and commitments, refer to
Note 5 – “Leases” and Note 10 – “Secured and unsecured senior debt” to our unaudited consolidated financial statements in Item 1.
Over the next several years, our balance sheet, capital structure, and liquidity objectives are as follows:
•
Retain net cash provided by operating activities, as adjusted, for investment in development and redevelopment projects
and/or acquisitions;
•
Maintain significant balance sheet liquidity;
•
Maintain a strong credit profile and relative long-term cost of capital;
•
Maintain diverse sources of capital, including sources from net cash provided by operating activities, as adjusted,
unsecured debt, secured debt, selective real estate asset sales, strategic real estate joint ventures, non-real estate
investment sales, and common stock;
•
Maintain commitment to long-term capital to fund growth;
•
Maintain prudent laddering of debt maturities;
•
Maintain solid credit metrics;
•
Prudently manage variable-rate debt exposure;
•
Maintain a large, unencumbered asset pool to provide financial flexibility;
•
Fund common stock dividends and distributions to noncontrolling interests from net cash provided by operating activities,
as adjusted;
•
Manage a disciplined level of development and redevelopment projects as a percentage of our gross real estate assets;
and
•
Maintain high levels of pre-leasing and percentage leased in development and redevelopment projects.
93
The following table presents the availability under our unsecured senior line of credit, net of amounts outstanding under our
commercial paper program; cash, cash equivalents, and restricted cash; and investments in publicly traded companies as of
March 31,
2026
(in thousands):
Description
Stated Rate
Aggregate
Commitments
Outstanding
Balance
Remaining
Commitments/
Liquidity
Availability under our unsecured senior line of credit, net of
amounts outstanding under our commercial paper program
SOFR+0.835%
$
5,000,000
$
1,355,271
$
3,644,729
Cash, cash equivalents, and restricted cash
423,385
Investments in publicly traded companies
102,076
Liquidity as of
March 31, 2026
$
4,170,190
Cash, cash equivalents, and restricted cash
As of
March 31, 2026
and
December 31, 2025
, we had
$423.4 million
and
$553.8 million
, respectively, of cash, cash
equivalents, and restricted cash. We expect existing cash, cash equivalents, and restricted cash, net cash provided by operating
activities, as adjusted, proceeds from real estate asset sales, sales of partial interests, strategic real estate joint ventures, non-real
estate investment sales, borrowings under our unsecured senior line of credit, issuances under our commercial paper program,
issuances of unsecured senior notes payable, and issuances of common stock to continue to be sufficient to fund our operating
activities and cash commitments for investing and financing activities, such as regular quarterly dividends, distributions to noncontrolling
interests, scheduled debt repayments, acquisitions, and certain capital expenditures, including expenditures related to construction
activities and any common stock repurchases.
Cash flows
We report and analyze our cash flows based on operating activities, investing activities, and financing activities. The following
table summarizes changes in our cash flows for the
three months ended March 31, 2026
and
2025
(in thousands):
Three Months Ended March 31,
2026
2025
Change
Net cash provided by operating activities
$
196,624
$
207,949
$
(11,325)
Net cash used in investing activities
$
(584,810)
$
(654,779)
$
69,969
Net cash provided by financing activities
$
258,003
$
370,775
$
(112,772)
Operating activities
Cash flows provided by operating activities
are primarily dependent upon the occupancy level of our asset base, the rental
rates of our leases, the collectibility of rent and recovery of operating expenses from our tenants, the timing of completion of
development and redevelopment projects, and the timing of acquisitions and dispositions of operating properties.
Net cash provided by
operating activities
for the
three months ended March 31, 2026
decreased
b
y
$11.3 million
,
or
5.4%
, to
$196.6 million
, compared to
$207.9 million
for the
three months ended March 31, 2025
, primarily reflecting the impact of real estate dispositions and sales of partial
interests completed since
January 1, 2025
.
94
Investing activities
Cash used in investing activities
for the
three months ended March 31, 2026
and
2025
consisted of the following (in
thousands):
Three Months Ended March 31,
Change
2026
2025
Sources of cash from investing activities:
Proceeds from sales of real estate
$
—
$
68,182
$
(68,182)
Sales of and distributions from non-real estate investments
35,000
12,691
22,309
Return of capital from unconsolidated real estate joint ventures
113
—
113
35,113
80,873
(45,760)
Uses of cash for investing activities:
Additions to real estate
545,999
645,841
(99,842)
Change in escrow deposits
—
9,506
(9,506)
Investments in unconsolidated real estate joint ventures
297
10,994
(10,697)
Additions to non-real estate investments
73,627
69,311
4,316
619,923
735,652
(115,729)
Net cash used in investing activities
$
584,810
$
654,779
$
(69,969)
The change in net cash used in investing activities for the
three months ended March 31, 2026
, compared to the
three months
ended March 31, 2025
, was primarily due to a decreased use of cash for additions to real estate and an increased source of cash from
sales of and distributions from non-real estate investments.
Refer to Note 3 – “Investments in real estate” to our unaudited consolidated
financial statements in Item 1 for additional information.
Financing activities
Cash flows provided by financing activities
for the
three months ended March 31, 2026
and
2025
consisted of the following
(in thousands):
Three Months Ended March 31,
2026
2025
Change
Borrowings under secured notes payable
$
—
$
824
$
(824)
Repayments of borrowings under secured notes payable
(8,892)
—
(8,892)
Proceeds from issuance of unsecured senior notes payable
747,592
548,532
199,060
Repayments of unsecured senior note payable
(1,252,203)
—
(1,252,203)
Proceeds from issuances under commercial paper program
12,319,811
2,700,000
9,619,811
Repayments of borrowings under commercial paper program
(11,318,040)
(2,400,000)
(8,918,040)
Payments of loan fees
(8,814)
(5,406)
(3,408)
Changes related to debt
479,454
843,950
(364,496)
Contributions from and sales of noncontrolling interests
18,065
54,409
(36,344)
Distributions to noncontrolling interests
(60,111)
(66,034)
5,923
Purchases and redemptions of noncontrolling interests
(49,707)
(17,818)
(31,889)
Repurchase of common stock
—
(208,187)
208,187
Dividends on common stock
(123,752)
(229,987)
106,235
Taxes paid related to net settlement of equity awards
(5,946)
(5,558)
(388)
Net cash provided by financing activities
$
258,003
$
370,775
$
(112,772)
95
Sources of capital
Net cash provided by operating activities, as adjusted
We expect to retain
$475 million
to
$575 million
of net cash provided by operating activities, as adjusted, for the year ending
December 31, 2026
.
Refer to “Net cash provided by operating activities, as adjusted” under “
Definitions and reconciliations
” in Item 2 for
the definition and reconciliation from the most directly comparable financial measure presented in accordance with GAAP. For the year
ending
December 31, 2026
, we expect our recently delivered projects, our development and redevelopment projects expected to be
delivered, and contributions from Same Properties to contribute to income from rentals, net operating income, and cash flows. We
anticipate contractual near-term growth in annual net operating income (cash basis) of
$25 million
related to the commencement of
contractual rents on the projects recently placed into service that are near the end of their initial free rent period. Refer to “
Cash flows
”
in Item 2 for a discussion of cash flows provided by operating activities for the
three months ended March 31, 2026
.
Debt
We expect to fund a portion of our capital needs for
2026
and beyond from issuances under our commercial paper program,
issuances of unsecured senior notes payable, and/or borrowings under our unsecured senior line of credit, and/or borrowings under
secured construction loans.
As of
March 31, 2026
,
our unsecured senior line of credit, which matures in
2030
, including extension options under our
control, had aggregate commitments of
$5.0 billion
a
nd
bore an interest rate of SOFR plus
0.835%
. In addition to the cost of borrowing,
the unsecured senior line of credit is subject to an annual facility fee of
0.14%
b
ased on the aggregate commitments outstanding.
Based upon our ability to achieve certain annual sustainability targets, the interest rate and facility fee rate are also subject to
upward or
downward adjustments of up to
four
basis points with respect to the interest rate and up to
one
basis point with respect to the facility fee
rate
.
During the three months ended March 31, 2026, we achieved certain annual sustainability targets, as described in our
unsecured senior line of credit agreement, which reduced the borrowing rate by
four
basis points for a one-year period to SOFR plus
0.835%
, from SOFR plus
0.875%
, and reduced the facility fee by
one
basis point to
0.14%
from
0.15%
.
As of
March 31, 2026
,
we had
no
outstanding balance on our unsecured senior line of credit.
O
ur commercial paper program provides us with the ability to issue up to
$2.50 billion
of commercial paper notes with a
maturity of generally
30
days or less and with a maximum maturity of
397
days from the date of issuanc
e
.
Our commercial paper
program is back-stopped by our unsecured senior line of credit, and at all times we expect to retain a minimum undrawn amount of
borrowing capacity under our unsecured senior line of credit equal to any outstanding balance under our commercial paper program.
We use borrowings under the program to fund short-term capital needs. The notes issued under our commercial paper program are
sold under customary terms in the commercial paper market. They are typically issued at a discount to par, representing a yield to
maturity dictated by market conditions at the time of issuance. In the event we are unable to issue commercial paper notes or refinance
outstanding commercial paper notes under terms equal to or more favorable than those under the unsecured senior line of credit, we
expect to borrow under the unsecured senior line of credit.
The commercial paper notes sold during the
three months ended
March 31, 2026
were issued at a weighted-average yield to maturity
o
f
4.08%
.
As of
March 31, 2026
, w
e had
$1.35 billion
of
c
ommercial paper notes outstanding
.
In
January 2026
and
April 2026
, we repaid, upon maturity,
$300.0 million
of
4.30%
unsecured senior notes payable and
$350.0 million
of
3.80%
unsecured senior notes payable
, respectively
.
These repayments were funded temporarily with borrowings
under our commercial paper program, which will be repaid through planned dispositions and sales of partial interests included in our
2026 guidance.
No
gain or loss was incurred in connection with these repayments.
I
n February 2026, we completed tender offers to repurchase an aggregate debt principal amount of
$1.33 billion
across a
portion of our outstandi
ng
4.00%
Senior Notes due
2050
,
3.00%
Senior Notes due
2051
, and
3.55%
Senior Notes due
2052
. Cash
consideration paid was
$952.2 million
. The repurchase was primarily funded through the issuance
of
$750.0 million
of
5.25%
unsecured
senior notes due
2036
, and approximately
$200 million
of short-term borrowings
under our commercial paper program, which we expect
to repay through planned 2026 dispositions and sales of partial interests. In connection with the debt repurchase,
we recognized a gain
on early extinguishment of debt aggregating
$366.4 million
, including the write-off of unamortized debt issuance costs and other
transaction-related costs.
96
The following table presents our average debt outstanding and weighted-average interest rates during the
three months ended
March 31, 2026
(dollars in thousands):
Three Months Ended March 31, 2026
Average Debt
Outstanding
Weighted-Average
Interest Rate
Long-term fixed-rate debt
$
11,432,675
3.94%
Short-term variable-rate unsecured senior line of credit and commercial paper
program
debt
1,736,226
4.05
Blended average interest rate
13,168,901
3.95
Loan fee amortization and annual facility fee related to unsecured senior line of credit
N/A
0.13
Total/weighted average
$
13,168,901
4.08%
Real estate dispositions and sales of partial interests
We expect to continue to focus on the disciplined execution of select sales of real estate. Future sales will provide an important
source of capital to fund our development and redevelopment projects and potential opportunistic share repurchases, capital for growth,
and to reduce debt. We may also consider additional sales of partial interests in core Class A/A+ properties, development projects, and/
or land. For the year ending December 31,
2026
, we expect real estate dispositions and sales of partial interests in real estate assets to
range from
$2.10 billion
to
$3.70 billion
. The amount of asset sales necessary to meet our forecasted sources of capital will vary
depending upon the amount of EBITDA associated with the assets sold.
Refer to Note 3 – “Investments in real estate” and Note 4 – “Consolidated and unconsolidated real estate joint ventures,” and
Note 14 – “Stockholders’ equity” to our unaudited consolidated financial statements in Item 1 and to “Dispositions and sales of partial
interests” in Item 2 for additional information on our real estate dispositions.
As a REIT, we are generally subject to a 100% tax on the net income from real estate asset sales that the IRS characterizes as
“prohibited transactions.” We do not expect our sales will be categorized as prohibited transactions. However, unless we meet certain
“safe harbor” requirements, whether a real estate asset sale is a “prohibited transaction” will be based on the facts and circumstances
of the sale. Our real estate asset sales may not always meet such “safe harbor” requirements. Refer to “Item 1A. Risk factors” in our
annual report on Form 10-K for the year ended
December 31, 2025
for additional information about the “prohibited transaction” tax.
Common equity transactions
During the
three months ended March 31, 2026
, we did not issue any common stock under our ATM program. As of
March 31,
2026
, the remaining aggregate amount available under our ATM program for future sales of common stock was
$1.47 billion
.
Other sources
As a well-known seasoned issuer, we may, from time to time, issue securities at our discretion based on our needs and market
conditions, including, as necessary, to balance our use of incremental debt capital.
Additionally, we, together with joint venture partners, hold interests in real estate joint ventures that we consolidate in our
financial statements. These existing joint ventures provide significant equity capital to fund a portion of our future construction spending,
and our joint venture partners may also contribute equity into these entities for financing-related activities.
From
April 1, 2026
through
December 31,
2027
and beyond, we expect to receive capital contributions aggregating
$120.0 million
from existing consolidated real
estate joint venture partners to fund construction
. During the year ending December 31,
2026
, contributions from noncontrolling
interests from existing joint venture partners are expected to aggregate to up to
$100.0 million
at the midpoint of our guidance range for
2026
construction spending
.
97
Uses of capital
Summary of capital expenditures
One of our primary uses of capital relates to the development, redevelopment, pre-construction, and construction of properties.
We currently have projects in our development and redevelopment pipeline aggregating
3.4 million
RSF
of Class A/A+ properties
undergoing construction.
We incur capitalized construction costs related to development, redevelopment, pre-construction, and other
construction activities. We also incur additional capitalized project costs, including interest, property taxes, insurance, and other costs
directly related and essential to the development, redevelopment, pre-construction, or construction of a project, during periods when
activities necessary to prepare an asset for its intended use are in progress. Refer to “
New
Class A/A+ development and redevelopment
properties:
under construction
” and “
Summary of capital expenditures
” in Item 2 for additional information on our capital expenditures.
We capitalize interest cost as a cost of the project only during the period in which activities necessary to prepare an asset for
its intended use are ongoing, provided that expenditures for the asset have been made and interest cost has been incurred. Capitalized
interest, classified in investments in real estate in our consolidated balance sheets,
a
ggregated
$70.0 million
f
or the
three months
ended March 31, 2026
, a
decrease
from
$80.1 million
capitalized during the
three months ended March 31, 2025
. This reflects a
lower
weighted-average capitalized cost basis of
$6.86 billion
for the
three months ended March 31, 2026
, as compared to
$8.03 billion
for
the
three months ended March 31, 2025
.
Property taxes, insurance on real estate, and indirect project costs, such as construction, administration, legal fees, and office
costs that clearly relate to projects under development or construction, are capitalized as incurred during the period an asset is
undergoing activities to prepare it for its intended use. We capitalized payroll and other indirect costs related to development,
redevelopment, pre-construction, and construction projects aggregating
$17.6 million
and
$24.8 million
, and property taxes, insurance
on real estate, and indirect project costs
aggregating
$36.9 million
and
$36.2 million
during
th
e
three months ended March 31, 2026
and
2025
, respectively.
Pre-construction activities include entitlements, permitting, design, site work, and other activities preceding commencement of
construction of aboveground building improvements. The advancement of pre-construction efforts is focused on reducing the time
required to deliver projects to prospective tenants. These critical activities add significant value for future ground-up development and
are required for the vertical construction of buildings. Should we cease activities necessary to prepare an asset for its intended use, the
interest, taxes, insurance, and certain other direct and indirect project costs related to the asset would be expensed as incurred.
Expenditures for repairs and maintenance are expensed as incurred.
Fluctuations in our development, redevelopment, and construction activities could result in significant changes to total
expenses and net income. For example, had we experienced a 10% reduction in development, redevelopment, and construction
activities without a corresponding decrease in indirect project costs, including interest and payroll, total expenses would have increased
by approximately
$12.5 million
for the
three months ended March 31, 2026
.
We use third-party brokers to assist in our leasing activity, who are paid on a contingent basis upon successful leasing. We are
required to capitalize initial direct costs related to successful leasing transactions that result directly from and are essential to the lease
transaction and would not have been incurred had that lease transaction not been successfully executed. During the
three months
ended March 31, 2026
, we capitalized total initial direct leasing costs of
$18.8 million
. Costs that we incur to negotiate or arrange a
lease regardless of its outcome, such as fixed employee compensation, tax, or legal advice to negotiate lease terms, and other costs,
are expensed as incurred.
Real estate acquisitions and common stock repurchase program
On December 8, 2025, we announced that our Board of Directors authorized a new common stock repurchase program that
allows for the repurchase of up to
$500.0 million
of our common stock through
December 31, 2026
. This new program replaced our
prior stock repurchase program. As of the date of this report,
no repurchases have been made under the new program and
$500.0 million
remains available for future share repurchases.
We did not make any real estate acquisitions during the
three months ended March 31, 2026
.
98
Dividends
During the
three months ended March 31, 2026
and
2025
, we paid
common stock dividends of
$123.8 million
and
$230.0 million
,
respectively. The
decrease
of
$106.2 million
in dividends
paid on our common stock for the
three months ended
March 31, 2026
, compared to the
three months ended March 31, 2025
, was primarily due to a decrease in the related dividends to
$0.72
per common share
paid for the
three months ended March 31, 2026
from
$1.32
per common share
paid during the
three months
ended March 31, 2025
.
We have historically funded the payment of our common stock dividends using net cash provided by operating activities, as
adjusted. We expect to continue funding future quarterly common stock dividends from net cash provided by operating activities, as
adjusted, which may be supplemented by proceeds from periodic asset dispositions, issuances of additional debt and/or equity
securities, and borrowings under our unsecured senior line of credit and/or our commercial paper program. Future dividends are at the
discretion of our Board and subject to various considerations, including net income, cash flows, capital requirements, debt covenants,
market conditions, dividend yield, taxable income, payout ratios, and other factors. There can be no assurance that we will maintain our
dividends at the current level or increase dividends in the future.
Unsecured senior notes payable and unsecured senior line of credit
The requirements of, and our actual performance with respect to, the key financial covenants under our unsecured senior
notes payable as of
March 31, 2026
were as follows:
Covenant Ratios
(1)
Requirement
March 31, 2026
Total Debt to Total Assets
Less than or equal to 60%
32%
Secured Debt to Total Assets
Less than or equal to 40%
—%
Consolidated EBITDA
(2)
to Interest Expense
Greater than or equal to 1.5x
7.7x
Unencumbered Total Asset Value to Unsecured Debt
Greater than or equal to 150%
302%
(1)
All covenant ratio titles utilize terms as defined in the respective debt agreements.
(2)
The calculation of consolidated EBITDA is based on the definitions contained in our loan agreements and is not directly comparable to the computation of EBITDA as
described in Exchange Act Release No. 47226.
In addition, the terms of the indentures, among other things, limit the ability of the Company, Alexandria Real Estate Equities,
L.P., and the Company’s subsidiaries to (i) consummate a merger, or consolidate, or sell all or substantially all of the Company’s assets
and (ii) incur certain secured or unsecured indebtedness.
The requirements of, and our actual performance with respect to, the key financial covenants under our unsecured senior line
of credit as of
March 31, 2026
were as follows:
Covenant Ratios
(1)
Requirement
March 31, 2026
Leverage Ratio
Less than or equal to 60.0%
34.5%
Secured Debt Ratio
Less than or equal to 45.0%
—%
Fixed-Charge Coverage Ratio
Greater than or equal to 1.50x
3.23x
Unsecured Interest Coverage Ratio
Greater than or equal to 1.75x
6.93x
(1)
All covenant ratio titles utilize terms as defined in the credit agreement.
In managing our liquidity, we also consider the contractual interest payment obligations associated with our outstanding debt.
Interest payments on our fixed-rate debt are determined based on contractual interest rates, including interest payment dates and
scheduled maturity dates. As of
March 31, 2026
,
89.2%
of our debt was fixed-rate debt
.
For additional information regarding our debt,
refer to Note 10 – “Secured and unsecured senior debt” to our unaudited consolidated financial statements in Item 1.
99
Ground lease obligations
Ground lease obligations as of
March 31, 2026
included leases for
31
of our properties and accounted for approximately
9%
of
our total number of properties.
Among these
31
properties,
17
properties are subject to ground leases with a weighted-average
remaining lease term of
53
years
, including extension options that we are reasonably certain to exercise.
These
leases are with a single
lessor in our Greater Stanford submarket with whom we have extended
three
ground leases over the past 10 years.
Our remaining
14
properties subject to ground leases are located across multiple submarkets and have remaining lease terms
ranging from approximately
45
to
81
years
. The weighted-average remaining lease term of these ground leases is
73
years
, including
extension options that we are reasonably certain to exercise.
In many cases, we seek to extend our ground leases well ahead of their scheduled contractual expirations. If we are
successful in extending ground leases, we could see significant up-front or increased recurring future payments to the ground lessor
and/or increased ground lease expense, which may require us to increase our capital funding needs.
Operating lease agreements
As of
March 31, 2026
, the remaining contractual payments under ground and office lease agreements in which we are the
lessee aggregated
$748.1 million
and
$19.2 million
,
respectively. As of
March 31, 2026
, our operating lease liability, calculated as the
present value of the remaining payments aggregating
$767.2 million
under our operating lease agreements, including our extension
options that we are reasonably certain to exercise, was
$358.6 million
and
was classified in accounts payable, accrued expenses, and
other liabilities in our consolidated balance sheet. As of
March 31, 2026
, the weighted-average remaining lease term of operating leases
in which we are the lessee was approximately
60 years
, including extension options that we are reasonably certain to exercise, and the
weighted-average discount rate was
4.7%
. Our corresponding operating lease right-of-use assets, adjusted for initial direct leasing
costs and other consideration exchanged with the landlord prior to the commencement of the lease, aggregated
$693.8 million
. We
classify the right-of-use asset in other assets in our consolidated balance sheets. Refer to “
Lease accounting
” in Note 2 – “Summary of
significant accounting policies” to our unaudited consolidated financial statements in Item 1 for additional information.
Commitments
As of
March 31, 2026
, remaining aggregate costs under contract for the construction of properties undergoing development,
redevelopment, and improvements under the terms of leases approxi
mated
$938.4 million
. We expect payments for these obligations to
occur over
one
to
three
year
s, subject to capital planning adjustments from time to time. We may have the ability to cease the
construction of certain projects, which would result in the reduction of our commitments. In addition, we have letters of credit and
performance obligations aggregati
n
g
$5.3 million
.
We are committed to funding approximately
$353.0 million
related to our non-real estate investments. These funding
commitments are primarily associated with our investments in privately held entities that report NAV and expire at various dates over
the next
12 years
, with a weighted-average expiration of
8.0 years
as of March 31, 2026
.
Our former joint venture partner in the Greater Boston market has an option, subject to certain conditions, to obtain a
$50 million
secured loan
from us, which, if the option is exercised, will bear interest at
6.5%
, with a floor of 9.0%
and
a term not to
exceed
five
years.
As of March 31, 2026
, the option has not been exercised and is set to expire in
July 2027
.
In connection with the sale of a property in our San Diego market, we entered into a loan agreement with the buyer under
which we committed to provide up to
$165.7 million
of financing through
December 30, 2029
.
As of March 31, 2026
,
$47.6 million
of the
commitment remained available to be drawn by the borrower.
Exposure to environmental liabilities
In connection with the acquisition of all of our properties, we have obtained Phase I environmental assessments to ascertain
the existence of any environmental liabilities or other issues. The Phase I environmental assessments of our properties have not
revealed any environmental liabilities that we believe would have a material adverse effect on our financial condition or results of
operations taken as a whole, nor are we aware of any material environmental liabilities that have occurred since the Phase I
environmental assessments were completed. In addition, we carry a policy of pollution legal liability insurance covering exposure to
certain environmental losses at substantially all of our properties.
100
Foreign currency translation gains and losses
The following table presents the change in accumulated other comprehensive
loss
attributable to Alexandria Real Estate
Equities, Inc.’s stockholders during the
three months ended March 31, 2026
primarily due to the changes in the foreign exchange rates
for our real estate investments in Canada (in thousands). We reclassify unrealized foreign currency translation gains and losses into net
income as we dispose of these holdings.
Total
Balance as of December 31, 2025
$
(29,395)
Other comprehensive loss before reclassifications
(1,518)
Reclassification adjustment for loss included in net income
(23)
Net other comprehensive loss
(1,541)
Balance as of March 31, 2026
$
(30,936)
Inflation
As of
March 31, 2026
, approximately
91%
of our leases
(on an annual rental revenue basis) were triple net leases, which
require tenants to pay substantially all real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and
other operating expenses (including increases thereto) in addition to base rent. Approximately
97%
of our leases (on an annual rental
revenue basis) contained effective annual rent escalations approximating
3%
th
at were either fixed or indexed based on a consumer
price index or other indices. Accordingly, we do not believe that our cash flows or earnings from real estate operations are subject to
significant risks from inflation. A period of inflation, however, could cause an increase in the cost of issuing new unsecured senior notes
payable and our variable-rate borrowings, including borrowings under our unsecured senior line of credit and commercial paper
program, and secured loans held by our unconsolidated real estate joint ventures.
101
Issuer and guarantor subsidiary summarized financial information
Alexandria Real Estate Equities, Inc. (the “Issuer”) has sold certain debt securities registered under the Securities Act of 1933,
as amended, that are fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P. (the “LP” or the “Guarantor
Subsidiary”), an indirectly 100% owned subsidiary of the Issuer. The Issuer’s other subsidiaries, including, but not limited to, the
subsidiaries that own substantially all of its real estate (collectively, the “Combined Non-Guarantor Subsidiaries”), will not provide a
guarantee of such securities, including the subsidiaries that are partially or 100% owned by the LP. The following summarized financial
information presents, on a combined basis, balance sheet information as of
March 31, 2026
and
December 31, 2025
, and results of
operations and comprehensive income for the
three months ended March 31, 2026
and year ended
December 31, 2025
for the Issuer
and the Guarantor Subsidiary. The information presented below excludes eliminations necessary to arrive at the information on a
consolidated basis. In presenting the summarized financial statements, the equity method of accounting has been applied to (i) the
Issuer’s interests in the Guarantor Subsidiary, (ii) the Guarantor Subsidiary’s interests in the Combined Non-Guarantor Subsidiaries,
and (iii) the Combined Non-Guarantor Subsidiaries’ interests in the Guarantor Subsidiary, where applicable, even though all such
subsidiaries meet the requirements to be consolidated under GAAP. All assets and liabilities have been allocated to the Issuer and the
Guarantor Subsidiary generally based on legal entity ownership.
The following tables present combined summarized financial information as of
March 31, 2026
and
December 31, 2025
and for
the
three months ended March 31, 2026
and
year ended December 31, 2025
for the Issuer and Guarantor Subsidiary. Amounts
provided do not represent our total consolidated amounts (in thousands):
March 31, 2026
December 31, 2025
Assets:
Cash, cash equivalents, and restricted cash
$
71,915
$
127,100
Other assets
182,017
173,303
Total assets
$
253,932
$
300,403
Liabilities:
Unsecured senior notes payable
$
11,166,009
$
12,047,394
Unsecured senior line of credit and commercial paper
1,353,986
353,161
Other liabilities
420,800
433,707
Total liabilities
$
12,940,795
$
12,834,262
Three Months Ended
March 31, 2026
Year Ended
December 31, 2025
Total revenues
$
14,508
$
48,748
Total expenses
(100,208)
(350,655)
Gain on early extinguishment of debt
366,435
—
Net income (loss)
280,735
(301,907)
Net income attributable to unvested restricted stock awards
(2,779)
(8,417)
Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders
$
277,956
$
(310,324)
As of
March 31, 2026
,
327
of our
339
properties
were held indirectly by the REIT’s wholly owned consolidated subsidiary,
Alexandria Real Estate Equities, L.P.
Critical accounting estimates
Refer to our annual report on Form 10-K for the year ended
December 31, 2025
for a discussion of our critical accounting
estimates related to recognition of real estate acquired, impairment of long-lived assets, impairment of non-real estate investments, and
monitoring of tenant credit quality.
102
Definitions and reconciliations
This section contains additional information on certain non-GAAP financial measures, including reconciliations from the most
directly comparable financial measure calculated and presented in accordance with GAAP and the reasons why we use these
supplemental measures of performance and believe they provide useful information to investors, as well as the definitions of other
terms used in this report.
Funds from operations and funds from operations, as adjusted, attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders
GAAP-basis accounting for real estate assets utilizes historical cost accounting and assumes that real estate values diminish
over time. In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the
Nareit Board of Governors established funds from operations as an improved measurement tool. Since its introduction, funds from
operations has become a widely used non-GAAP financial measure among equity REITs. We believe that funds from operations is
helpful to investors as an additional measure of the performance of an equity REIT. Moreover, we believe that funds from operations, as
adjusted, allows investors to compare our performance to the performance of other real estate companies on a consistent basis, without
having to account for differences recognized because of real estate acquisition and disposition decisions, financing decisions, capital
structure, capital market transactions, variances resulting from the volatility of market conditions outside of our control, or other
corporate activities that may not be representative of the operating performance of our properties.
The 2018 White Paper published by the Nareit Board of Governors (the “Nareit White Paper”) defines funds from operations as
net income (computed in accordance with GAAP), excluding gains or losses on sales of real estate, and impairments of real estate, plus
depreciation and amortization of operating real estate assets, and after adjustments for our share of consolidated and unconsolidated
partnerships and real estate joint ventures. Impairments represent the write-down of assets when fair value over the recoverability
period is less than the carrying value due to changes in general market conditions and do not necessarily reflect the operating
performance of the properties during the corresponding period.
We compute funds from operations, as adjusted, as funds from operations calculated in accordance with the Nareit White
Paper, excluding significant gains, losses, and impairments realized on non-real estate investments, unrealized gains or losses on non-
real estate investments, impairments of real estate primarily consisting of right-of-use assets and pre-acquisition costs related to
projects that we decided to no longer pursue, gains or losses on early extinguishment of debt, changes in the provision for expected
credit losses on financial instruments, significant termination fees, acceleration of stock compensation expense due to the resignations
of executive officers, deal costs, the income tax effect related to such items, and the amount of such items that is allocable to our
unvested restricted stock awards. We compute the amount that is allocable to our unvested restricted stock awards with nonforfeitable
dividends using the two-class method. Under the two-class method, we allocate net income (after amounts attributable to noncontrolling
interests) to common stockholders and to unvested restricted stock awards with nonforfeitable dividends by applying the respective
weighted-average shares outstanding during each quarter-to-date and year-to-date period. This may result in a difference of the
summation of the quarter-to-date and year-to-date amounts. Neither funds from operations nor funds from operations, as adjusted,
should be considered as alternatives to net income (determined in accordance with GAAP) as indications of financial performance, or to
cash flows from operating activities (determined in accordance with GAAP) as measures of liquidity, nor are they indicative of the
availability of funds for our cash needs, including our ability to make distributions.
We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a
reconciliation for funds from operations on a forward-looking basis. This is due to the inherent difficulty of forecasting the timing and/or
amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and
financing decisions, as well as components such as gain on sales of real estate, unrealized gains or losses on non-real estate
investments, impairments of real estate, impairments of non-real estate investments, and changes in provision for expected credit
losses on financial instruments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would
potentially be misleading for our investors.
103
The following tables present a reconciliation of net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders, the most directly comparable financial measure presented in accordance with GAAP, including our share of amounts from
consolidated and unconsolidated real estate joint ventures, to funds from operations attributable to Alexandria Real Estate Equities,
Inc.’s common stockholders – diluted, and funds from operations attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – diluted, as adjusted, and the related per share amounts for the
three months ended March 31, 2026
and
2025
(in
thousands, except per share amounts). Per share amounts may not add due to rounding.
Three Months Ended March 31,
2026
2025
Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common stockholders –
basic and diluted
$
358,874
$
(11,599)
Depreciation and amortization of real estate assets
303,296
339,381
Noncontrolling share of depreciation and amortization from consolidated real estate JVs
(29,473)
(33,411)
Our share of depreciation and amortization from unconsolidated real estate JVs
914
1,054
Gain on sales of real estate
—
(13,165)
Impairment of real estate – rental properties and land
5,499
(1)
—
Allocation to unvested restricted stock awards
(2,181)
(686)
Funds from operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders
– diluted
(2)
636,929
281,574
Unrealized losses on non-real estate investments
10,332
68,145
Impairment of non-real estate investments
12,448
(3)
11,180
Impairment of real estate
—
32,154
Gain on early extinguishment of debt
(366,435)
(4)
—
Increase in provision for expected credit losses on financial instruments
—
285
Allocation to unvested restricted stock awards
2,674
(1,329)
Funds from operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders
– diluted, as adjusted
$
295,948
$
392,009
(1)
Primarily represents an incremental
impairment charge recognized during the
three months ended March 31, 2026
in connection with the amendment of the sales
agreement for our Canada portfolio,
which was classified as held for sale as of December 31, 2025. Refer to Note 3 – “
Sales of real estate assets and impairment of real
estate
” under Item 1 to our unaudited consolidated financial statements for additional details.
(2)
Calculated in accordance with standards established by the Nareit Board of Governors.
(3)
Primarily related to
two
non-real estate investments
in privately held entities that do not report NAV.
(4)
I
n February 2026, we completed tender offers to repurchase debt principal aggregating
$1.33 billion
across a portion of our outstanding
4.00%
Senior Notes due
2050
,
3.00%
Senior Notes due
2051
, and
3.55%
Senior Notes due
2052
for
$952.2 million
. The gain includes the write-off of unamortized debt issuance costs and other
transaction-related costs. Refer to Note 10 – “Secured and unsecured senior debt” under Item 1 to our unaudited consolidated financial statements for additional details.
104
Three Months Ended March 31,
(Per share)
2026
2025
Net income (loss) per share attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – diluted
$
2.10
$
(0.07)
Depreciation and amortization of real estate assets
1.61
1.80
Gain on sales of real estate
—
(0.08)
Impairment of real estate – rental properties and land
0.03
—
Allocation to unvested restricted stock awards
(0.01)
—
Funds from operations per share attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – diluted
3.73
1.65
Unrealized losses on non-real estate investments
0.06
0.40
Impairment of non-real estate investments
0.07
0.07
Impairment of real estate
—
0.19
Gain on early extinguishment of debt
(2.14)
—
Allocation to unvested restricted stock awards
0.01
(0.01)
Funds from operations per share attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – diluted, as adjusted
$
1.73
$
2.30
Weighted-average shares of common stock outstanding – diluted
(1)
Earnings per share – diluted
170,867
170,522
Funds from operations – diluted, per share
170,867
170,599
Funds from operations – diluted, as adjusted, per share
170,867
170,599
(1)
Refer to “
Weighted-average shares of common stock outstanding – diluted
” in this section for additional information.
The following table reconciles net income (loss) to funds from operations for the share of consolidated real estate joint
ventures attributable to noncontrolling interests and our share of unconsolidated real estate joint ventures for the
three months ended
March 31, 2026
(in thousands):
Three Months Ended March 31, 2026
Noncontrolling Interest
Share of Consolidated
Real Estate Joint Ventures
Our Share of
Unconsolidated Real
Estate Joint Ventures
Net income (loss)
$
36,724
$
(147)
Depreciation and amortization of real estate assets
29,473
914
Funds from operations
$
66,197
$
767
105
Adjusted EBITDA and Adjusted EBITDA margin
We use Adjusted EBITDA as a supplemental performance measure of our operations, for financial and operational decision-
making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated
as earnings before interest, taxes, depreciation, and amortization (“EBITDA”), excluding stock compensation expense, gains or losses
on early extinguishment of debt, gains or losses on sales of real estate, impairments of real estate, changes in provision for expected
credit losses on financial instruments, and significant termination fees. Adjusted EBITDA also excludes unrealized gains or losses and
significant realized gains or losses and impairments that result from our non-real estate investments. These non-real estate investment
amounts are classified in our consolidated statements of operations outside of total revenues.
We believe Adjusted EBITDA provides investors with relevant and useful information as it allows investors to evaluate the
operating performance of our business activities without having to account for differences recognized because of investing and
financing decisions related to our real estate and non-real estate investments, our capital structure, capital market transactions, and
variances resulting from the volatility of market conditions outside of our control. For example, we exclude gains or losses on the early
extinguishment of debt to allow investors to measure our performance independent of our indebtedness and capital structure. We
believe that adjusting for the effects of impairments and gains or losses on sales of real estate, significant impairments and realized
gains or losses on non-real estate investments, changes in provision for expected credit losses on financial instruments, and significant
termination fees allows investors to evaluate performance from period to period on a consistent basis without having to account for
differences recognized because of investing and financing decisions related to our real estate and non-real estate investments or other
corporate activities that may not be representative of the operating performance of our properties.
In addition, we believe that excluding charges related to stock compensation and unrealized gains or losses facilitates for
investors a comparison of our business activities across periods without the volatility resulting from market forces outside of our control.
Adjusted EBITDA has limitations as a measure of our performance. Adjusted EBITDA does not reflect our historical expenditures or
future requirements for capital expenditures or contractual commitments. While Adjusted EBITDA is a relevant measure of performance,
it does not represent net income (loss) or cash flows from operations calculated and presented in accordance with GAAP, and it should
not be considered as an alternative to those indicators in evaluating performance or liquidity.
In order to calculate the Adjusted EBITDA margin, we divide Adjusted EBITDA by total revenues as presented in our
consolidated statements of operations. We believe that this supplemental performance measure provides investors with additional
useful information regarding the profitability of our operating activities.
We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a
reconciliation for Adjusted EBITDA on a forward-looking basis. This is due to the inherent difficulty of forecasting the timing and/or
amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and
financing decisions, as well as quarterly components such as gain on sales of real estate, unrealized gains or losses on non-real estate
investments, impairments of real estate, impairments of non-real estate investments, and changes in provision for expected credit
losses on financial instruments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would
potentially be misleading for our investors.
106
The following table reconciles net income (loss), the most directly comparable financial measure calculated and presented in
accordance with GAAP, to Adjusted EBITDA and calculates the Adjusted EBITDA margin for the
three months ended March 31, 2026
and
2025
(dollars in thousands):
Three Months Ended March 31,
2026
2025
Net income
$
398,377
$
38,662
Interest expense
64,584
50,876
Income taxes
3,225
1,145
Depreciation and amortization
305,441
342,062
Stock compensation expense
11,032
10,064
Gain on early extinguishment of debt
(366,435)
(1)
—
Gain on sales of real estate
—
(13,165)
Unrealized losses on non-real estate investments
10,332
68,145
Impairment of real estate
5,499
32,154
Impairment of non-real estate investments
12,448
11,180
Decrease in provision for expected credit losses on financial instruments
—
285
Adjusted EBITDA
$
444,503
$
541,408
Total revenues
$
671,022
$
758,158
Adjusted EBITDA margin
66%
71%
(1)
In February 2026, we completed tender offers to repurchase debt principal aggregating
$1.33 billion
across a portion of our outstanding
4.00%
Senior Notes due
2050
,
3.00%
Senior Notes due
2051
, and
3.55%
Senior Notes due
2052
for
$952.2 million
. The gain includes the write-off of unamortized debt issuance costs and other
transaction-related costs. Refer to Note 10 – “Secured and unsecured senior debt” under Item 1 to our unaudited consolidated financial statements.
Annual rental revenue
Annual rental revenue represents the annualized fixed base rental obligations, calculated in accordance with GAAP. It includes
the amortization of deferred revenue related to tenant-funded and tenant-built landlord improvements for leases in effect as of the end
of the period, related to our operating RSF. Annual rental revenue is presented using 100% of the annual rental revenue from our
consolidated properties and our share of annual rental revenue for our unconsolidated real estate joint ventures. Annual rental revenue
per RSF is computed by dividing annual rental revenue by the sum of 100% of the RSF of our consolidated properties and our share of
the RSF of properties held in unconsolidated real estate joint ventures. As of
March 31, 2026
, approximately
91%
of our leases (on an
annual rental revenue basis) were triple net leases, which require tenants to pay substantially all real estate taxes, insurance, utilities,
repairs and maintenance, common area expenses, and other operating expenses (including increases thereto) in addition to base rent.
Annual rental revenue excludes these operating expenses recovered from our tenants. Amounts recovered from our tenants related to
these operating expenses, along with base rent, are classified in income from rentals in our consolidated statements of operations.
Capitalization rates
Capitalization rates are calculated based on net operating income and net operating income (cash basis) annualized,
excluding lease termination fees, on stabilized operating assets for the quarter preceding the date on which the property is sold, or
near-term prospective net operating income.
Capitalized interest
We capitalize interest cost as a cost of a project during periods for which activities necessary to develop, redevelop, or
reposition a project for its intended use are ongoing, provided that expenditures for the asset have been made and interest cost has
been incurred. Activities necessary to develop, redevelop, or reposition a project include pre-construction activities such as
entitlements, permitting, design, site work, and other activities preceding commencement of construction of aboveground building
improvements. The advancement of pre-construction efforts is focused on reducing the time required to deliver projects to prospective
tenants. These critical activities add significant value for future ground-up development and are required for the vertical construction of
buildings. If we cease activities necessary to prepare a project for its intended use, interest costs related to such project are expensed
as incurred.
107
Cash interest
Cash interest is equal to interest expense calculated in accordance with GAAP plus capitalized interest, less amortization of
loan fees and debt premiums (discounts).
Refer to “
Fixed-charge coverage ratio
” in this section for a reconciliation of interest expense,
the most directly comparable financial measure calculated and presented in accordance with GAAP, to cash interest.
Class A/A+ properties and AAA locations
Class A/A+ properties are properties clustered in AAA locations that provide innovative tenants with highly dynamic and
collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity,
efficiency, creativity, and success. These properties are typically well-located, professionally managed, and well-maintained, offering a
wide range of amenities and featuring premium construction materials and finishes. Class A/A+ properties are generally newer or have
undergone substantial redevelopment and are generally expected to command higher annual rental rates compared to other classes of
similar properties. AAA locations are in close proximity to concentrations of specialized skills, knowledge, institutions, and related
businesses. It is important to note that our definition of property classification may not be directly comparable to other equity REITs.
Credit rating
Represents the credit ratings assigned by S&P Global Ratings or Moody’s Ratings as of
March 31, 2026
. A credit rating is not
a recommendation to buy, sell, or hold securities and may be subject to revision or withdrawal at any time.
Development, redevelopment, and pre-construction
A key component of our business model is our disciplined allocation of capital to the development and redevelopment of new
Class A/A+ properties, as well as property enhancements identified during the underwriting of certain acquired properties. These efforts
are primarily concentrated in collaborative Megacampus ecosystems within AAA life science innovation clusters, as well as other
strategic locations that support innovation and growth. These projects are generally focused on providing high-quality, generic, and
reusable spaces that meet the real estate requirements of a wide range of tenants. Upon completion, each development or
redevelopment project is expected to generate increases in rental income, net operating income, and cash flows. Our development and
redevelopment projects are generally in locations that are highly desirable to high-quality entities, which we believe results in higher
occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Development projects generally consist of the ground-up development of generic and reusable laboratory facilities.
Redevelopment projects generally consist of the permanent change in use of acquired office, warehouse, or shell space into facilities
designed for life science innovation or advanced technology. We generally will not commence new development projects for
aboveground construction of new Class A/A+ laboratory space without first securing significant pre-leasing for such space, except when
there is solid market demand for high-quality Class A/A+ properties.
Pre-construction activities include entitlements, permitting, design, site work, and other activities preceding commencement of
construction of aboveground building improvements. The advancement of pre-construction efforts is focused on reducing the time
required to deliver projects to prospective tenants. These critical activities add significant value for future ground-up development and
are required for the vertical construction of buildings. Ultimately, these projects will provide high-quality facilities and are expected to
generate significant revenue and cash flows.
Development, redevelopment, and pre-construction spending also includes the following costs: (i) amounts to bring certain
acquired properties up to market standard and/or other costs identified during the acquisition process (generally within two years of
acquisition) and (ii) permanent conversion of space for highly flexible, move-in-ready laboratory space to foster the growth of promising
early- and growth-stage life science companies.
Revenue-enhancing and repositioning capital expenditures represent spending to reposition or significantly change the use of
a property, including through improvement in the asset quality from Class B to Class A/A+.
Non-revenue-enhancing capital expenditures represent costs required to maintain the current revenues of a stabilized
property, including the associated costs for renewed and re-leased space.
Dividend payout ratio (common stock)
Dividend payout ratio (common stock) is the ratio of the absolute dollar amount of dividends on our common stock (shares of
common stock outstanding on the respective record dates multiplied by the related dividend per share) to funds from operations
attributable to Alexandria’s common stockholders – diluted, as adjusted.
108
Dividend yield
Dividend yield for the quarter represents the annualized quarter dividend divided by the closing common stock price at the end
of the quarter.
Fixed-charge coverage ratio
Fixed-charge coverage ratio is a non-GAAP financial measure representing the ratio of Adjusted EBITDA to cash interest and
fixed charges. We believe that this ratio is useful to investors as a supplemental measure of our ability to satisfy fixed financing
obligations and preferred stock dividends. Cash interest is equal to interest expense calculated in accordance with GAAP plus
capitalized interest, less amortization of loan fees and debt premiums (discounts).
The following table reconciles interest expense, the most directly comparable financial measure calculated and presented in
accordance with GAAP, to cash interest and computes fixed-charge coverage ratio
for the
three months ended March 31, 2026
and
2025
(dollars in thousands):
Three Months Ended March 31,
2026
2025
Adjusted EBITDA
$
444,503
$
541,408
Interest expense
$
64,584
$
50,876
Capitalized interest
69,973
80,065
Amortization of loan fees
(4,428)
(4,691)
Amortization of debt discounts
(320)
(349)
Cash interest and fixed charges
$
129,809
$
125,901
Fixed-charge coverage ratio:
– quarter annualized
3.4x
4.3x
– trailing 12 months
3.8x
4.4x
We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a
reconciliation for fixed-charge coverage ratio on a forward-looking basis. This is due to the inherent difficulty of forecasting the timing
and/or amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and
financing decisions, as well as quarterly components such as gain on sales of real estate, unrealized gains or losses on non-real estate
investments, impairments of real estate, impairments of non-real estate investments, and changes in provision for expected credit
losses on financial instruments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would
potentially be misleading for our investors.
Gross assets
Gross assets are calculated as total assets plus accumulated depreciation
as of
March 31, 2026
and
December 31, 2025
(in
thousands):
March 31, 2026
December 31, 2025
Total assets
$
34,167,397
$
34,081,835
Accumulated depreciation
6,393,658
6,127,525
Gross assets
$
40,561,055
$
40,209,360
Incremental annual net operating income on development and redevelopment projects
Incremental annual net operating income represents the amount of net operating income, on an annual basis, expected to be
realized upon a project being placed into service and achieving full occupancy. Incremental annual net operating income is calculated
as the initial stabilized yield multiplied by the project’s total cost at completion.
109
Initial stabilized yield (unlevered)
Initial stabilized yield is calculated as the estimated amounts of net operating income at stabilization divided by our investment
in the property. For this calculation, we exclude any tenant-funded and tenant-built landlord improvements from our investment in the
property. Our initial stabilized yield excludes the benefit of leverage. Our cash rents related to our development and redevelopment
projects are generally expected to increase over time due to contractual annual rent escalations. Our estimates for initial stabilized
yields, initial stabilized yields (cash basis), and total costs at completion represent our initial estimates at the commencement of the
project. We expect to update this information upon completion of the project, or sooner if there are significant changes to the expected
project yields or costs.
•
Initial stabilized yield reflects rental income, including contractual rent escalations and any rent concessions over the
term(s) of the lease(s), calculated on a straight-line basis, and any amortization of deferred revenue related to tenant-
funded and tenant-built landlord improvements.
•
Initial stabilized yield (cash basis) reflects cash rents at the stabilization date after initial rental concessions, if any, have
elapsed and our total cash investment in the property.
Investment-grade or publicly traded large cap tenants
Investment-grade or publicly traded large cap tenants represent tenants that are investment-grade rated or publicly traded
companies with an average daily market capitalization greater than $10 billion for the twelve months ended
March 31, 2026
, as reported
by Bloomberg Professional Services. Credit ratings from Moody’s Ratings and S&P Global Ratings reflect credit ratings of the tenant’s
parent entity, and there can be no assurance that a tenant’s parent entity will satisfy the tenant’s lease obligation upon such tenant’s
default. We monitor the credit quality and related material changes of our tenants. Material changes that cause a tenant’s market
capitalization to decrease below $10 billion, which are not immediately reflected in the twelve-month average, may result in their
exclusion from this measure.
Investments in real estate
The following table presents our new Class A/A+ development and redevelopment pipeline, excluding properties held for sale,
as a percentage of gross assets and as a percentage of annual rental revenue as of
March 31, 2026
(dollars in thousands):
Book Value
Percentage of
Gross Assets
Projects under active construction
$
3,117,332
8%
Future development projects
(1)
and land parcels primarily located in Megacampuses
3,740,237
9
Total Class A/A+ development and redevelopment pipeline, excluding properties held for
sale
6,857,569
17
Properties held for sale – land parcels
230,905
1
Total Class A/A+ development and redevelopment pipeline
$
7,088,474
18%
(1)
Includes projects with existing buildings that are generating or can generate operating cash flows. Also includes development rights associated with existing operating
campuses.
110
The square footage presented in the table below is classified as operating as of
March 31, 2026
.
These lease expirations or
vacant space at recently acquired properties represent future opportunities for which we intend, subject to market conditions and
leasing, to commence first-time conversion from non-laboratory space to laboratory space, or to commence future ground-up
development:
Dev/Redev
RSF of Lease Expirations Targeted for
Development and Redevelopment
Property/Submarket
2026
2027
Thereafter
(1)
Total
Future projects:
446, 458, and 500 Arsenal Street/Cambridge/Inner Suburbs
Dev
—
—
116,623
116,623
1122 and 1150 El Camino Real/South San Francisco
Dev
—
—
375,232
375,232
2100 Geng Road/Greater Stanford
Dev
—
—
12,125
12,125
960 Industrial Road/Greater Stanford
Dev
—
—
112,590
112,590
Campus Point by Alexandria/University Town Center
Dev
—
—
96,805
96,805
Sequence District by Alexandria/Sorrento Mesa
Dev/Redev
—
—
555,754
555,754
Canada
Redev
—
—
247,743
247,743
Total
—
—
1,516,872
1,516,872
(1)
Includes vacant square footage as of
March 31, 2026
.
Joint venture financial information
We present components of balance sheet and operating results information related to our real estate joint ventures, which are
not presented, or intended to be presented, in accordance with GAAP. We present the proportionate share of certain financial line items
as follows: (i) for each real estate joint venture that we consolidate in our financial statements, which are controlled by us through
contractual rights or majority voting rights, but of which we own less than 100%, we apply the noncontrolling interest economic
ownership percentage to each financial item to arrive at the amount of such cumulative noncontrolling interest share of each component
presented; and (ii) for each real estate joint venture that we do not control and do not consolidate, which are instead controlled jointly or
by our joint venture partners through contractual rights or majority voting rights, we apply our economic ownership percentage to each
financial item to arrive at our proportionate share of each component presented.
The components of balance sheet and operating results information related to our real estate joint ventures do not represent
our legal claim to those items. For each entity that we do not wholly own, the joint venture agreement generally determines what equity
holders can receive upon capital events, such as sales or refinancing, or in the event of a liquidation. Equity holders are normally
entitled to their respective legal ownership of any residual cash from a joint venture only after all liabilities, priority distributions, and
claims have been repaid or satisfied.
We believe that this information can help investors estimate the balance sheet and operating results information related to our
partially owned entities. Presenting this information provides a perspective not immediately available from consolidated financial
statements and one that can supplement an understanding of the joint venture assets, liabilities, revenues, and expenses included in
our consolidated results.
The components of balance sheet and operating results information related to our real estate joint ventures are limited as an
analytical tool as the overall economic ownership interest does not represent our legal claim to each of our joint ventures’ assets,
liabilities, or results of operations. In addition, joint venture financial information may include financial information related to the
unconsolidated real estate joint ventures that we do not control. We believe that, to facilitate investors’ clear understanding of our
operating results and our total assets and liabilities, joint venture financial information should be examined in conjunction with our
consolidated statements of operations and balance sheets. Joint venture financial information should not be considered an alternative
to our consolidated financial statements, which are presented and prepared in accordance with GAAP.
Megacampus™
A Megacampus ecosystem is a cluster campus that consists of approximately 1 million RSF or greater, including operating,
active development/redevelopment, and land RSF less operating RSF expected to be demolished.
111
The following table reconciles our annual rental revenue and development and redevelopment pipeline RSF, excluding
properties classified as held for sale, as of
March 31, 2026
(dollars in thousands):
Annual Rental
Revenue
Development and
Redevelopment
Pipeline RSF
Megacampus
$
1,414,438
16,919,119
Core and non-core
388,856
4,990,866
Total
$
1,803,294
21,909,985
Megacampus as a percentage of annual rental revenue and of total development and
redevelopment pipeline RSF
78%
77%
Net cash provided by operating activities, as adjusted
We use net cash provided by operating activities, as adjusted, as a supplemental measure for financial and operational
decision-making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Net cash provided by
operating activities, as adjusted, is calculated as net cash provided by operating activities as shown in our consolidated statements of
cash flows, adjusted for changes in operating assets and liabilities (as they represent timing differences), and reduced by dividends and
distributions to noncontrolling interests (excludes liquidating distributions from asset sales).
We believe net cash provided by operating activities, as adjusted, provides investors with relevant and useful information as it
allows investors to evaluate our operating cash flows on a more consistent basis that excludes period-to-period timing differences in
operating assets and liabilities (working capital) and reflects cash dividends and distributions paid quarterly.
The following table reconciles net cash flows from operating activities, the most directly comparable financial measure
presented in accordance with GAAP, to net cash provided by operating activities, as adjusted:
Three Months Ended March 31,
(in thousands)
2026
2025
Net cash provided by operating activities
$
196,624
207,949
Decreases in operating assets and liabilities
143,523
220,294
Common stock dividends paid
(123,752)
(229,987)
Distributions to noncontrolling interests
(60,111)
(66,034)
Net cash provided by operating activities, as adjusted
$
156,284
$
132,222
Net debt and preferred stock to Adjusted EBITDA
Net debt and preferred stock to Adjusted EBITDA is a non-GAAP financial measure that we believe is useful to investors as a
supplemental measure of evaluating our balance sheet leverage. Net debt and preferred stock is equal to the sum of total consolidated
debt less cash, cash equivalents, and restricted cash, plus preferred stock outstanding as of the end of the period.
Refer to “
Adjusted
EBITDA and Adjusted EBITDA margin
” in this section for further information on the calculation of Adjusted EBITDA.
We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a
reconciliation for net debt and preferred stock to Adjusted EBITDA on a forward-looking basis. This is due to the inherent difficulty of
forecasting the timing and/or amount of items that depend on market conditions outside of our control, including the timing of
dispositions, capital events, and financing decisions, as well as quarterly components such as gain on sales of real estate, unrealized
gains or losses on non-real estate investments, impairments of real estate, impairments of non-real estate investments, and changes in
provision for expected credit losses on financial instruments. Our attempt to predict these amounts may produce significant but
inaccurate estimates, which would potentially be misleading for our investors.
112
The following table reconciles debt to net debt and preferred stock and computes the ratio to Adjusted EBITDA as of
March 31,
2026
and
December 31, 2025
(dollars in thousands):
March 31, 2026
December 31, 2025
Unsecured senior notes payable
$
11,166,009
$
12,047,394
Unsecured senior line of credit and commercial paper
1,353,986
353,161
Unamortized deferred financing costs
69,071
74,314
Cash and cash equivalents
(418,720)
(549,062)
Restricted cash
(4,665)
(4,693)
Preferred stock
—
—
Net debt and preferred stock
$
12,165,681
$
11,921,114
Adjusted EBITDA:
– quarter annualized
$
1,778,012
$
2,097,444
– trailing 12 months
$
2,044,906
$
2,141,811
Net debt and preferred stock to Adjusted EBITDA:
– quarter annualized
6.8x
5.7x
– trailing 12 months
5.9x
5.6x
Net operating income, net operating income (cash basis), and operating margin
The following table reconciles net income (loss) to net operating income and net operating income (cash basis) and computes
operating margin for the
three months ended March 31, 2026
and
2025
(dollars in thousands):
Three Months Ended March 31,
2026
2025
Net income
$
398,377
$
38,662
Equity in losses of unconsolidated real estate joint ventures
147
507
General and administrative expenses
34,685
30,675
Interest expense
64,584
50,876
Depreciation and amortization
305,441
342,062
Impairment of real estate
5,499
32,154
Gain on early extinguishment of debt
(366,435)
—
Gain on sales of real estate
—
(13,165)
Investment loss
4,582
49,992
Net operating income
446,880
531,763
Straight-line rent revenue
(17,862)
(22,023)
Amortization of deferred revenue related to tenant-funded and -built landlord improvements
(5,405)
(1,651)
Amortization of acquired below-market leases
(5,615)
(15,222)
Provision for expected credit losses on financial instruments
—
285
Net operating income (cash basis)
$
417,998
$
493,152
Net operating income (from above)
$
446,880
$
531,763
Total revenues
$
671,022
$
758,158
Operating margin
67%
70%
113
Net operating income is a non-GAAP financial measure calculated as net income (loss), the most directly comparable financial
measure calculated and presented in accordance with GAAP, excluding equity in the earnings of our unconsolidated real estate joint
ventures, general and administrative expenses, interest expense, depreciation and amortization, impairments of real estate, gains or
losses on early extinguishment of debt, gains or losses on sales of real estate, and investment income or loss. We believe net operating
income provides useful information to investors regarding our financial condition and results of operations because it primarily reflects
those income and expense items that are incurred at the property level. Therefore, we believe net operating income is a useful measure
for investors to evaluate the operating performance of our consolidated real estate assets. Net operating income on a cash basis is net
operating income adjusted to exclude the effect of straight-line rent, amortization of acquired above- and below-market lease revenue,
amortization of deferred revenue related to tenant-funded and tenant-built landlord improvements, and changes in the provision for
expected credit losses on financial instruments required by GAAP. We believe that net operating income on a cash basis is helpful to
investors as an additional measure of operating performance because it eliminates straight-line rent revenue and the amortization of
acquired above- and below-market leases and tenant-funded and tenant-built landlord improvements.
Furthermore, we believe net operating income is useful to investors as a performance measure of our consolidated properties
because, when compared across periods, net operating income reflects trends in occupancy rates, rental rates, and operating costs,
which provide a perspective not immediately apparent from net income or loss. Net operating income can be used to measure the initial
stabilized yields of our properties by calculating net operating income generated by a property divided by our investment in the property.
Net operating income excludes certain components from net income in order to provide results that are more closely related to the
results of operations of our properties. For example, interest expense is not necessarily linked to the operating performance of a real
estate asset and is often incurred at the corporate level rather than at the property level. In addition, depreciation and amortization,
because of historical cost accounting and useful life estimates, may distort comparability of operating performance at the property level.
Impairments of real estate have been excluded in deriving net operating income because we do not consider impairments of real estate
to be property-level operating expenses. Impairments of real estate relate to changes in the values of our assets and do not reflect the
current operating performance with respect to related revenues or expenses. Our impairments of real estate represent the write-down in
the value of the assets to the estimated fair value less cost to sell. These impairments result from investing decisions or a deterioration
in market conditions. We also exclude realized and unrealized investment gain or loss, which results from investment decisions that
occur at the corporate level related to non-real estate investments in publicly traded companies and certain privately held entities.
Therefore, we do not consider these activities to be an indication of operating performance of our real estate assets at the property
level. Our calculation of net operating income also excludes charges incurred from changes in certain financing decisions, such as
losses on early extinguishment of debt and changes in provision for expected credit losses on financial instruments, as these charges
often relate to corporate strategy. Property operating expenses included in determining net operating income primarily consist of costs
that are related to our operating properties, such as utilities, repairs, and maintenance; rental expense related to ground leases;
contracted services, such as janitorial, engineering, and landscaping; property taxes and insurance; and property-level salaries.
General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional
fees, rent, and supplies that are incurred as part of corporate office management. We calculate operating margin as net operating
income divided by total revenues.
We believe that, to facilitate investors’ clear understanding of our operating results, net operating income should be examined
in conjunction with net income or loss as presented in our consolidated statements of operations. Net operating income should not be
considered as an alternative to net income or loss as an indication of our performance, nor as an alternative to cash flows as a measure
of our liquidity or our ability to make distributions.
We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a
reconciliation for net operating income on a forward-looking basis. This is due to the inherent difficulty of forecasting the timing and/or
amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and
financing decisions, as well as components such as gain on sales of real estate, unrealized gains or losses on non-real estate
investments, impairments of real estate, impairments of non-real estate investments, and changes in provision for expected credit
losses on financial instruments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would
potentially be misleading for our investors.
Operating statistics
We present certain operating statistics related to our properties, including number of properties, RSF, occupancy percentage,
leasing activity, and contractual lease expirations as of the end of the period. We believe these measures are useful to investors
because they facilitate an understanding of certain trends for our properties. We compute the number of properties, RSF, occupancy
percentage, leasing activity, and contractual lease expirations at 100%, excluding RSF at properties classified as held for sale, for all
properties in which we have an investment, including properties owned by our consolidated and unconsolidated real estate joint
ventures.
For operating metrics based on annual rental revenue, refer to “
Annual rental revenue
” in this section.
114
Same property comparisons
As a result of changes within our total property portfolio during the comparative periods presented, including changes from
assets acquired or sold, properties placed into development or redevelopment, and development or redevelopment properties recently
placed into service, the consolidated total income from rentals, as well as rental operating expenses in our operating results, can show
significant changes from period to period. In order to supplement an evaluation of our results of operations over a given quarterly or
annual period, we analyze the operating performance for all consolidated properties that were fully operating for the entirety of the
comparative periods presented, referred to as same properties. We separately present quarterly and year-to-date same property results
to align with the interim financial information required by the SEC in our management’s discussion and analysis of our financial
condition and results of operations. These same properties are analyzed separately from properties acquired subsequent to the first day
in the earliest comparable quarterly or year-to-date period presented, properties that underwent development or redevelopment at any
time during the comparative periods, unconsolidated real estate joint ventures, properties classified as held for sale, and corporate
entities (legal entities performing general and administrative functions), which are excluded from same property results. Additionally,
termination fees, if any, are excluded from the results of same properties.
Refer to “
Same properties
” in Item 2 for additional information.
Stabilized occupancy date
The stabilized occupancy date represents the estimated date on which a development or redevelopment project is expected to
reach occupancy of 95% or greater.
Tenant collections
Tenant collections represent the percentage of recognized rental income billed during the respective quarter that has been
collected as of the date of this report. Rental income from tenants for whom collection is considered not probable is recognized only
upon receipt of cash and, accordingly, is included in this calculation only to the extent recognized and collected.
Tenant recoveries
Tenant recoveries represent revenues comprising reimbursement of real estate taxes, insurance, utilities, repairs and
maintenance, common area expenses, and other operating expenses and earned in the period during which the applicable expenses
are incurred and the tenant’s obligation to reimburse us arises.
We classify rental revenues and tenant recoveries generated through the leasing of real estate assets within revenues in
income from rentals in our consolidated statements of operations.
We provide investors with a separate presentation of rental revenues
and tenant recoveries in “
Results of operations
” in Item 2 because we believe it promotes investors’ understanding of our operating
results.
We believe that the presentation of tenant recoveries is useful to investors as a supplemental measure of our ability to recover
operating expenses under our triple net leases, including recoveries of utilities, repairs and maintenance, insurance, property taxes,
common area expenses, and other operating expenses, and of our ability to mitigate the effect to net income for any significant
variability to components of our operating expenses.
The following table reconciles income from rentals to tenant recoveries for the
three months ended March 31, 2026
and
2025
(in thousands):
Three Months Ended March 31,
2026
2025
Income from rentals
$
653,013
$
743,175
Rental revenues
(474,786)
(552,112)
Tenant recoveries
$
178,227
$
191,063
Total equity capitalization
Total equity capitalization is equal to the outstanding shares of common stock multiplied by the closing price on the last trading
day at the end of each period presented.
Total market capitalization
Total market capitalization is equal to the sum of total equity capitalization and total debt.
Unencumbered net operating income as a percentage of total net operating income
115
Unencumbered net operating income as a percentage of total net operating income is a non-GAAP financial measure that we
believe is useful to investors as a performance measure of the results of operations of our unencumbered real estate assets as it
reflects those income and expense items that are incurred at the unencumbered property level. Unencumbered net operating income is
derived from assets classified in continuing operations, which are not subject to any mortgage, deed of trust, lien, or other security
interest, as of the period for which income is presented.
The following table summarizes unencumbered net operating income as a percentage of total net operating income for the
three months ended March 31, 2026
and
2025
(dollars in thousands):
Three Months Ended March 31,
2026
2025
Unencumbered net operating income
$
446,880
$
530,691
Encumbered net operating income
—
1,072
Total net operating income
$
446,880
$
531,763
Unencumbered net operating income as a percentage of total net operating income
100.0%
99.8%
Weighted-average shares of common stock outstanding – diluted
From time to time, we enter into capital market transactions, including forward equity sales agreements (“Forward
Agreements”), to fund acquisitions, to fund construction of our development and redevelopment projects, and for general working
capital purposes. While the Forward Agreements are outstanding, we are required to consider the potential dilutive effect of our Forward
Agreements under the treasury stock method. Under this method, we also include the dilutive effect of unvested restricted stock awards
(“RSAs”) with forfeitable dividends in the calculation of diluted shares.
Refer to Note 13 – “Earnings per share” and Note 14 –
“Stockholders’ equity” to our unaudited consolidated financial statements in Item 1 for additional information.
The weighted-average shares of common stock outstanding used in calculating EPS – diluted, funds from operations per
share – diluted, and funds from operations per share – diluted, as adjusted, for the
three months ended March 31, 2026
and
2025
are
calculated as follows. Also shown are the weighted-average unvested RSAs with nonforfeitable dividends used in calculating the
amounts allocable to these awards pursuant to the two-class method for each of the respective periods presented below (in thousands):
Three Months Ended March 31,
2026
2025
Basic shares for earnings per share
170,598
170,522
Unvested RSAs with forfeitable dividends
269
—
Diluted shares for earnings per share
170,867
170,522
Basic shares for funds from operations per share and funds from operations per share, as
adjusted
170,598
170,522
Unvested RSAs with forfeitable dividends
269
77
Diluted shares for funds from operations per share and funds from operations per share, as
adjusted
170,867
170,599
Weighted-average unvested RSAs with nonforfeitable dividends used in the allocations of net
income, funds from operations, and funds from operations, as adjusted
1,340
2,053
116
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest rate risk
The primary market risk to which we believe we may be exposed is interest rate risk, which may result from many factors,
including government monetary and tax policies, domestic and international economic and political considerations, and other factors
that are beyond our control.
In order to modify and manage the interest rate characteristics of our outstanding debt and to limit the effects of interest rate
risks on our operations, we may utilize a variety of financial instruments, including interest rate hedge agreements, caps, floors, and
other interest rate exchange contracts. The use of these types of instruments to hedge a portion of our exposure to changes in interest
rates may carry additional risks, such as counterparty credit risk and the legal enforceability of hedge agreements. As of
March 31,
2026
, we did not have any outstanding interest rate hedge agreements.
Our future earnings and fair values relating to our outstanding debt are primarily dependent upon prevalent market rates of
interest. The following tables illustrate the effect of a 1% change in interest rates, assuming a zero percent interest rate floor, on our
fixed- and variable-rate debt as of
March 31, 2026
(in thousands):
As of
March 31, 2026
December 31, 2025
Annualized effect on future earnings due to variable-rate debt:
Rate increase of 1%
$
(4,706)
$
(1,259)
Rate decrease of 1%
$
4,706
$
1,259
Effect on fair value of total consolidated debt:
Rate increase of 1%
$
(658,167)
$
(746,058)
Rate decrease of 1%
$
742,060
$
852,698
These amounts are determined by considering the effect of the hypothetical interest rates on our borrowings as of
March 31,
2026
and
December 31, 2025
. These analyses do not consider the effects of the reduced level of overall economic activity that could
exist in such an environment. Furthermore, in the event of a change of such magnitude, we would consider taking actions to further
mitigate our exposure to the change. Because of the uncertainty of the specific actions that would be taken and their possible effects,
the sensitivity analyses assume no changes in our capital structure.
Equity price risk
We have exposure to equity price market risk because we hold equity investments in publicly traded companies and privately
held entities. All of our investments in actively traded public companies are reflected in our consolidated balance sheets at fair value.
Our investments in privately held entities that report NAV per share are measured at fair value using NAV as a practical expedient to fair
value. Our equity investments in privately held entities that do not report NAV per share are measured at cost less impairments,
adjusted for observable price changes during the period. Changes in fair value of public investments, changes in NAV per share
reported by privately held entities, and observable price changes of privately held entities that do not report NAV per share are
classified as
investment income
(loss) in our consolidated statements of operations. There is no assurance that future declines in value
will not have a material adverse effect on our future results of operations. The following table illustrates the effect that a 10% change in
the value of our equity investments would have on earnings as of
March 31, 2026
and
December 31, 2025
(in thousands):
As of
March 31, 2026
December 31, 2025
Equity price risk:
Fair value increase of 10%
$
116,854
$
114,387
Fair value decrease of 10%
$
(116,854)
$
(114,387)
117
Foreign currency exchange rate risk
We have exposure to foreign currency exchange rate risk related to our operations in Canada. The functional currency of our
Canadian subsidiaries is the Canadian dollar. Gains or losses resulting from the translation of these subsidiaries’ balance sheets and
statements of operations are classified in accumulated other comprehensive income (loss) as a separate component of total equity and
are excluded from net income (loss). Gains or losses will be reflected in our consolidated statements of operations when there is a sale
or partial sale of our investment in these operations or upon a complete or substantially complete liquidation of the investment. The
following tables illustrate the effect that a 10% change in Canadian dollar exchange rates relative to the USD would have on our
potential future earnings and on the fair value of our net investment in Canadian subsidiaries, based on our current operating assets
outside the U.S. as of
March 31, 2026
and
December 31, 2025
(in thousands):
As of
March 31, 2026
December 31, 2025
Effect on potential future earnings due to foreign currency exchange rate:
Rate increase of 10%
$
290
$
182
Rate decrease of 10%
$
(290)
$
(182)
Effect on the fair value of net investment in foreign subsidiaries due to foreign currency
exchange rate:
Rate increase of 10%
$
35,164
$
35,306
Rate decrease of 10%
$
(35,164)
$
(35,306)
Change in the fair value of cross-currency swap agreements designated as a net
investment hedge
(1)
:
Rate increase of 10% (USD weakening)
$
24,400
$
(24,600)
Rate decrease of 10% (USD strengthening)
$
(24,400)
$
24,600
(1)
Refer to Note 11 – “Hedge agreements” to our unaudited consolidated financial statements for additional information.
The sensitivity analyses assume a parallel shift of all foreign currency exchange rates with respect to the U.S. dollar; however,
foreign currency exchange rates do not typically move in such a manner, and actual results may differ materially.
Our exposure to market risk elements for the
three months ended March 31, 2026
was consistent with the risk elements
presented above, including the effects of changes in interest rates, equity prices, and foreign currency exchange rates.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of disclosure controls and procedures
As of
March 31, 2026
, we had performed an evaluation, under the supervision of our principal executive officers and principal
financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. These controls and
procedures have been designed to ensure that information required for disclosure is recorded, processed, summarized, and reported
within the requisite time periods. Based on our evaluation, the principal executive officers and principal financial officer concluded that
our disclosure controls and procedures were effective as of
March 31, 2026
.
Changes in internal control over financial reporting
There has not been any change in our internal control over financial reporting during the three months ended
March 31, 2026
that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
118
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Stockholder Matters
On November 25, 2025, a securities class action was filed against the Company and certain of its officers and directors in the
United States District Court for the Central District of California. On April 15, 2026, the lead plaintiffs filed an amended complaint
alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, based on alleged
material misrepresentations and omissions related to the Company’s business performance and real estate impairment charges
(captioned Hern v. Alexandria Real Estate Equities, Inc., et al.). The amended complaint seeks damages and other relief on behalf of
investors who acquired the Company’s securities between January 30, 2024 and December 5, 2025. The Company does not believe
the amended complaint states any meritorious claims and intends to defend this case vigorously.
On February 3, 2026 and March 25, 2026, stockholder derivative actions were filed against certain officers and directors of the
Company, with the Company named as a nominal defendant, in the United States District Court for the District of Maryland (captioned
De Albuquerque Torres v. Alexandria Real Estate Equities, Inc., et al.) and the United States District Court for the Central District of
California (captioned Tabone v. Moglia, et al.). The derivative complaints allege violations of federal securities laws and breaches of
fiduciary duty based on allegations similar to those in the securities class action and seek damages and other relief on behalf of the
Company. On April 8, 2026, the Maryland derivative action was stayed pending resolution of any motion to dismiss in the securities
class action. The Company does not believe the derivative complaints state any meritorious claims and intends to defend these cases
vigorously.
At this time, we cannot predict the outcome of these matters or reasonably estimate the amount or range of any possible loss,
if any, and therefore we have not recorded an accrual related to these
matters.
Option Parcel Development at Alexandria Center
®
for Life Science – New York City Campus
Refer to “Other” in Note 3 – “Investments in real estate” to our unaudited consolidated financial statements for information
regarding litigation involving our subsidiary in connection with an option and ground lease for a development parcel at the Alexandria
Center
®
for Life Science – New York City campus.
ITEM 1A. RISK FACTORS
In addition to the information set forth in this
quarterly report
on Form
10-Q
, one should also carefully review and consider the
information contained in the other reports and periodic filings that we make with the SEC, including, without limitation, the information
contained under the caption “Item 1A. Risk factors” in our annual report on Form 10-K for the year ended
December 31, 2025
. Those
risk factors could materially affect our business, financial condition, and results of operations. The risks that we describe in our public
filings are not the only risks that we face. Additional risks and uncertainties not currently known to us, or that we presently deem to be
immaterial, also may materially adversely affect our business, financial condition, and results of operations.
There have been no material changes in our risk factors from those disclosed under the caption “Item 1A. Risk factors” in our
annual report on Form 10-K for the year ended
December 31, 2025
.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Purchases
of equity securities
On
December 8, 2025
, we announced that our Board of Directors authorized a new share repurchase program that allows the
repurchase of shares with an aggregate value of up to
$500.0 million
through
December 31, 2026
in the open market, through privately
negotiated transactions, or otherwise, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the
Exchange Act. This new program replaced our prior stock repurchase program. As of the date of this report, no repurchases have been
made under the new program and
$500.0 million
remains available for future share repurchases.
ITEM 5. OTHER INFORMATION
Disclosure of 10b5-1 plans
During the
three months ended March 31, 2026
, none of our officers or directors adopted or terminated any contract,
instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of
Rule 10b5-1(c) or any “non-Rule 10b5-1
trading arrangement.
”
119
ITEM 6. EXHIBITS
Exhibit
Number
Exhibit Title
Incorporated by
Reference to:
Date Filed
3.1*
Articles of Amendment and Restatement of the Company, dated May 21, 1997
Form 10-Q
August 14, 1997
3.2*
Certificate of Correction of the Company, dated June 20, 1997
Form 10-Q
August 14, 1997
3.3*
Articles of Amendment of the Company, effective as of May 10, 2017
Form 8-K
May 12, 2017
3.4*
Articles of Amendment of the Company, effective as of May 18, 2022
Form 8-K
May 19, 2022
3.5*
Articles Supplementary, dated June 9, 1999, relating to the 9.50% Series A
Cumulative Redeemable Preferred Stock
Form 10-Q
August 13, 1999
3.6*
Articles Supplementary, dated February 10, 2000, relating to the election to be
subject to Subtitle 8 of Title 3 of the Maryland General Corporation Law
Form 8-K
February 10, 2000
3.7*
Articles Supplementary, dated February 10, 2000, relating to the Series A
Junior Participating Preferred Stock
Form 8-K
February 10, 2000
3.8*
Articles Supplementary, dated January 18, 2002, relating to the 9.10%
Series B Cumulative Redeemable Preferred Stock
Form 8-A
January 18, 2002
3.9*
Articles Supplementary, dated June 22, 2004, relating to the 8.375% Series C
Cumulative Redeemable Preferred Stock
Form 8-A
June 28, 2004
3.10*
Articles Supplementary, dated March 25, 2008, relating to the 7.00% Series D
Cumulative Convertible Preferred Stock
Form 8-K
March 25, 2008
3.11*
Articles Supplementary, dated March 12, 2012, relating to the 6.45% Series E
Cumulative Redeemable Preferred Stock
Form 8-K
March 14, 2012
3.12*
Articles Supplementary, effective as of May 10, 2017, relating to Reclassified
Preferred Stock
Form 8-K
May 12, 2017
3.13*
Articles Supplementary, effective as of March 31, 2026, relating to Subtitle 8 of
Title 3 of the Maryland General Corporation Law
Form 8-K
March 31, 2026
3.14*
Amended and Restated Bylaws of the Company (Amended December 6,
2024)
Form 8-K
December 9, 2024
4.1*
Indenture, dated as of February 13, 2025, among Alexandria Real Estate
Equities, Inc., as issuer, Alexandria Real Estate Equities, L.P., as Guarantor,
and U.S. Bank Trust Company, National Association, as Trustee
Form 8-K
February 13, 2025
4.2*
Supplemental Indenture No. 2, dated as of February 25, 2026, by and among
Alexandria Real Estate Equities, Inc., as Issuer, Alexandria Real Estate
Equities, L.P., as Guarantor, and U.S. Bank Trust Company, National
Association, as trustee
Form 8-K
February 25, 2026
4.3*
Form of 5.25% Senior Note due 2036 (included in Exhibit 4.2 above)
Form 8-K
February 25, 2026
22.1
List of Guarantor Subsidiaries of the Company
N/A
Filed herewith
31.1
Certification of Principal Executive Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
N/A
Filed herewith
31.2
Certification of Principal Executive Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
N/A
Filed herewith
31.3
Certification of Principal Financial Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
N/A
Filed herewith
32.0
Certification of Principal Executive Officers and Principal Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002
N/A
Filed herewith
101.1
The following materials from the Company’s quarterly report on Form 10-Q for
the quarterly period ended March 31, 2026, formatted in iXBRL (Inline
eXtensible Business Reporting Language): (i) Consolidated Balance Sheets
as of March 31, 2026 and December 31, 2025 (unaudited), (ii) Consolidated
Statements of Operations for the three months ended March 31, 2026 and
2025 (unaudited), (iii) Consolidated Statements of Comprehensive Income for
the three months ended March 31, 2026 and 2025 (unaudited), (iv)
Consolidated Statements of Changes in Stockholders’ Equity and
Noncontrolling Interests for the three months ended March 31, 2026 and 2025
(unaudited), (v) Consolidated Statements of Cash Flows for the three months
ended March 31, 2026 and 2025 (unaudited), and (vi) Notes to Consolidated
Financial Statements (unaudited)
N/A
Filed herewith
104
Cover Page Interactive Data File – the cover page from this Quarterly Report
on Form 10-Q for the quarter ended March 31, 2026 is formatted in Inline
XBRL and contained in Exhibit 101.1
N/A
Filed herewith
(*) Incorporated by reference.
(1) Management contract or compensatory arrangement.
120
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized, on
April 27, 2026
.
ALEXANDRIA REAL ESTATE EQUITIES, INC.
/s/ Joel S. Marcus
Joel S. Marcus
Executive Chairman
(Principal Executive Officer)
/s/ Peter M. Moglia
Peter M. Moglia
Chief Executive Officer and Chief Investment Officer
(Principal Executive Officer)
/s/ Marc E. Binda
Marc E. Binda
Chief Financial Officer and Treasurer
(Principal Financial Officer)